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SUMMARY 
 
Aloe-emodin (AE) is a major bioactive hydroxyanthraquinone in Rhubarb 
(Rheum palmatum), a well known Chinese herbal medicine. This compound is known 
to exhibit multiple pharmacological and anti-cancer effects, although the precise 
molecular mechanisms were not well studied. AE was shown to have higher 
cytotoxicity in cancer cells, compared to its analogue emodin (EM). However, several 
studies suggested that AE, unlike EM, is a poor kinase inhibitor. In order to have a 
better understanding of the target molecules and relevant molecular pathways of AE, a 
systemic study integrating functional proteomics and conventional biochemical 
approaches was thus conducted on the anti-cancer effect of AE. 
Our preliminary results showed that AE inhibited the growth of hepatoma cells in 
vitro. This action was cell line specific when compared to other non-tumorous cells. 
Furthermore, AE induced apoptosis and cell cycle arrest, which may account for its 
higher cytotoxicity compared to EM. Two-dimensional difference gel electrophoresis 
(2D-DIGE) proteomics analysis revealed that AE affected various proteins 
functionally associated with oxidative stress, cell cycle arrest, anti-metastasis and 
other anti-cancer activities. On the contrary, EM affected fewer proteins, consistent 
with its lower cytotoxicity. Further biochemical validation of the 2D-DIGE results 
revealed several novel anti-cancer functions of AE. 
Firstly, antioxidant peroxiredoxins were found to be highly up-regulated while 
blocking peroxiredoxins expression by small interfering RNA (siRNA) sensitized 
AE-induced apoptosis, suggesting AE induced reactive oxygen species 
   x
(ROS)-dependent apoptosis. It was further found that AE induced excessive ROS 
generation and depleted the intracellular reduced glutathione. AE treatment also led to 
sustained activation of c-Jun N-terminal kinase (JNK), an important stress-responsive 
mitogen activated protein kinase (MAPK). Over-expression of antioxidant gene sod1 
significantly reduced AE-induced JNK activation and cell death, suggesting that 
oxidative stress-mediated JNK is one of the effector molecules in AE-induced 
apoptosis. More importantly, JNK deactivation by treatment of JNK inhibitor, JNK 
siRNA knockdown or over-expression of dominant negative JNK protected 
AE-induced apoptosis. In addition, the results demonstrated the critical role of 
apoptosis signal-regulating kinase1 (ASK1), a well established MAPK kinase kinase, 
in AE-induced JNK activation and apoptotic cell death. Finally, dissociation of 
inactive JNK-GST-pi complex was also involved in JNK activation through GST-pi 
oxidation. Taken together, these results clearly demonstrated that AE-induced 
apoptosis is mediated via oxidative stress and sustained JNK activation.  
On the other hand, the 2D-DIGE result of the up-regulation of the tumor 
suppressor p16 was validated and confirmed to be responsible for AE-induced 
inhibition of DNA synthesis; while up-regulation of the metastasis suppressor, 
nucleoside diphosphate kinase A (NDKA), may account for AE-induced inhibition of 
cell migration/invasion.  
In summary, the present study, which integrates the functional proteomics and 
biochemical approach, provides a comprehensive understanding of AE-induced 
anti-cancer effect.  
   xi
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1.1   Aloe-emodin (AE) 
1.1.1 Introduction: rhubarb and AE 
Rhubarb root (also named as Da Huang in Chinese) is one of the earliest and 
best-known Chinese herbal medicines (Figure 1.1). The most commonly used species 
are Rheum palmatum, Rheum palmatum var. tanguticum and Rheum officinale of the 
Polygonaceae family. The first record of rhubarb can be traced back to Classic of the 
Materia Medica (Shen Nong Ben Cao Jing in Chinese) as early as 2500 years ago in 
China (Yang, 1997). In Traditional Chinese Medicine (TCM), rhubarb was ranked as a 
top medicinal herbal plant in Beng Cao Gang Mu (Li, 1982). Rhubarb was 
traditionally used for remedies of digestive system diseases, such as constipation (as a 
purgative agent), gastritis, enteritis, hepatitis, gastro-intestinal hemorrhage and ulcers. 
Currently, many of the Chinese herbal preparations also contain rhubarb.  
The major bioactive constituents in rhubarb are hydroxyanthraquinone derivatives, 
including aloe-emodin (AE, ~1.5% of chemical content), emodin (EM, ~2.6%), rhein 
(~1.9%), chrysophanol (~1.9%), physcion (~0.8%), and danthron (<0.2%), along with 
di-O, C-glucosides of the monomeric reduced forms (rheinosides A–D), and dimeric 
reduced forms (sennosides A–F) (Cai et al., 2004). Generally, rhubarb 
hydroxyanthraquinones are responsible for the main pharmacological effects of 
rhubarb. Chemical structures of the main rhuarb hydroxyanthraquinones are shown in 
Fig. 1.2. The presence and/or sites of the hydroxyl groups may be the main structural 
factors for the different biological activities of these hydroxyanthraquinone 
compounds.  
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AE and EM, two main rhubarb hydroxyanthraquinones, exhibit multiple 
biological functions in vitro and in vivo. Recently, both of them have aroused 
increasing research interests, due to their potent anti-cancer and pharmacological 
properties. It was found that both AE and EM can induce growth inhibition and 
apoptotic cell death either by itself or in combination with other cancer therapeutic 
agents in a variety of cancer cells (Huang et al., 2006a; Srinivas et al., 2006). 
Furthermore, a broader cancer-therapeutic value was credited to EM when EM was 
found to be effective in preventing cancer angiogenic and metastatic processes (Huang 
et al., 2004; , 2005; Huang et al., 2006b; Zhang et al., 1998). Current molecular 
mechanistic studies suggested that the anti-cancer potency of EM is attributed to its 
inhibitory effect on protein tyrosine kinases, and a number of other kinases (e.g. CK2, 
PKC, and PI3K) (Huang et al., 2006a). Compared to EM, the molecular mechanism of 
AE has been less understood. It was believed that AE may share the same or similar 
anti-cancer properties with EM, due to the similarity in chemical structure of AE (1, 
8-dihydroxy-3-hydroxylmethyl-anthraquinone) and EM (1, 3, 8-trihydroxy-6- 
methylanthraquinone, Fig. 1.2). Unexpectedly, some recent studies demonstrated that 
AE is a poorer kinase inhibitor against several pro-survival kinases than EM (Huang 
et al., 2006a; Sarno et al., 2002). These anti-cancer mechanisms of AE are still very 
much unknown.  
In the following sections, the metabolism, pharmacological and anti-cancer 
properties of AE, including the recent reports on its mechanistic actions will be 
reviewed.  
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Fig. 1.2 Major hydroxyanthraquinones of rhubarb 
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1.1.2 Source and metabolism of AE 
Aloe-emodin (AE) exists in many herbal plants besides rhubarb, e.g. Aloe Vera, 
Senna, etc (Thomson, 1971). Another important source for AE in vivo is the natural 
metabolic conversion from other anthraquinone derivatives (e.g. sennoside C, 
barbaloin, and chrysophanol). Sennoside C, the dimeric reduced forms of 
hydroxyanthraquinone, can be transformed by the action of intraluminal bacteria in 
mice into an active metabolite, aloe-emodin anthrone, which can subsequently be 
further auto-oxidized to AE (Yamauchi et al., 1992). Similarly, barbaloin, the 
glycosidic derivative precursor of AE, can be converted by human intestinal bacterial 
(Eubacterium sp. strain BAR) into purgative aloe-emodin anthrone (Akao et al., 1996). 
Besides, hydroxyanthraquinone chrysophanol can also be transformed to AE in a 
cytochrome P450-dependent oxidation manner (Mueller et al., 1998).  
Absorption, excretion, tissue distribution and metabolism of AE have been 
studied after a single oral administration of [14C] AE (4.5 mg/kg) to both male and 
female rats (Lang, 1993). The maximum plasma concentration of AE reached after 
1.5-3 hr of treatment was 248 ng/ml (male rat) and 441 ng/ml (female rat) equivalents. 
The terminal half-life (for radioactivity) in blood was about 50 hr. Most of AE in rat 
plasma was found to be presented in a conjugated form, while 10% 14C-activity in 
plasma was identified as free AE. Higher concentrations of AE were found to 
accumulate in liver, kidney and intestinal tract but its concentration were lower in 
ovaries and testes. 20-30% of the administrated dose was excreted in urine and the rest 
in feces. A similar study was carried in which a 25 mg single dose of AE was 
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administrated orally to albino rats of 120-150 g in weight (Maity et al., 2001). About 
15.4% of the administered AE was excreted while the rest was probably bound to 
serum proteins or metabolized in the rat.   
1.1.3 Pharmacological properties of AE 
Rhubarb has been used in TCM for thousands of years. Although accumulating 
data have shown that AE is potent in purgative, hepatoprotective and anti-microbial 
effects, it is still, however, far from being able to explain the multi-functional effects of 
AE.  
1.1.3.1 Purgative activities 
AE itself may not act directly as a purgative. It has been reported that intracaecal 
administration of AE (ED50 246.3 μM/kg) and other anthraquinones (EM and 
chrysophanol) are less potent than rhein anthrone (ED50 11.4 μM/kg) (Yagi and 
Yamauchi, 1999). Instead, the observed purgative effect of AE is probably executed 
through its precursor, aloe-emodin anthrone. Aloe-emodin anthrone, as an active 
metabolite transformed from sennoside C or barbaloin, can act independently or 
synergistically with rhein anthrone to exert purgative effects in vivo (Akao et al., 1996; 
Yamauchi et al., 1992).  
1.1.3.2 Hepatoprotective effect 
Studies have revealed that AE is capable of preventing induced hepatic damage 
and/or fibrosis. AE protected liver from carbon tetrachloride (CCl4) induced hepatic 
damage. This protective action was reported to be associated with its antioxidant 
property by decreasing CCl4-induced radical production and lipid peroxidation (Arosio 
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et al., 2000). AE may also inhibit hepatic fibrosis, as indicated by the finding that AE 
decreased PDGF-stimulated rat hepatic stellate cell activation and proliferation, a key 
process in the pathogenesis of hepatic fibrosis (Woo et al., 2002).   
1.1.3.3 Anti-fungal, anti-protozoal and anti-bacterial effects  
Similar to other hydroxyanthraquinones, AE has strong anti-fungal, and 
anti-bacterial properties. It has been reported that AE showed selective fungicidal 
activities against B. cinerea and R. solani, C. albicans and T. mentagrophytes, but did 
not inhibited the growth of E. graminis, P. infestans, P. recondita, Py. Grisea, Cry. 
Neoformans, and S. schenckii (Agarwal et al., 2000; Kim et al., 2004). Besides, AE 
treatment inhibit growth of protozean T. b. brucei (Camacho et al., 2000) and 
methicillin-resistant bacterial Staphylococcus aureus (Hatano et al., 1999).  
On the other hand, the antibacterial effect of AE and its glycoside precursor 
barbaloin was compared and the result showed a stronger inhibitory effect of barbaloin 
against E. coli. It was suggested that the glycoside side chain may help barbaloin invade 
E. coli cells and enhance its cytotoxicity (Tian et al., 2003). Moreover, it has been 
recently reported that AE could inhibit 3C-like protease (3CLpro) of coronavirus in 
severe acute respiratory syndrome (SARS), which was found to be an important target 
for SARS therapy (Lin et al., 2005a). It may credit AE and other 
hydroxyanthraquinones as promising therapeutic agents in the treatment of SARS.  
1.1.3.4 Other pharmacological effects 
It was of great interest that AE may cause dose-dependent falls in mean arterial 
blood pressure in rats (Saleem et al., 2001). This finding suggested that AE may work 
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as a potent hypotensive agent. On the other hand, another study (Yin and Xu, 1998) 
pointed out that AE may inhibit the proliferation of smooth muscle cells after arterial 
injury by decreasing protein and mRNA level of proliferating cell nuclear antigen. 
These two studies may indicate AE’s potential protective role in the cardiovascular 
system, although more in-depth work is needed.  
Similar to its analogue EM and the rhubarb extract, AE has been found to inhibit 
the formation of advanced glycation end products, that play a key etiologic role in the 
development of diabetic nephropathy (Nakagawa et al., 2005). This finding may help 
to understand the clinical efficacy of rhubarb against renal failure.  
1.1.4 Anti-cancer potential of AE 
Besides its multiple pharmacological effects, AE has also attracted increasing 
research interests in its anti-cancer properties. These studies aimed to unravel both the 
potent activities of AE in cancer-prevention and cancer-therapy, and its mechanism 
actions. In the following sections, these findings will be summarized accordingly.  
1.1.4.1 Anti-mutagenic and anti-carcinogenic effects 
Among all hydroxyanthraquinones, only danthron was found to be capable of 
initiating cancer in animal models (Mori et al., 1986). Whether AE initiates or prevents 
cancer is still debatable. Earlier studies had focused on the mutagenicity of AE. It had 
been reported that AE exhibited mutagenic activities in a battery of in vitro mutagenesis 
assays (e.g. bacterial cultures (Salmonella typhimurium assay) and mammalian cell 
cultures (chromosome aberration test in Chinese hamster ovary cells)). Contradictory 
non-mutagenic results, however, were found in other in vitro assays (mammalian cell 
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HGPRT test) and all in vivo assays (bone marrow assay (micronucleus test; 
chromosome aberration test), mouse spot test in melanoblast cells and unscheduled 
DNA synthesis test in male Wistar rats and NMRI mice) (Heidemann et al., 1993; 
Heidemann et al., 1996; Westendorf et al., 1990). Therefore based on these findings, 
Heidemann et al concluded that it is unlikely for AE to be mutagenic and genotoxic in 
vivo (Heidemann et al., 1996). Moreover, no rodent study has yet been reported to 
suggest that AE exhibited carcinogenic or tumor promoting property (Siegers et al., 
1993). It was believed that hydorxyanthraquinones including AE do not represent a 
genotoxic risk, if the estimated daily intake, concentration of hydroxyanthraquinones 
and the genotoxic potency, as well as protective effects of the food matrix in a balanced 
human diet were taken into consideration (Mueller et al., 1999). 
Besides the anti-mutagenesis effect, AE was found to be effective in inhibiting 
DNA adduct formation by decreasing N-acetyltransferases (NATs) expression level and 
activity in mice leukemia cells (Chung et al., 2003) and human malignant melanoma 
cells (Lin et al., 2005b). NATs are involved in the metabolic transformation of 
arylamine chemicals into carcinogenic intermediate metabolite and promoting the latter 
to induce DNA adducts formation and finally carcinogenesis. This action by AE was 
proposed to be cancer-preventive.  
On the contrary, carcinogenic concern arose when Strickland and his colleagues  
reported that topical administration of AE in ethanol vehicle could switch ultraviolet- 
induced skin tumor to malignant melanoma in C3H/HeN mice, although in the absence 
of ultraviolet stimulation neither AE nor ethanol alone induced skin tumors (Strickland 
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et al., 2000). The same group (Badgwell et al., 2004) later reported found that topical 
co-administration of AE and ethanol in the presence of ultraviolet exposure in mice may 
induce p53 mutation, which is in a similar spectrum to human p53 mutation. The 
precise molecular mechanism for that induced phototoxicity is still unknown. Besides, 
no epidemiological or case report could be found linking the usage of AE or rhubarb 
extract with skin cancer up to now. On the other hand, under some circumstances, the 
phototoxic effects of AE and other hydroxylanthraquinones can be beneficial. For 
example, some bis(ainoalkyl)-anthraquinones are photosensitizer agents and used in the 
medical treatment known as photodynamic therapy (Cardenas et al., 2006).  
Taken together, AE may not be carcinogenic and/or mutagenic by itself in vivo. 
Furthermore, AE may even exhibit cancer-preventive properties by inhibiting NATs 
activation. But topical administration of AE together with ethanol may pose a 
carcinogenic risk under stimulation of ultraviolet exposure, although no 
epidemiological report has ever been conducted on this important issue. 
1.1.4.2 Inhibition of tumor cell growth and induction of cell cycle arrest 
A number of in vitro studies have shown that AE exhibited high cytotoxicity 
against a variety of tumor cells, including human neuroectodermal tumor (Pecere et al., 
2000; Pecere et al., 2003), lung carcinoma (Lee et al., 2001), oral squamous cell 
carcinoma (Shi et al., 2001), merkel carcinoma (Wasserman et al., 2002), hepatoma 
(Shi et al., 2001), leukemia (Chen et al., 2004a), glioma (Mijatovic et al., 2005a) and 
mouse L929 fibrosarcoma and rat astrocytoma cells (Mijatovic et al., 2005a). More 
importantly, this cytotoxic effect of AE was cell line specific when compared with 
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non-carcinogenic normal human gingival fibroblasts (HGF) (Shi et al., 2001), human 
lung fibroblast (MRC5) cells and hemopoietic progenitor cells (Pecere et al., 2000), rat 
primary astrocytes and fibroblasts (Mijatovic et al., 2004). It is also noteworthy to 
mention that this specific cytotoxicity against cancer cells was not found in barbaloin, a 
glycosidic derivative of AE (Fenig et al., 2004; Pecere et al., 2000; Wasserman et al., 
2002). The glycoside side chain in barbaloin may inhibit drug incorporation through 
cell membrane in mammalian cells, but promote the incorporation in E. coli (Tian et al., 
2003). Moreover, AE showed a high specificity for neuroectodermal tumor cells 
(Pecere et al., 2000; Pecere et al., 2003). According to Pecere and colleagues’ report, 
specific energy-dependent drug incorporation of AE may account for the greater 
sensitivity of neuroectodermal tumor cells than normal human cells and other malignant 
cells (Pecere et al., 2000). In the neuroectrodermal cells, after treatment with 5 μM AE 
for 45 min, the drug’s intracellular concentration could reach to 2.5 mM (500 times).  
Regulated cellular proliferation is essential for mammalian cell homeostasis. 
Instead, deregulated cell proliferation is a hallmark of cancer. Thus, one of the 
important approaches for cancer therapy is to re-regulate cell cycle progression. This 
regulation is mostly played via checkpoint proteins that control normal cell cycle 
progression. The effect of AE on G2/M cell cycle had been demonstrated in a number of 
cancer cells, including hepatoma (Kuo et al., 2002; Shieh et al., 2004), leukemia (Chen 
et al., 2004a) and neuroectodermal cells(Pecere et al., 2003). Similarly, G1/S cell cycle 
arrest was also found in human colon carcinoma (Schorkhuber et al., 1998), hepatoma 
(Kuo et al., 2004; Kuo et al., 2002), lung carcinoma (Yeh et al., 2003), glioma 
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(Acevedo-Duncan et al., 2004; Mijatovic et al., 2005a) and leukemia cells (Chen et al., 
2004a). However, lower dose (less than 10 μM) of AE may increase DNA synthesis, 
which was suggested as a cellular response for AE’s cytotoxicity (Wolfle et al., 1990).  
Some studies suggested that p53 and p21 pathways may be involved in the cell 
cycle arrest induced by AE (Kuo et al., 2002; Pecere et al., 2003). These studies, 
however, mainly focused on the apoptotic role of p53 and p21 (discussed below). The 
exact molecular mechanism for AE-induced cell cycle arrest is still unclear.  
1.1.4.3 Induction of cell death in cancer cells 
The process of apoptosis (also named as programmed cell death) is fundamental in 
the developmental and homeostatic maintenance of complex biological systems. 
Deregulation of normal apoptotic mechanisms may contribute to cell malignant 
transformation and provide a growth advantage to cancer cells against surrounding 
normal cells (Evan and Vousden, 2001). Apoptosis is morphologically characterized by 
cell shrinkage, chromatin condensation, DNA fragmentation and enzymatic activation 
of specific cysteine proteases known as caspases. Two pathways converge on the key 
apoptosis executor caspase-3: one involving extrinsic cell death receptor activation and 
caspase-8 activation, and the other involving intrinsic mitochondrial disruption and 
activation of caspase-9 (Fischer and Schulze-Osthoff, 2005). 
Pecere and colleagues firstly reported that AE induced DNA fragmentation (one of 
the biomarkers of apoptosis) at 48 hours after G2/M arrest in neuroectodermal tumor 
cells (Pecere et al., 2000). It was also found that AE could induce apoptosis in many 
other cancer cells derived from human lung carcinoma (Lee, 2001; Lee et al., 2001), 
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hepatoma (Kuo et al., 2002), leukemia (Chen et al., 2004a) and bladder carcinoma (Lin 
et al., 2006). Moreover, the induction of apoptosis by AE was found to be irreversible, 
as evidenced by the finding that replacement of fresh drug-free medium after 4 hr 
treatment of AE cannot decrease the induced apoptosis level (Lee et al., 2001).  
Furthermore, several groups have investigated whether AE initiates apoptosis from 
mitochondria-involved intrinsic or death receptor-involved extrinsic apoptotic 
pathways or both. In neuroblastoma cells, the intrinsic mitochondrial-mediated but not 
extrinsic death receptor-mediated apoptotic pathway activation was found to be 
involved in AE-induced apoptosis (Pecere et al., 2003). Similarly in transformed rat 
hepatic stellate cells, AE treatment also failed to activate caspase-8, the key caspase in 
extrinsic apoptotic pathway (Lian et al., 2005). Although in lung carcinoma CH27 cells 
the activation of caspase-3, -8, and -9 were all found in AE-induced apoptosis, 
caspase-8 activation occurred later than that of caspase-3 and -9 (Lee et al., 2001). 
Therefore, all the above results indicate that mitochondria-involved intrinsic apoptotic 
pathway played a more important role in apoptosis induced by AE.  
To further explore the intrinsic mitochondria–mediated apoptotic pathway induced 
by AE, several groups examined the role of Bcl-2 family members. The Bcl-2 family 
proteins consist of both antiapoptotic (Bcl-2, Bcl-XL) and proapoptotic (Bax, Bak) 
proteins and they are well-characterized regulators of apoptosis, especially the intrinsic 
apoptotic pathway (Cory and Adams, 2002). The antiapoptotic Bcl-2 members (Bcl-2, 
Bcl-XL) was found to be down-regulated upon AE treatment on CH27 (Lee et al., 2001) 
and H460 cells (Yeh et al., 2003). In contrast, proapoptotic members (Bax and Bak) 
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were found to be up-regulated in hepatoma cells (Kuo et al., 2002). Moreover, 
translocation of Bax and Bak from cytosol to mitochondria is an important event to 
initiate mitochondria-mediated apoptosis. CH27 cells exhibited such translocation of 
Bax and Bak upon treatment of AE (Lee et al., 2001). 
In addition to the caspase-dependent apoptosis, AE was once reported to induce 
autophagy (caspase-independent type II programmed cell death) in glioma cells 
(Mijatovic et al., 2005a). But this finding was made based on two indirect evidence. 
One was the formation of acidic vesicle (possible indication for autophagic vacuole). 
And the other was that pan-caspase inhibitor z-VAD-FMK could not protect 
AE-induced growth inhibition as detected by the MTT assay. However, the second 
observation could not exclude possible involvement of cell cycle arrest and/or 
senescence because both of them were AE-inducible and capable of decreasing cell 
proliferation. Moreover, whether the formation of acidic vesicle played a role in 
survival or cell death was still unknown. Thus, more direct experiments are needed to 
establish the role of autophagy (e.g. knocking-down the key executor atg-5 in 
autophagy (Kroemer and Jaattela, 2005)) induced by AE treatment.  
1.1.4.4 Sensitization effect 
Acquired chemoresistance (or relapse from cancer therapy) is a significant 
impediment for effective chemotherapy for various tumors. Different combinations of 
chemotherapeutic drugs may offer great potential for improving anti-cancer responses 
and decreasing off-target side effects in various carcinomas (Nakanishi and Toi, 2005).  
AE has been reported to potentiate the cytotoxic effect of some common 
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chemotherapeutic agents (cisplatin, doxorubicin, and 5-fluoroucil) in Merkel 
carcinoma cells (Fenig et al., 2004). However, the exact mechanism for the synergistic 
effect is less studied. Furthermore, AE can sensitize apoptosis in this cell line when 
co-treated with a tyrosine kinase inhibitor ST1 571 (Fenig et al., 2004). As mentioned 
above, AE coexists with EM in rhubarb and EM is commonly used as a tyrosine 
kinase inhibitor (Huang et al., 2006a). One interesting question to be raised is whether 
these two compounds have some synergistic effects on cell death, although no relevant 
studies had been conducted. In addition, AE as well as EM and rhubarb extract, have 
been reported to sensitize tumor cells to arsenic trioxide-induced apoptosis (Yang et 
al., 2004) and this action was attributed to their potential in inducing oxidative stress.  
On the contrary, controversies arose as there were two reports indicated that AE 
could protect some tumor cells from cell growth inhibition induced by other 
chemotherapeutic agents. Mijatovic et al reported that AE decreased the cytotoxicity 
induced by interferon-γ (INF-γ) and interleukin-1 (IL-1) in mouse fibrosarcoma cells 
(L929), although AE itself can inhibit L929 cell growth (Mijatovic et al., 2004). This 
protective action was linked to the antioxidant property of AE in decreasing 
transcription of inducible nitric oxide synthase (iNOS) and inhibiting production of 
nitric oxide (NO). But AE, being not a direct NO-scavenger, failed to protect SIN-1 
(nitric oxygen donor) induced cytotoxicity. Paradoxically this combined effect was 
only found in L929 cells but not rat C6 astrocytoma cells (Mijatovic et al., 2004). 
Whether this effect would occur in vivo is yet to be confirmed. On the other hand, as 
the authors mentioned in their report, this anti-NO effects by AE may be beneficial 
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under certain circumstances (e.g. treatment of NO-resistant tumors or protection of 
deleterious NO release). Another study done by the same group (Mijatovic et al., 
2005b) showed that AE can reduce slightly the cytotoxicity of cisplatin in L929 and 
C6 cells. The deactivation of ERK kinase by AE was proposed to play a protective 
role in that reaction. Paradoxically the same authors reported that ERK inhibition was 
a key process leading to apoptosis in AE-treated C6 cells (Mijatovic et al., 2005a). 
Since ERK convey both cell death and cell survival signals, AE’s role in tumor cell 
may depend on cell type and treatment.  
1.1.4.5 in vivo anti-cancer effect   
Only a few studies on the in vivo anti-neoplastic effect of AE have been reported. 
Kupchan and his co-workers found that AE exhibited tumor-inhibitory activity in mice 
against P-388 lymphocytic leukemia (Kupchan, 1976; Kupchan and Karim, 1976). 
However, the authors stated that this anti-leukemic activity was observed only when 
AE was administered as a suspension in acetone-Tween 80. In addition, Pecere et al. 
reported that treatment of 50 mg/kg/day AE significantly reduced xenograft 
neuroectodermal tumor (IMR5) growth without any acute or chronic toxic effects 
(Pecere et al., 2000). Under the same condition, AE failed to inhibit the growth of 
human colon carcinoma cells, LoVo109, thus suggesting that the anti-neoplastic effect 
of AE was highly specific to neuroectodermal tumors cells. 
1.1.5 Molecular mechanism of anti-cancer action of AE 
There are only a few studies examining the molecular mechanism of anti-cancer 
action of AE, as compared to its analogue, EM. It is believed that AE might share the 
   17
same or similar molecular pathways with EM. This conclusion might be right if we 
considered only their shared pathway in the induction of p53 and oxidative stress. 
However, the anti-cancer potency of EM was at least partially attributed to its 
inhibition on prosurvival protein tyrosine kinases, and a number of other kinases (e.g. 
CK2, PKC, and PI3K) (Huang et al., 2006a). In fact, AE, by comparison, was found to 
be a poor kinase inhibitor in many studies. Thus it might be of great interest to examine 
how AE, a poorer kinase inhibitor, is able to exhibit similar or higher cytotoxicity as 
EM (Fenig et al., 2004; Lee, 2001; Shi et al., 2001). In the next three subsections, these 
three aspects: p53 pathway, oxidative stress, and kinase inhibition, will be discussed in 
detail. In addition, some of the AE-affected molecular mechanisms will be discussed in 
comparison with EM.  
1.1.5.1 Tumor suppressor gene p53 
Tumor suppressor gene p53 is an important “gatekeeper” molecule in the process of 
cancer development (Sherr, 2004). It regulates cancer cell death and cell cycle arrest 
pathways. Many tumor cells evade apoptosis and cell cycle arrest via mutation of p53. 
In response to stress stimuli (such as DNA damage), p53 is stabilized and translocated 
to the nucleus and then transactivates many target genes (e.g. p21, Bax, CD95). In 
certain cells, activation of p53 leads to apoptosis and activation of another tumor 
suppressor gene p21, which contributes to cell cycle arrest in G1 phase by inhibiting 
cyclin-CDK complex. One of the important chemotherapeutic strategies is thus to 
restore the p53 expression and function.  
Cells with wild-type and deficient/mutant p53 have been used to study the function 
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of p53 in AE-induced anti-cancer effects. Kuo and his colleagues reported that AE can 
induce apoptosis in both HepG2 (wild-type p53) and Hep3B cells (deficient p53) (Kuo 
et al., 2002). In HepG2 cells (cytotoxic IC50: 41 μM) induction of apoptosis and G1/S 
arrest was accompanied with up-regulation of p53 and p21. Although p53-deficient 
Hep3B cells were more resistant to AE (cytotoxic IC50: 56 μM), the p53-independent 
transcription of p21 and up-regulation of Bax were suggested to be responsible for 
AE-induced apoptosis (Kuo et al., 2002). Another report by Pecere et al. convincingly 
revealed that p53 conveyed the sensitivity of neuroblastoma cells to AE (Pecere et al., 
2003). In their study, neuroblastoma SJ-N-KP cells (wild-type p53, IC50: 4.2 μM) were 
seven-fold more sensitive than SK-N-BE(2c) cells (deficient in p53 nuclear 
transcriptional activity, IC50: 29.1 μM) to AE treatment, although similar amount of 
drug was uptaken by these two different types of neuroblastoma cells. p53 wild type 
SJ-N-KP cell underwent p53 transcriptional-dependent apoptosis, while p53 mutant 
SK-N-BE(2c) cells succumbed to p53 transcription-independent apoptosis via 
translocation of p53 to mitochondria (Pecere et al., 2003). Taken together, these two 
studies suggested that p53 is a key protein governing the cell sensitivity to AE. In cells 
with deficient or mutated p53, other pathways (e.g. p21 and mitochondria-mediated cell 
death) may be responsible for AE-induced apoptosis, although the precise mechanisms 
are yet to be determined.  
Similarly, EM has been shown to induce the accumulation of p53 in HepG2 cells 
with the resultant increase in p21 expression and subsequent cell cycle arrest (Shieh et 
al., 2004). The underlying mechanism on how EM increases p53 level is still under 
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investigation. One hypothesis suggested this action was attributed to the inhibitory 
effect of EM on kinase CK2 (Uhle et al., 2003). Deactivation of CK2 by EM may block 
CK2-directed phosphorylation and subsequent ubiquitin-mediated degradation of p53, 
and thus lead to p53 accumulation. Unfortunately, AE may not follow the same pathway 
because AE was found to be a poor inhibitor of kinase CK2 (discussed below).  
1.1.5.2 Oxidative stress 
Sustained oxidative stresses are maintained in cancer cells (Toyokuni et al., 1995). 
This high but tolerable production of reactive oxygen species (ROS) may help cancer 
cells survive and proliferate through activating redox-sensitive transcription factors and 
responsive genes (e.g. NF-kB and AP1). However, when intolerable level of ROS 
production (e.g. induced by therapeutic agents) reaches a certain threshold, such as 
irreversible DNA damage, cell may switch to senescence or apoptotic cell death (Buttke 
and Sandstrom, 1995). Through manipulation of the redox balance, some 
phytochemicals, such as hydroxyanthraquinones from rhubarb (Huang et al., 2006a), 
and polyphenols from grapes (Delmas et al., 2003) seem to be good candidates for a 
direct or combined application in cancer chemotherapeutics and/or chemoprevention.  
AE was found to be effective in preventing induced oxidative stress in vitro, such as 
peroxidation of linoleic acid catalyzed by soybean 15-lipoxygenase (Malterud et al., 
1993), and oxidative modification of low-density lipoprotein formed with 
2,2’-azobis(4-methoxy-2,4-dimethylvaleronitrile) (Iizuka et al., 2004). Moreover, it 
could also inhibit IFN-γ- and IL-1-stimulated NO production and apoptosis (Mijatovic 
et al., 2004). This inhibitory action on NO production was found to be a consequence of 
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a suppressed expression of iNOS gene, but not the direct interference of NO or iNOS 
enzyme activity (Mijatovic et al., 2004). In addition, the in vivo hepatoprotective effect 
of AE against carbon tetrachloride (CCl4) was also proposed to be correlated with its 
antioxidant properties, because AE decreased CCl4-induced lipid peroxidation and liver 
damage (Arosio et al., 2000).  
However, similar to other so-called “antioxidant” hydroxyanthraquinones, AE may 
also induce oxidative stress in cells. In human lung carcinoma H460 cells, AE induced 
DNA single strand damage through generation of reactive oxygen species (Lee et al., 
2006a). Similarly, its analogue, EM has been reported to induce excessive ROS 
generation and ROS-dependent cell death (Jing et al., 2002; Su et al., 2005; Yi et al., 
2004), although one report suggested that in leukemia HL60 cells, the antioxidant NAC, 
catalase, and SOD failed to protect EM-induced apoptosis (Chen et al., 2002). 
Furthermore, it has been found that AE also induced phototoxicity via oxidative stress. 
Thus AE could efficiently generate single oxygen when irradiated with ultraviolet light 
and lead to decreased cell survival (Vath et al., 2002). In addition, Vargas et al. also 
showed that AE and other two anthraquinones (EM and rhein) were photolabile when 
stimulated with visible light under aerobic conditions. Indeed, many other 
phytochemicals, such as curcumin (Atsumi et al., 2007), were found to exhibit similar 
phototoxic actions. This photoexcitabe property of AE was suggested to be beneficial as 
a potential candidate drug in photodynamic therapy (Cardenas et al., 2006), although 
more research work needs to be conducted.  
Collectively, AE may exhibit a dual-role in radical species production and 
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subsequent oxidative stress. On the one hand, its phenolic structure enables AE to 
counteract the harmful oxidative injury induced by other strong oxidants; whilst on the 
other; therapeutic dose of AE can selectively induce oxidative stress in cancer cells. The 
option to be an antioxidant or oxidant for AE thus depends on the basal cellular 
oxidant/antioxidant level, the dose of AE, and other crucial factors.  
1.1.5.3 Modulation of kinase activity  
Compared to EM, AE has been less reported as a kinase inhibitor. In this section, 
some protein tyrosine kinases and other Ser/Thr kinase pathways (e.g. PKC, MAPK) 
reported to be affected by AE will be discussed in detail in parallel with EM. 
1.1.5.3.1 Direct inhibition of kinase activity 
AE is a poor kinase inhibitor when compared with its analogue EM. The inhibitory 
effect of EM against several prosurvival protein kinases (e.g. protein tyrosine kinase, 
HER2/neu, CK2, PI3K) was well-established (Battistutta et al., 2000; Frew et al., 1994; 
Jayasuriya et al., 1992; Zhang et al., 1995; Zhou et al., 2006). On the contrary, AE is 
less studied with respect to the direct inhibition of kinase activity. The inhibitory IC50 of 
AE against many kinases (e.g. IC50 of 28 μM for CK2) was much higher than that of EM 
(IC50 of 2.0 μM for CK2) (Sarno et al., 2002), suggesting that the inhibitory effect of AE 
on cell proliferation is unlikely to act through the inhibition of certain kinases. Instead, 
short-term treatment of AE (20 μM) has been reported to increase protein tyrosine 
phosphorylation in SW480 colon carcinoma cells and VACO235 adenoma cells 
(Schorkhuber et al., 1998). Moreover, a recent paper revealed that unlike inactive EM, 
aloe-emodin-8-O-β–D-glucopyranoside (IC50: 26.6 μM), together with rhein-8-O-β-D- 
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glucopyranoside and chrysophanol were mild inhibitors against protein tyrosine 
phosphatase 1B (hPTP1B) in vitro (Li et al., 2006), although the precise mechanisms 
have not been well elucidated. Therefore, AE may be less potent than EM in terms of 
kinase inhibition.  
1.1.5.3.2 Protein kinase C (PKC) 
Protein kinase C (PKC) is a family of serine/threonine kinases that have important 
roles in cell-cycle regulation, apoptosis and malignant transformation (Griner and 
Kazanietz, 2007). There are almost 11 PKC genes. Among them, PKC α, δ and ε are 
widely expressed in mammalian cells but the other PKC members are largely cell-type 
specific. Of particular interest, PKC ε has been shown to be up-regulated, while PKC α 
and δ are down-regulated in various types of cancers (Griner and Kazanietz, 2007). The 
effects of distinct PKCs are still unclear and some of them even have opposing effects. 
For example, active cleavage of PKC δ by caspase-3 has been reported to be important 
for caspase-3 activation (Emoto et al., 1995) whereas PKC ε is mainly involved in cell 
survival, chemotherapeutic resistance and invasive metastasis (Cacace et al., 1996; Pan 
et al., 2006; Tachado et al., 2002). 
Similar to EM, AE decreased protein expression of PKC δ and ε in lung carcinoma 
CH27 (Lee, 2001) and H460 cells (Yeh et al., 2003). Surprisingly, unlike EM, AE 
treatment increased the total PKC kinase activity instead of decreasing it (Lee, 2001) 
and PKC inhibitor (forskolin) failed to protect AE-induced apoptosis (Yeh et al., 2003). 
Moreover, caspase-3 inhibitor could prevent caspase-3-dependent cleavage of PKC δ in 
EM-treated cells, but not in AE-treated cells (Lee, 2001), suggesting that other 
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caspase-3-independent mechanisms may be responsible for the decreased expression of 
PKC δ by AE treatment. The involvement of PKC after AE treatment was determined in 
glioma cells by another lab (Acevedo-Duncan et al., 2004). Down-regulation of most 
PKC isozymes (except anti-apoptotic PKC ι), together with inhibition of PKC activity 
were executed by AE. Therefore, AE may promote apoptosis through modulation of 
PKC activities, most probably via the down-regulation of PKC δ and ε.  
1.1.5.3.3 Mitogen-activated protein kinases (MAPK) 
Another Ser/Thr kinases mitogen-activated protein kinases (MAPK) play a central 
role in regulating cell proliferation, apoptosis and migration (Chen et al., 2001; Reddy 
et al., 2003). The MAPK members consist of three major classes: the c-jun N-terminal 
kinases (JNKs), the extracellular signal regulated proteins kinase (ERKs) and p38. They 
are well-established redox-sensitive pathways (discussed below in Section 2.6.2). 
Both AE and EM could disrupt ERK activation/phosphorylation. AE treatment 
inhibited ERK activation and subsequently induced cell differentiation and cell death in 
rat C6 glioma cells (Mijatovic et al., 2005a). This ERK deactivation by AE was then 
found to be associated with cell differentiation but not cell death, because treatment of 
PD98059 (ERK upstream kinase MEK inhibitor) could mimic AE-induced cytotoxicity 
and differentiation effects but not apoptosis. Moreover, inhibition of ERK by AE was 
further found to decrease cisplatin-induced cytotoxicity in C6 cells (Mijatovic et al., 
2005b). Thus, the involvement of ERK pathway on AE’s cytotoxicity may depend on 
cell type and treatment dose, due to the complicated ERK involvement in both apoptotic 
and survival pathway. On the other hand, several studies revealed that EM may not be a 
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direct kinase inhibitor of ERK and its inhibition is stimulator-dependent. EM could 
inhibit EGF-, TNF-α- IGF- or TPA-stimulated ERK activation/phosphorylation (Huang 
et al., 2004; Kwak et al., 2006; Lee et al., 2006b; Zhou et al., 2006), but not 
PDGF-stimulated ERK activation (Zhou et al., 2006). 
Compared to ERK, proapoptotic p38 and JNK pathways are less studied in 
AE-treated cells. It has been reported that exposure of lung carcinoma H460 cells to 40 
μM AE resulted in the degradation of p38 (Yeh et al., 2003). Unexpectedly, 
pretreatment of p38 inhibitor (SB202190) prevented AE-induced p38 degradation and 
apoptosis, suggesting a proapoptotic role of p38 in AE-induced apoptosis (Yeh et al., 
2003). And in this study JNK pathway was unaffected by AE. However, the action by 
EM on p38 pathway is somewhat dissimilar to AE. EM alone has been found to be 
incapable of affecting p38 activation (Kaneshiro et al., 2006; Su et al., 2005). But EM 
may inhibit EGF- or streptozotocin-stimulated p38 activation (Kwak et al., 2006; Wang 
et al., 2006a). Similarly, EM can inhibit TPA- or TNF-α-stimulated JNK activation 
(Huang et al., 2004; Lee et al., 2006b), although JNK activation was found to be 
induced in EM and rhein-treated cells (Lin et al., 2003; Olsen et al., 2007).  
1.1.5.4 Inhibition of other non-kinase biomolecules 
Biomolecules other than kinases may also be targeted by AE. AE and other 
anthraquinones may interact with DNA (Pecere et al., 2003). This property prompted 
researchers to investigate whether AE, like anthracycline drugs, inhibit topoisomerase 
II activity. It was because these widely-used anti-cancer anthracycline drugs are derived 
from the anthraquinone structure and capable of inhibiting topoisomerase II catalytic 
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functions by intercalating themselves into the DNA structure and interacting with 
topoisomerase II (Froelich-Ammon and Osheroff, 1995). Topo II inhibition may in turn 
promote DNA cleavage by inhibiting the DNA resealing reaction after double nucleic 
acid cleavage. However, AE, unlike EM, showed poor inhibition on topoisomerase II 
activity (IC50 of 741 μM for AE vs.7 μM for EM respectively) in a cell-free 
decatenation assay (Mueller and Stopper, 1999). Furthermore, AE was found to inhibit 
but not stimulate double-stranded DNA breaks formation (Pecere et al., 2003).  
Nuclear factor kappaB (NF-κB) is a ubiquitous transcription factor that conveys 
inflammatory, anti-apoptotic and prosurvival signals (Hoffmann et al., 2006; Karin, 
2006). This transcription factor is constitutively activated in tumor cells and is subject 
to be further activated upon stress. There are less studies on AE’s effect on activation of 
NF-κB. Mijatovic and colleagues reported that AE could not affect INF-γ and 
IL-1-induced IκBα phosphorylation (key factor for NF-κB activation) at any treatment 
time point in mouse fibrosarcoma L929 and rat astrocytoma C6 cells (Mijatovic et al., 
2004), although the possibilities that AE might interfere downstream of NF-κB 
activation can not be excluded in that paper. On the contrary, EM has been shown to 
inhibit TNF-α- and TPA-stimulated NF-κB activation (Huang et al., 2004; Kumar et al., 
1998). The stabilization of inhibitory binding subunit IκBα by EM may account for this 
deactivation of NF-κB (Huang et al., 2004; Kumar et al., 1998). Furthermore, EM at 
high concentration (50-500 μM) could directly inhibit the binding efficiency of NF-κB 
to DNA through oxidation of NF-κB p50 (Jing et al., 2006). It is noteworthy that this 
inhibitory action by EM depends highly on the stimulator used, since Bhat-Nakshatri et 
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al reported that activation of NF-κB by heregulin through EGFR and Erb3 
phosphorylation was unaffected by EM (Bhat-Nakshatri et al., 2002).  
Monoamine oxidase is an important metabolic enzyme for a wide range of 
monoamine neurotransmitters, such as dopamine (Youdim et al., 2006). Screening of 
plant-derived anthraquinones had been conducted for identification of potential 
inhibitors for monoamine oxidase in treatment of Parkinson’s disease (Kong et al., 
2004). Only EM was found to be active as an inhibitor against monoamine oxidase B 
(IC50: 35.4 μM), while AE, rhein, chrysophanol, physcion were inactive.  
Phytoestrogens may counteract or replace estrogen for the binding of estrogen 
receptor (ER). Synthetic estrogen-replacement therapy has been reported to be effective 
for the treatment of osteoporosis, hypercholesteremia and symptoms of menopause 
(Messina et al., 2006). In a search of phytoestrogens from herb root of Polygonum 
cuspidatum, EM was found to exhibit strong affinity to human estrogen receptors (IC50 
for ER-α: 2.7 μM and IC50 for ER-β: 5.2 μM), while AE failed to bind to either ER-α or 
ER-β even at a higher concentration of 40 μM (Matsuda et al., 2001).  
Taken together, previous reports suggested that AE executed its anti-cancer 
activity through induction of p53 and oxidative stress. However, it is still unclear why 
AE, as a poor kinase inhibitor, exhibit similar or higher cytotoxicity compared to its 
analogue EM. In the next Sections, some relevant molecular pathways to be covered 
in the present study, in terms of oxidative stress and redox-sensitive signaling in 
apoptosis and cancer, will be discussed. 
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1.2  Reactive oxygen species (ROS) and protein oxidative modifications 
1.2.1 ROS generation and antioxidant defense systems 
The major reactive oxygen species (ROS) include superoxide anion (O2-), 
hydroxyl radical (·OH) and the nonradical hydrogen peroxide (H2O2). These redox 
radicals can react with and oxidatively modify key cellular macromolecules: DNA, 
proteins and lipids. In terms of immunology, ROS are regarded as host defending 
radicals generated by neutrophil to attack exogenous pathogens (Pryor, 1982). Recent 
studies increasingly indicate that ROS are important signaling transduction molecules. 
The redox imbalance between the elevated generation of ROS and impaired 
ability of biological system to neutralize them in favor of the former causes oxidative 
stress (Benhar et al., 2002; Poli et al., 2004). The aberrant ROS homeostasis is thus 
generally thought to be associated with a variety of physiological and pathological 
processes, including ischemia/reperfusion, cardiovascular diseases, neurodegenerative 
diseases, ageing and cancer (Boonstra and Post, 2004; Otani, 2004; Poli et al., 2004; 
Stadtman and Berlett, 1998; Toyokuni et al., 1995; Ueda et al., 2002; Wu, 2006). 
In mammalian cells, several enzyme systems are capable of producing 
intracellular ROS, including the mitochondrial electron transport chain, cytochrome 
P450 in endoplasmic reticulum, NADPH oxidase complex, xanthine oxidase, 
cyclooxygenase, lipoxygenase, and peroxisomes (Inoue et al., 2003). Among them, 
mitochondrial oxygen metabolism via electron transport chain is the major source of 
cellular ROS. Any disruption of the mitochondrial electron transport system can 
drastically increase superoxide (O2-) production (Fig. 1.3, reaction ①).  
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Fig. 1.3 Main cellular pathways of ROS formation from superoxide anion. SOD, 
superoxide dismutase; CAT, catalase; GPX, glutathione peroxidase; GR, glutathione 
reductase; GSH, reduced glutathione; GSSG, oxidized glutathione. (Adapted from 
Halliwell and Cross. Environ Helath Perspect. 1994; 102 suppl 10: 5-12) 
 
Normally, O2- is rapidly converted to nonradical H2O2 and O2 (Fig. 1.3, reaction 
②) by manganese superoxide dismutase (MnSOD) present in mitochondria and 
copper/zinc superoxide dismutase (Cu/Zn-SOD) in cytosol. Nonradical H2O2 can be 
further detoxified to water by the enzymes catalase (Fig. 1.3, reaction ⑤) and 
glutathione peroxidase (Fig. 1.3, reaction ⑥). Alternatively, H2O2 reacts with reduced 
transition metal Fe2+ or Cu+ via Fenton reaction (Fig. 1.3, reaction ③) to form the 
highly reactive hydroxyl radicals (·OH). In addition, ·OH can also be generated by the 
metal catalyzed Haber-Weiss reaction (Fig. 1.3, reaction ④). Unlike O2- and H2O2, 
reactive ·OH is unable to be eliminated by an enzymatic reaction. It is probably 
because of its short half-life, which is too fast to diffuse to the enzyme’s active site 
that ·OH reacts with any oxidizable compound in its close proximity and thus causes 
oxidative damage to all types of macromolecules. 
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Under normal conditions, the adverse effects caused by excessive ROS can be 
minimized by both enzymatic and non-enzymatic antioxidant defenses (Kern and 
Kehrer, 2005; Loo, 2003; Sun and Oberley, 1996). The enzymes SOD (MnSOD and 
Cu/Zn-SOD) and catalase belong to the primary defense system used to destroy the 
radical superoxide and nonradical H2O2, respectively. Another major enzymatic 
antioxidant defense system against H2O2 is the glutathione redox cycle. This defense 
system consists of glutathione (GSH), glutathione peroxidase (GPX) and glutathione 
reductase (GR), and it resides in both the cytosol and mitochondria. This is different 
from catalase, which is present only in the peroxisome. Glutathione peroxidase (Fig. 
1.3, reaction ⑥), for example, catalyses the reduction of H2O2 and other peroxidases 
by oxidizing cofactor GSH to its oxidized disulfide form GSSG. In contrast, 
glutathione reductase, with its cofactor NADPH, reverses this reaction by reducing 
GSSG back to GSH (Fig. 1.3, reaction ○7 ).  
In addition, cells are also equipped with other non-enzymatic antioxidative 
proteins (e.g. thioredoxin, glutathione-S-transferase π, peroxiredoxins, etc) and some 
small-molecule antioxidants (e.g. Vitamin E). These antioxidants reduce excessive 
ROS mainly by oxidizing themselves. In general, all the redox-based antioxidants are 
interconnected with each other to form an “antioxidant network” that comprised of 
both enzymatic and non-enzymatic reactions. In this way, antioxidants can be 
regenerated and/or recycled by cellular biological reductants. In addition, in response 
to oxidant insults, cells tend to up-regulate antioxidative enzymes or stress-responsive 
proteins to counteract the harmful effects caused by excessive ROS production. 
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1.2.2 Protein oxidative modifications 
Oxidative stress often results in reversible or irreversible oxidative modifications 
of cellular macromolecules, including proteins (as carbonyl derivatives), lipids (as 
isoprostanes, age pigment) and DNA (as 8-hydroxy-2-deoxyguanosine). Proteins are 
the major targets for reactive oxidants and other radicals in vivo (Davies et al., 1999). 
It has been estimated that proteins can scavenge up to 50-75% of reactive radicals 
(Davies et al., 1999). Protein oxidation, as well as lipid peroxidation, is generally 
more stable than oxidant radicals themselves, since the latter has short half-lives and 
are highly reactive (Dalle-Donne et al., 2005). Protein oxidation retains the feature of 
oxidative damage, and is generally regarded as a sensitive and stable biomarker for 
oxidative stress in vivo (Dalle-Donne et al., 2005). More importantly, protein 
oxidation is frequently found to be associated with induction of redox-sensitive 
signaling pathways and a variety of pathophysiological processes and diseases, such 
as cardiovascular diseases, ageing and cancer (Davis and Dean, 1997).   
Oxidative stress can reversibly or irreversibly modify sensitive proteins (Fig.1.4) 
and in turn modulate cellular signaling pathways. This process is termed as redox 
regulation (Stadtman and Berlett, 1998). Reversible modifications usually occur at 
cysteinyl residues. These residues may not only protect key cellular macromolecules 
from intolerable irreversible oxidative damage, but also modulate a number of protein 
functions. On the contrary, irreversible oxidative modifications, such as 
protein-protein cross-linking and protein carbonylation, may lead to protein 
loss-of-function, degradation or accumulation into cytoplasmic inclusions (Baty et al., 
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2005; Butterfield and Lauderback, 2002; Giasson et al., 2000; Grune et al., 2003; 
Picklo et al., 2002). In general, protein oxidative modifications can modulate a 
number of biochemical properties of proteins, such as enzymatic activity (Oliver, 1987; 
Starke et al., 1987), DNA binding activity of transcription factors (Clive and Greene, 
1996; Hainaut and Milner, 1993) and proteolytic degradation rates (Banan et al., 2000; 
Zaffagnini et al., 2007). Although the association between protein oxidation and 
ageing has been suggested (Stadtman, 1992), little is known about how oxidative 
modification of individual protein affects the pathophysiologic processes. 
 
Fig. 1.4 Interplay of ROS and antioxidants results in protein redox regulation. 
Redox imbalance in favor of excessive ROS generation may cause reversible or 
irreversible chemical modifications of sensitive proteins. This may in turn lead to 
protein functional regulation, loss-of-function or degradation. (Adapted from Ghezzi 
and Bonetto. Proteomics 2004: 3, 1145-1153.) 
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1.2.2.1 Oxidative modification of protein thiols 
Thiols of cysteinyl (Cys) residues in proteins can be oxidized into reversible 
S-glutathionylation, sulfenic acid (P-SOH), and intra- or inter-molecular disulfides. 
These chemical modifications may have different pathophysiological properties, 
depending on the oxidation level, the nature of affected proteins and oxidation sites.  
S-glutathionylation refers to the reaction of protein thiols conjugated with low- 
molecular-weight compounds under mild oxidative stress. In this reaction, GSH is a 
predominant ligand to be conjugated because of its high concentration (0.5-10 mM) in 
mammalian cells (Halliwell and Gutteridge, 1999). Generally, S-glutathionylation is 
regarded as a protective mechanism against further irreversible protein thiol oxidation 
(Klatt and Lamas, 2000; Schafer and Buettner, 2001). However, if the Cys residue in a 
protein is functionally critical, S-glutathionylation will render this protein inactive 
(Eaton et al., 2002). Various systems can reverse this reaction, such as thioredoxin 
(Trx) and protein disulfide isomerase, using GSH or NADPH as a reducing donor.  
Another thiol oxidation product, sulfenic acid, is extremely unstable. This 
oxidative modification could be easily reduced by intracellular reductants. 
Alternatively, strong oxidative insults are ready to further oxidize sulfenic acid to 
sulfinic (P-SO2H) and sulfonic acid (P-SO3H). For example, 2-Cys peroxiredoxins 
could be oxidized further into the form of P-SO2H and/or P-SO3H. This reaction was 
found to be a molecular switch controlling the transcriptional response to increasing 
level of hydrogen peroxide (Bozonet et al., 2005; Wood et al., 2003). Unlike P-SOH, 
formation of P-SO2H and P-SO3H cause protein loss-of-function and this modification 
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generally cannot be reversed by metabolic processes. However, an exception has 
recently been observed that the sulfinic inactive form of peroxiredoxin-1 could be 
reduced through an unknown mechanism (Woo et al., 2003).  
Labeled thiol reactive reagents were applied in the identification of protein thiol 
modifications. Proteomic approaches utilizing radioactively [35S]-labeled GSH 
(Fratelli et al., 2002) and non-radioactive biotinylated GSH ester (Eaton et al., 2003) 
have been developed for the detection of S-glutathionylated proteins. Furthermore, the 
instability of disulfide formation in these methods using labeled GSH was overcome 
by a more sophisticated strategy (Lind et al., 2002). In this method, selective 
reduction and then stable alkylation of glutathionylated proteins with biotin-labeled 
N-ethylmaleimide (NEM) were conducted instead, which could be finally enriched by 
avidin-based affinity chromatography. 
1.2.2.2 Oxidative formation of protein carbonylation 
Protein carbonylation is an irreversible oxidative modification. It occurs at many 
sites of a protein (especially side chains of Pro, Arg, Lys and Thr) and by different 
mechanisms upon oxidative stress. Introduction of carbonyl groups into protein 
side-chains generally leads to loss of catalytic or structural functions in the oxidized 
proteins, which is associated with ageing and neurodegenerative diseases (Levine, 
2002). Normal cellular processes may also utilize this modification on specific 
proteins as a mechanism for protein degradation (Levine, 2002; Nystrom, 2005).  
Because the increase in the number of protein carbonyls correlates well with the 
increased protein damage (Shacter et al., 1994), assessment of protein carbonyl has 
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been used widely as a marker for oxidative stress (Dalle-Donne et al., 2003; Levine et 
al., 2000). The pioneering analysis of 2, 4-dinitrophenylhydrazine (DNPH) 
derivatization developed by Levine and coworkers is the most widely utilized 
methodology for detection of protein carbonyls (Levine et al., 1990; Levine et al., 
1994). Biochemically, protein carbonyls could be derivatized with DNPH, which thus 
enables them to be recognizable and quantifiable by an immunoassay using 
commercially-available anti-DNP IgG. Since Reinheckel and coworkers (Reinheckel 
et al., 2000) introduced post-IEF DNP derivatization in 2DE into the measurement of 
protein carbonyls, this relative comprehensive and reproducible method greatly 
facilitated the discovery of new carbonylated proteins in many oxidative stressed 
(Mostertz and Hecker, 2003; Reinheckel et al., 2000) or diseased samples (Castegna et 
al., 2002; Choi et al., 2002; Rabek et al., 2003). Furthermore, double staining of 2DE 
immunoblots (e.g. anti-DNP immunoblot in combination with SYPRO Ruby 
fluorescent total protein staining) enabled the determination of the oxidation ratio of 
susceptible proteins (Korolainen et al., 2002). 
1.2.2.3 Other oxidative modifications 
Similar to thiol groups, methioninyl residues in a protein are highly susceptible to 
oxidation by redox radicals. Since this modification is enzymatically reversible, 
methionine oxidation has been proposed to serve as an endogenous antioxidant 
defensing mechanism (Levine et al., 2000). However, recent studies reveled that 
methionine oxidation may also be associated with protein loss-of-function, such as 
DJ-1 and actin (Choi et al., 2006; Dalle-Donne et al., 2002).  
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1.3   Oxidative stress in apoptosis  
1.3.1 Apoptosis 
Apoptosis, or apoptotic cell death, is well characterized as a physiologically 
‘suicidal’ programmed cell death. Dys-regulation of apoptosis has been shown in 
various pathological processes, including neurodegenerative diseases, autoimmunity 
and cancer. It has also been well-recognized that defects in apoptosis account for not 
only carcinogenesis, but also resistance to cancer therapeutics (Jacobson et al., 1997; 
Kerr et al., 1972; Okada and Mak, 2004).  
Apoptosis was initially found as a series of distinct morphological changes, 
including plasma membrane blebbing, nuclear fragmentation and chromatin 
condensation, degradation of apoptotic cells and formation of membrane-enclosed 
apoptotic bodies (Jacobson et al., 1997). With the discovery of the key molecules (e.g. 
caspase, bcl-2, etc.) which govern the apoptotic processes, apoptosis is proven to be 
well-regulated by a chain of biochemical reactions. Among these changes, 
cleavage/activation of caspases (a family of cysteine proteases) is central for apoptosis 
(Alnemri et al., 1996; Riedl and Shi, 2004; Thornberry and Lazebnik, 1998). Caspases 
are normally kept inactive as precursor procaspases. Upon apoptotic stimulation, the 
initiator caspases (caspase-8 and -9) are activated by oligomerization to form the 
active caspases, which subsequently cleave/activate the precursor form of executor 
caspases (caspase-3 and -7). Activated executor caspases in turn cleave a specific set 
of key cellular substrates, resulting in the well-defined biological and morphological 
changes (Salvesen and Dixit, 1997; Thornberry and Lazebnik, 1998).  
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Fig. 1.5 ROS involvement in extrinsic and intrinsic apoptotic pathways. Upon 
apoptotic stimuli, extrinsic death receptor (TNFR1/2)- and intrinsic mitochondria- 
mediated apoptosis pathways trigger caspase activation cascade from formation of 
DISC and apoptosome complex, activation of initiator caspases (caspase 8 and 9) to 
activation of executor caspase (caspase 3/7). Excessive ROS generation from 
mitochondria and other sources promoted MOMP and release of sequestered cyt c to 
form apoptosome. ASK1 and JNK are redox-sensitive molecules to transduce ROS to 
induce mitochondria-mediated apoptosis. (Adapted from Shen and Liu. Free Radical 
Bioloby & Medicine. 2006; 40; 928-939.) 
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There are two apoptotic pathways (extrinsic and intrinsic, see Fig. 1.5) by which 
caspase activation is triggered (Boatright and Salvesen, 2003). The extrinsic pathway 
is mediated by signaling cascade of cell surface death receptors (e.g. Fas and TNF 
receptor) upon stimulatory binding of ligands such as FasL and TNF-α, respectively. 
The activation of death receptor in turn induces the formation of the death-induced 
signaling complex (DISC), further recruiting FADD, TRADD and procaspase-8. The 
recruitment of procaspase-8 on the DISC promotes caspase-8 oligomerization/ 
activation and apoptotic cascade that follows. On the other hand, the intrinsic pathway 
is mitochondria-mediated (Garrido et al., 2006; Kroemer and Reed, 2000; Spierings et 
al., 2005; Youle and Karbowski, 2005). It could be activated by various extracellular 
and intracellular stresses including oxidative stress, nutrient deprivation, and 
cytoskeletal disruption. Upon apoptosis stimulation, a series of biochemical changes 
lead to mitochondrial outer membrane permeabilization (MOMP), a pivotal event in 
apoptosis. Proteins sequestered in the mitochondrial intermembrane space (between 
the inner and outer mitochondrial membrane) thus are released and accessible to other 
proteins in the cytosol. This action is essential for the intrinsic apoptotic pathway, as 
demonstrated in cell-free system (Liu et al., 1996; Newmeyer et al., 1994).  
Proteins that are released to the cytosol in the process of MOMP, comprise 
cytochrome c, Smac/DIABLO, Omi, and other proapoptotic molecules (Kroemer and 
Reed, 2000; Spierings et al., 2005; Youle and Karbowski, 2005). Among them, 
cytochrome c binds to cytosolic, monomeric apoptotic protease activating factor-1 
(APAF-1). This action promotes APAF-1 oligomerization to form a protein complex 
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called “apoptosome” (Zou et al., 1999). The latter further recruits initiator 
procaspase-9 and then activates it by dimerization. The active caspase-9 is capable of 
cleavage/activation of the executor caspase-3 and -7. Similarly, Smac/DIABLO and 
Omi can bind to cytosolic IAPs (inhibitor of apoptosis proteins). IAPs repressively 
bind to caspases in normal conditions while released Smac/DIABLO and Omi could 
sequester IAPs from the inhibitory binding to caspase (Du et al., 2000; Hegde et al., 
2002; Martins et al., 2002; Suzuki et al., 2001; Verhagen et al., 2000). 
1.3.2 ROS involvement in apoptosis 
ROS are involved in both intrinsic and extrinsic apoptosis. On the one hand, ROS 
may be essential for the extrinsic apoptotic pathway (Shen and Pervaiz, 2006). 
Ligation of TNF-α or other death signals to the death receptor is capable of inducing 
ROS production through the mitochondria, while scavenging ROS (by addition of 
pharmacological antioxidants or genetic over-expression of SOD and Trx) is able to 
abolish caspase activation and apoptosis that follows (Delhalle et al., 2002; Devadas 
et al., 2003; Goossens et al., 1999; Kasahara et al., 1997; Lee et al., 2002; 
Schulze-Osthoff et al., 1993; Wong and Goeddel, 1988). The molecular mechanism 
linking death receptors to ROS production from the mitochondrial source is yet 
unclear. A recent study comparing JNK knockout cells with wild-type cells suggested 
that TNF-α-induced JNK activation may account for the mitochondrial-derived ROS 
production (Ventura et al., 2004). Furthermore, the generated ROS may promote death 
receptor-mediated apoptosis through increased expression of death receptors on cell 
surface (Jung et al., 2005; Kim et al., 2006; Minana et al., 2002).  
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On the other hand, ROS may directly activate the mitochondria-mediated intrinsic 
apoptotic pathway (Fruehauf and Meyskens, 2007; Kroemer and Reed, 2000; Youle 
and Karbowski, 2005). This effect is primarily mediated through opening of the 
mitochondrial permeability transition pore complex in the process of MOMP. The 
pore complex consists of an inner membrane segment, adenine nucleotide translocase 
(ANT), and an outer membrane segment, voltage dependent ion channel (VDAC), as 
well as cyclophilin D and intermembrane creatine kinase. These two mitochondrial 
membrane proteins VDAC and ANT were proposed to account for the induction of 
MOMP and apoptosis that follows. VDAC functions in regulating superoxide flux 
from the mitochondria to the cytosol, making itself vulnerable to superoxide-mediated 
MOMP (Han et al., 2003; Shoshan-Barmatz et al., 2006). It has been well recognized 
that upon oxidative stress, pore-opening proteins (such as Bax and Bak, together with 
chaperone tBid, and Bim) are up-regulated and target VDAC to destabilize it 
(Scorrano and Korsmeyer, 2003). In contrast, Bcl-2 and Bcl-XL exert antiapoptotic 
effects by stabilizing VDAC configuration (Scorrano and Korsmeyer, 2003). VDAC 
destabilization in turn promotes ion influx, and ultimately induction of MOMP and the 
release of proteins normally sequestered in the mitochondrial inter-membrane space. 
While in terms of ANT, its three cysteinyl residues (Cys 57, 160, and 257) are 
redox-sensitive and are ready to be oxidized to form intramolecular Cys cross-links 
upon oxidative stress (Bauer et al., 1999; Costantini et al., 2000; Faustin et al., 2004). 
ANT with such oxidative modifications alters its structural conformation and becomes 
incapable of binding nucleotide and allowing calcium entry, which finally induces 
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MOMP and pore opening. This biochemical chain of MOMP, especially ANT 
oxidation, could be blocked by mitochondrial antioxidant, such as GSH and Trx 
(Armstrong and Jones, 2002; Wudarczyk et al., 1996).  
It is, however, noteworthy that direct treatment with redox radicals, such as 
hydrogen peroxide and redox-active quinones, can initiate either apoptosis when given 
in lower doses or necrosis when given in higher doses (Hampton and Orrenius, 1997). 
The switch from apoptotic to necrotic cell death in increasing level of oxidative stress 
has been proposed to be a result of the oxidative deactivation of caspases (such as 
thiol oxidation (Nobel et al., 1997; Samali et al., 1999) and S-nitrosylation (Melino et 
al., 1997)) and/or dys-regulated ATP depletion (Leist et al., 1999).  
1.4   Oxidative stress in cancer: double-edged sword  
Oxidative stress have long been believed to be associated with cancer (Jacobson 
et al., 1997; Kerr et al., 1972; Okada and Mak, 2004). Current understanding also 
favors the idea that lowering oxidative stress may have a health benefit from cancer. 
However, it is still controversial for the clinical usage of antioxidant supplements to 
prevent and/or treat cancer. Two large, blind, clinical trials of supplementation with 
beta-carotene (a moderate antioxidant) yielded the same result that beta-carotene 
supplementation even increased the risk of lung cancer in current and former smokers 
(Group, 1994; Omenn et al., 1996). Although other tenable explanations may account 
for that risk, the role of ROS in cancer initiation and/or progression seems more 
complex than previously expected. Actually a dual role (so called “doubled-edged 
sword” effect) of oxidative stress in cancer is suggested, according to current findings.  
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1.4.1 Constitutive oxidative stress in cancer cells 
ROS has long been associated with carcinogenesis and malignant transformation. 
Toyuki and coworkers proposed the concept of “persistent oxidative stress in cancer” 
over 10 years ago (Toyokuni et al., 1995). This concept was based on the observations 
of increased generation of ROS in human tumor cells in vitro (Szatrowski and Nathan, 
1991), formation of DNA oxidative adduct in vivo (8-hydroxy-2’- deoxyguanosine 
(Jaruga et al., 1994; Malins and Haimanot, 1991; Olinski et al., 1992)) but decreased 
antioxidants expression in tumor tissues (e.g. down-regulation of catalase in hepatoma 
(Sato et al., 1992)). Considering the growth-stimulatory effect of ROS in growth 
factor signaling pathways, these observations suggest that the increase in basal level 
of redox signaling may confer tumor cells higher proliferative potentials than their 
parental normal cells (Klaunig and Kamendulis, 2004; Loo, 2003). It is, however, 
difficult to validate the results obtained from these types of comparisons in vitro or in 
vivo, because of the lack of genetically comparable normal control cells.  
Wallace hypothesized that dysfunctional mutations in either nuclear or 
mitochondrial genes encoding components of mitochondrial electron transport chain 
may account for excessive ROS generation, genetic instability and carcinogenesis that 
follows (Wallace, 2005). Recently, increasing generation of ROS was found to occur 
in genetically transformed cells (Trachootham et al., 2006). The authors introduced 
either oncogenic H-RAS or Bcr-Abl to form tumorigenic cells from an immortalized 
but tumor-incapable epithelial cell line (T72 cells). Their results indicated a significant 
elevation of ROS generation in the transformed cells compared to T72 control cells. 
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These results supported the hypothesis that oxidative stress occur in neoplastic 
transformation. However, it is still difficult to answer the question whether this high 
ROS generation is only a response to high-rate metabolism in fast proliferating cells 
or a causative factor for carcinogenesis. The natural role of increased ROS generation 
in cells during carcinogenesis is yet to be determined.  
1.4.2 Therapeutic or suicidal level of ROS: beyond the breaking point 
Contrary to the above model favoring the carcinogenesis-stimulatory effect of 
ROS, some other models had suggested a therapeutic or suicidal effect could result 
from increased ROS generation. It is common to observe an exaggerated oxidative 
stress in cell death triggered by a variety of cancer therapeutic drugs, such as redox 
cycling agents (e.g. anthracycline (Muller et al., 1998) and arsenic (Kang et al., 
2004)), histone deacetylase inhibitors (Rosato et al., 2003), proteosome inhibitors 
(Perez-Galan et al., 2006). These findings all suggest that cancer cells are susceptible 
to oxidative stress. Thus it has been proposed that the already elevated level of ROS in 
cancer cells may make these cells more vulnerable than normal cells, when the 
induced oxidative stress by therapeutic agents reached an intolerable level (Benhar et 
al., 2002; Trachootham et al., 2006). Cell death and/or senescent pathways as 
responses are sensitized in such circumstances. This notion is consistent with the dual 
effects of H2O2 treatment. H2O2 may either promote or inhibit growth proliferation in 
cancer cells, depending on the intracellular concentration of H2O2 (Rhee et al., 2003). 
According to the above model, modulation of the intracellular ROS level in 
cancer cells may be effective in controlling cancer proliferation. For example, in the 
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transformed tumorigenic T72 cells with increased ROS level (as mentioned above), 
treatment with β-phenylethyl isothiocyanate (PEITC) further increased ROS 
generation and induced cell death (Trachootham et al., 2006). It was demonstrated that 
the augmented oxidative stress is not only from the increased ROS generation but also 
from the impaired detoxifying antioxidant system (depletion of intracellular reduced 
GSH and inhibition of glutathione peroxidase). By contrast, the normal T72 cells only 
exhibited a smaller increase of ROS generation and cell death upon PEITC treatment. 
Therefore, this difference in cell death is possibly a result of the lower baseline ROS 
level in normal cells, compared to the tumorigenic cells. The depletion of GSH by 
PEITC presumably had no observable effect for the cellular redox environment in 
normal cells but potentiated cell death in tumorigenic cells with a high level of ROS. 
The cell may itself also be equipped with a suicidal ROS-mediated anti-cancer 
mechanism even without exogenous treatment. Two recent papers disclosed the 
enforcing effect of ROS on senescence and cell death. The study by Takahasi et al  
showed that higher level of ROS was maintained in senescent cells and treatment of 
ROS scavenger could block this hard-to-reverse process (Takahashi et al., 2006). They 
proposed that in normal cells E2F-dependent transcription switched off senescence 
and detoxified excessive ROS. But under oxidative stress, this action was inactivated. 
Excessive ROS thus potentiated PKC-mediated inhibition of cytokinesis, which may 
account for the induction of senescence. In another paper, Dolado and coworkers 
found that excessive ROS could inhibit carcinogenesis via a selective sensor p38 
MAPK (Dolado et al., 2007). p38 deficient cells formed subcutaneous tumors much 
   44
faster than wild–type cells. Importantly these actions could be rescued by 
reintroducing ectopic expression of p38. In their model, p38 appears to sense 
oncogene-stimulated oxidative stress and p38 activation protect cells from 
ROS-induced oncogenic transformation by induction of apoptosis and growth arrest. 
 Taken together, constitutive oxidative stress is maintained in cancer cells and 
functions for oncogenic transformation and higher proliferative potentials. But this 
elevation of ROS may make cancer cells vulnerable to higher level of ROS by 
inducing cell death and cell growth arrest. Accordingly, addition of any agent that 
either increase ROS production or impair the intracellular detoxifying antioxidant 
system may push tumor cells move beyond the breaking point for a suicidal or 
therapeutic purpose. Due to the complexity of cancer etiology, it is however still 
unknown whether this “double-edged sword” effect of ROS works in all types of 
cancers (e.g. chemical or virus-induced carcinoma).  
1.5   Cellular signaling by ROS 
A wide range of intracellular molecules involved in gene transcription, cell 
growth arrest, senescence and apoptosis (or necrosis) are susceptible to redox radicals. 
But unlike other second messengers or small-molecular kinase inhibitors, redox 
radicals are unlikely to bind specifically to certain proteins, because they are too 
simple in chemical structure to be recognized. It has been suggested that proteins with 
low-pKa cysteinyl residues are highly vulnerable to oxidative stress (Rhee et al., 
2003). In addition, the extent and duration of oxidative stress, in combination with the 
level of cellular detoxifying antioxidants influence the cell fate. Thus the effect of 
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redox radicals on proteins and relevant molecular pathways is highly dependent on the 
susceptibility of the specific protein (Rhee et al., 2003). In the following sections, a 
few redox-sensitive pathways (e.g. NF-κB and MAPK) will be discussed.   
1.5.1 Nuclear factor-κB (NF-κB) 
It has been well-established that nuclear factor-κB (NF-κB) and AP-1 are the most 
important transcription factors affected by redox radicals. Activation of these two 
transcription factors can induce genes involved in either cell proliferation or cell death 
(Bubici et al., 2006; Clive and Greene, 1996; Gloire et al., 2006; Loo, 2003).  
As an example, NF-κB is a ubiquitously expressed transcription factor for a 
variety of genes involved in cell proliferation, differentiation and inflammation 
(Gloire et al., 2006; Hoffmann et al., 2006; Karin, 2006). An increasing number of 
evidence indicates the association of NF-κB activation with cancer development and 
progression (Karin, 2006). A recent mice study revealed that activation of NF-κB was 
essential for inflammation-initiated cancer development in later stages (Lavon et al., 
2003; Pikarsky et al., 2004). It was further proposed that NF-κB executed this action 
through its negative-feedback regulation of ROS-initiated apoptosis (Bubici et al., 
2006; Karin, 2006). In addition, NF-κB could reduce ROS through transcriptional 
regulation of antioxidant proteins (e.g. sod1) (Bubici et al., 2006; Gloire et al., 2006). 
Normally NF-κB is kept in an inactive state in the cytosol by binding to the 
inhibitor of NF-κB (IκB). In response to various extracellular stimuli, NF-κB gets 
activated and translocated to the nucleus by IKK (IκB kinase)-dependent 
phosphorylation and degradation of IκB. Early models for NF-κB activation by ROS 
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suggested that most stimuli (e.g. TNFα, IL-1, TPA, lipopolysaccharide and H2O2) 
activate NF-κB through generation of ROS and more importantly, pretreatment of 
ROS scavengers can significantly prevent the induced activation of NF-κB (Baeuerle 
and Henkel, 1994; Bowie and O'Neill, 2000; Michiels et al., 2002; Schoonbroodt and 
Piette, 2000). However, these models were challenged by some recent findings that 
activation of NF-κB is independent of ROS in some cell lines and under some 
stimulations (Brennan and O'Neill, 1995; Gloire et al., 2006; Li and Karin, 1999).  
On the contrary, oxidative stress, above a certain threshold, may negatively affect 
NF-κB activation through oxidation of NF-κB (Cys62) and interruption of its DNA 
binding activity (Matthews et al., 1992; Nishi et al., 2002; Pineda-Molina et al., 2001). 
In addition, inactivation of NF-κB can also be obtained by H2O2 treatment through 
negative oxidative modification of its upstream kinase IKK (Cys179) and subsequent 
stabilization of IκB (Korn et al., 2001). Therefore, ROS here exhibits a dual action on 
NF-κB: low level of ROS stimulate NF-κB activation while excessive ROS may 
directly oxidize NF-κB and interrupt its DNA-binding property. 
1.5.2 Mitogen-activated protein kinase (MAPK) 
The mitogen-activated protein kinase (MAPK) pathway is one of the most 
well-established redox-sensitive cell signaling pathways (Benhar et al., 2002). Three 
MAPKs subgroups have been found: ERK (extracellular signal-regulated kinases), 
JNKs (c-Jun N-terminal kinases) and p38. Among them, JNK and p38 mainly play a 
pro-apoptotic function in response to various cellular stress including redox radicals, 
while ERK subgroup is primarily involved in mitogen-activated proliferative 
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responses (Kyriakis and Avruch, 2001; Lewis et al., 1998; Shen and Liu, 2006). In the 
classical model, activation of these three MAPK members is mainly through a series 
of phosphorylation/activation of the MAPK modules including MAP kinase kinase 
kinase (MPAKKK), MAP kinase kinase (MAPKK) and MAPK (see Fig. 1.6).  
1.5.2.1  c-Jun N-terminal kinases (JNK) 
It has been proposed that the reciprocal, negative cross-talk between pro-survival 
NF-κB and pro-apoptotic JNK is critical for cell decision in entering either survival or 
apoptosis (Bubici et al., 2006). In this model, ROS is regarded as a central player in 
determining the activity of JNK and NF-κB. Also named as stress-activated protein 
kinases (SAPK), JNK are activated by various environmental stresses including 
oxidative stress, chemotherapeutic agents and cytokines. JNK are primarily activated 
through phosphorylation at sites Thr 183 and 185 by two upstream MAPKK 
(JNNK1/MKK4/SEK1 and JNKK2/MKK7). Activated JNK regulate various cellular 
processes comprising cell proliferation, apoptosis, and differentiation.  
Two different modes of JNK activation (transient pro-survival and sustained 
pro-apoptotic) have now been well recognized (Shen and Liu, 2006; Shen and Pervaiz, 
2006). Signaling cascades of pro-inflammatory cytokines (such as TNF-α and IL-1) 
are responsible for the earlier and transient mode of JNK activation. Under 
non-stressed circumstances, transient JNK activation mediates pro-survival responses. 
This effect was clearly demonstrated in some transgenic and biochemical studies 
(Behrens et al., 2000; Chen et al., 2001; Lamb et al., 2003). In contrast, excessive 
ROS may account for the delayed and sustained mode of JNK activation. Sustained 
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JNK activation leads to stress-induced apoptotic cell death (Tournier et al., 2000). 
Thus the pro-apoptotic effect of JNK depends on the extent and duration of its 
activation by exogenous stress.  
Oxidative stress is of particular importance in modulation of sustained JNK 
activation and JNK-mediated apoptosis (Bubici et al., 2006; Shen and Liu, 2006; 
Torres, 2003). The main activator of JNK pathway has been proposed to be apoptosis 
signal-regulating kinase-1 (ASK1), another redox-sensitive pro-apoptotic kinase 
(Saitoh et al., 1998; Shen and Liu, 2006; Tobiume et al., 2002). ASK1 is a 
ubiquitously expressed MAPKKK that activate both JNK and p38 by phosphorylating 
respective MAPKKs. In the presence of ROS, ASK1 was activated by oligomerization 
after dissociation from its inhibitory binding subunit thioredoxin (Trx) (Liu et al., 
2000; Saitoh et al., 1998; Tobiume et al., 2002). Trx functions as an antioxidant 
protein, but when it is exposed to excessive redox radicals, it can be oxidized and 
deactivated on residues Cys32 and Cys35 and form a intramolecular disulfide bond 
(Liu and Min, 2002; Saitoh et al., 1998). This oxidation may release ASK1 and then 
activate it. It is noteworthy that several other redox-sensitive molecules (GST-μ, 
glutaredoxin and heat shock protein 72) could activate ASK1 in a similar mode (Cho 
et al., 2001; Park et al., 2002; Song et al., 2002).  
Furthermore, JNK itself was also regulated by inhibitory binding with another 
redox-sensitive protein glutathione S-transferase π (GST-π) (Adler et al., 1999). Upon 
oxidative stress, GST-π was oxidized and underwent oligomerization, thus losing its 
inhibitory binding with JNK. Importantly, this module of GST-π oxidation-involved 
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modulation of JNK is independent of the ASK1/JNK module mentioned above. Thus, 
ROS are capable of activating JNK through multiple redox-sensitive pathways.  
The precise mechanism for JNK-mediated apoptosis has yet to be determined, 
although current understanding favors the role of mitochondria as its main target. 
Upon apoptotic stress, activated cytosol JNK may directly translocate to mitochondria 
and cause the release of sequestered apoptogenic factors such as cytochrome c from 
mitochondrial intermembrane space (Aoki et al., 2002; Kharbanda et al., 2000). JNK 
also executes its pro-apoptotic role through its modulation of the Bcl-2 family 
members. This action may be a result of JNK-dependent negative phosphorylation of 
anti-apoptotic Bcl-2 (Yamamoto et al., 1999) and myeloid cell leukemia 1 (Inoshita et 
al., 2002). JNK may also activate pro-apoptotic Bim by phosphorylation (Putcha et al., 
2003) and promote Bax mitochondrial translocation (Tsuruta et al., 2004). 
1.5.2.2   p38 
Similar to JNK, p38 (also known as SAPK2) is another redox-sensitive MAPK 
member (Otani, 2004; Torres, 2003; Ueda et al., 2002). Although p38 has different 
upstream MAPKKs (MKK3 and MKK6) from JNK, it shares some similar upstream 
and downstream pathways in terms of ROS-mediated apoptosis. For example, the 
signaling pathway of ROS-mediated JNK activation through ASK1 also applies to p38 
(Ichijo et al., 1997). Beside its primary function in inflammatory diseases, p38 also 
works as a tumor suppressor. For example, Dolado and coworkers had reported that 
p38 MAPK was a selective sensor for oncogene-stimulated ROS and it could protect 
cells from oncogenic transformation by induction of apoptosis and growth arrest 
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(Dolado et al., 2007). Under oxidative stress, p38 and JNK may exhibit redundant 
functions in apoptosis. However their cross-talk in vivo is yet to be determined.   
1.5.2.3   Extracellular signal-regulated kinases (ERK) 
Different from JNK and p38, extracellular signal-regulated kinases (ERK) is a 
pro-survival MAPK member (Reddy et al., 2003; Torres, 2003). Activation of ERK is 
generally associated with the regulation of meiosis, mitosis in differentiated cells, in 
response to a variety of stimuli, including growth factors, cytokines, virus infection 
and carcinogens. Furthermore, oncogenic Ras activate ERK pathways, which accounts 
for the increased proliferative potential of tumor cells. Activation of ERK by oxidant 
radicals has been reported in a number of studies (Dong et al., 2004; Gupta et al., 
1999; Guyton et al., 1996; Tournier et al., 1997). However, the mechanism for ERK 
activation by ROS is still unclear. It was proposed that stimulation of growth factor 
receptor through oxidative deactivation of phosphatase may account for ERK 
activation (Knebel et al., 1996). Pharmacological deactivation of ERK usually 
sensitizes cells to ROS-induced cell death, suggesting the anti-apoptotic role of ERK 
(Ikeyama et al., 2002; Mijatovic et al., 2005a; Torres, 2003). This action may be due 
to the fact that activation of ERK contributes to phosphorylation and inactivation of 
pro-apoptotic BAD (Hayakawa et al., 2000; Scheid et al., 1999). However, 
contradictory results have been reported that ERK could also promote apoptosis 
depending on the cell type, the stimulus, and the duration of ERK activation 
(Ramachandiran et al., 2002; Tikoo et al., 2001; Zhuang and Schnellmann, 2006).  
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1.5.3 Fig. 1.6 ROS involvement in MAPK pathways. Upon apoptotic stress, 
increased generation of ROS potentiated cells for apoptotic cell death through signaling 
cascade of ASK1-JNK and ASK1-p38 activation. Oxidation and deactivation of 
thioredoxin (Trx) and GST-π (GST) release ASK1 and JNK from their inhibitory 
binding, respectively. Sustained activation of JNK and p38 may in turn result in 
mitochondria-involved apoptosis. In contrast, ERK generally accounts for cell 
survival and differentiation. (Adapted from Shen and Liu. Free Radical Bioloby & 
Medicine. 2006; 40; 928-939.)
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Other redox-sensitive signaling pathways 
Besides the above redox-sensitive pathways, redox radicals could increase protein 
tyrosine phosphorylation by negatively oxidizing protein phosphatase. Active Cys215 
of protein tyrosine phosphatases (PTP) has been found to be reversibly oxidized to 
Cys-SO2H after stimulation of epidermal growth factor (EGF) (Lee et al., 1998). The 
requirement of PTP oxidation in EGF-, PDGF- or insulin-induced protein tyrosine 
phosphorylation indicated the important role of oxidative modification and 
inactivation of PTP (Lee et al., 1998; Mahadev et al., 2001; Meng et al., 2002).  
In conclusion, ROS are important signal transduction molecules involved in cell 
proliferation, senescence and apoptosis (necrosis). ROS mediate these actions through 
reversible or irreversible oxidative modification of key cellular macromolecules. 
Proteins, as the major targets of radical oxidants, are sensitive markers for oxidative 
stress and signaling mediators for the redox-sensitive pathways. Upon oxidative stress, 
low ROS generation may potentiate cell proliferation and malignant transformation. 
However, when ROS reaches intolerable level, pro-apoptotic pathways, such as the 
well-established redox-sensitive ASK1-JNK pathways, are ready to be activated. Thus, 
ROS appear to be a “double-edged sword” on cancer cells, although the precise 
mechanisms are yet to be determined. If this hypothesis works under in vivo 
conditions in human, therapies could be developed accordingly through delicate redox 
modulation: either to keep a relative reducing environment or to strengthen ROS 
generation beyond the tolerable limit to induce apoptotic cell death in vulnerable 
cancer cells. 
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1.6   Objectives of the study  
Presently, the exact anti-cancer molecular mechanism for AE is still unknown. 
Although previous investigations focusing on a single pathway disclosed some of the 
anti-cancer molecular mechanisms of AE, no comprehensive and large-scale studies 
have ever been carried out before. Therefore, we proposed to perform a system-wide 
investigation using a high-throughput proteomics approach followed by biochemical 
validation to identify the functional targets of AE, which are responsible for its 
anti-cancer properties.   
Thus the main objectives of this study are 
1. to comprehensively identify the anti-cancer protein targets of AE by 
proteomic approaches in vitro; 
2. to characterize and validate the affected targets and involved molecular 
pathways by conventional biochemical and cellular approaches; 
The integration of the proteomic and biochemical approaches may help to 
elucidate the relevant molecular pathways affected by AE treatment in hepatoma cells. 
These results will thus lead to a better understanding of the multi-functional effects of 
AE, such as apoptosis, cell cycle arrest, hepatoprotection, anti-metastatic effect, etc. In 
addition, comparison of the affected pathways between AE and EM may help to reveal 
why these two chemically similar hydroxyanthraquinones behave so differently 
biochemically. This comparison might also be useful to understand the combined 
effect of these two hydroxyanthraquinones in the usage of Rhuarb in TCM.  












ALOE-EMODIN INHIBITED TUMOR CELL GROWTH BY AFFECTING 
MULTIPLE PROTEINS 
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2.1 Introduction 
Aloe-emodin (AE) and its analogue emodin (EM) are two main 
hydroxyanthraquinones in Rhubarb root (Huang et al., 2006a). Several earlier studies 
suggested that both AE and EM could inhibit cancer cell growth directly or 
synergistically with other anti-cancer agents (Kuo et al., 2002; Pecere et al., 2000; 
Shieh et al., 2004; Yi et al., 2004; Zhang et al., 1995). The anti-cancer potency of EM 
was at least partially attributed to its inhibition on protein tyrosine kinases, and a 
number of other kinases (e.g. CK2, PKC, and PI3K) (see Chapter 1). In vitro evidence 
also revealed that AE could suppress cell proliferation through induction of cell cycle 
arrest and apoptosis in several cancer cell lines, including human hepatoma (Kuo et 
al., 2002), glioma(Mijatovic et al., 2005a), leukemia (Chen et al., 2004a) and lung 
carcinoma cells (Lee et al., 2005), although the mechanisms are yet unclear. In 
general, the anti-cancer effect of AE, as compared to EM, is less well studied.  
Recently, both AE and EM have received much attention because of their potent 
hepatoprotective (Arosio et al., 2000; Lin et al., 1996) and anti-hepatoma effects (Kuo 
et al., 2002; Shieh et al., 2004). In Traditional Chinese Medicine, rhubarb extract had 
been used to treat hepatitis, one of the main causes of hepatoma (Feng et al., 1994). 
Both AE and EM were also capable of protecting liver from injury induced by carbon 
tetrachloride or D-galactosamine (Arosio et al., 2000; Lin et al., 1996). Furthermore, 
AE had been reported to inhibit stellate cell transformation, which was known to play 
a key role in the pathogenesis of hepatic fibrosis (Woo et al., 2002). Taken together, 
these findings revealed the hepatoprotective capability of AE.  
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To uncover the anti-cancer mechanism of AE, a proteomic approach 
(2D-difference gel electrophoresis (2D-DIGE) coupled with MALDI TOF/TOF 
MS/MS) was adopted to obtain a global view of the differences in protein expression 
levels and/or post-translational modifications in the human hepatoma celll lines, 
HepG2, after AE treatment. This strategy, together with cellular and biomolecular 
studies may reveal the main protein targets of AE. 
2.2 Material and methods 
2.2.1 Chemicals and reagents  
AE, EM and other chemicals were purchased from Sigma-Aldrich (St Louis, 
MO). Cy3, Cy5 and Cy2 N-hydroxysuccinamide ester DIGE dyes, 4-7 linear IPG 
strips and buffer were from GE Healthcare (Bucks, UK). z-VAD-FMK and 
Ac-DEVD-AFC were obtained from Calbiochem (San Diego, CA).  
2.2.2 Cell lines and cell culture 
The human hepatoma cell lines, HepG2 and HCC-M cells were cultured as 
described previously (Liang et al., 2002; Neo et al., 2005). Briefly, cells were grown 
in the DMEM medium (with 100 U/ml penicillin, 100 μg/ml streptomycin, 3.7 g/L 
sodium bicarbonate, pH 7.4) plus 10% FBS in standard incubator conditions (37 °C, 
5% CO2). Similarly, three immortal non-tumorous normal cell lines, including the 
opossum kidney proximal tubule OK cell line, human keratinocyte HACAT cell line 
and human airway epithelial BEAS-2B cell line were cultured under the same 
condition.  
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2.2.3 Cell viability determination by trypan blue exclusion 
The number of total cells and number of dead cells (with damaged cell 
membrane) were counted by the trypan blue exclusion assay. In brief, after the 
indicated treatment, cells were collected by trypsinization, re-suspended in PBS and 
then incubated with 0.2 % (w/v) trypan blue (in Hank’s balanced salt solution) for 5 
min. The number of total cells and number of stained cells were counted using a 
hemacytometer under an inverted light microscope.  
The number of cells and percentage of stained cells were calculated as follows:  
Number of cells per ml = cell number per quadrant * Dilution factor * 10000.  
Percent dead cells = (Number of stained cells / Total number cells) *100.  
2.2.4 Cell viability determination by MTT assay 
Cell proliferation was determined by the 3-(4, 5-dimethylthiazol-2-yl)-2, 5- 
diphenyl tetrazolium bromide (MTT) assay (Mosmann, 1983). In brief, after the 
indicated treatment, cells were re-incubated in fresh medium plus 25 μl MTT solution 
(5 mg/ml in PBS) for 1.5 hr in 37 °C, and lysed in 100 μl lysis buffer (50% 
N,N-dimethyl formamide, 10% (w/v) SDS, 1% acetic acid, pH 4.6) for another 0.5 hr. 
The MTT OD was measured at 590 nm using a TECAN SpectraFluor Plus® 
fluorescence and absorbance microplate reader (Tecan Austria GmbH, Austria).  
2.2.5 DNA content determination by flow cytometry 
The DNA content was determined by flow cytometry (Yang et al., 2000). Briefly, 
after the indicated treatment, trypsinized cells were re-suspended, fixed in pre-chilled 
70% ethanol for at least 2 hr, and incubated with 20 μg/ml propidium iodide (with 0.2 
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mg/ml RNAse A and 0.1% triton X-100 in PBS) for 15 min. Ten thousand cells per 
sample were counted with a flow cytometer (BD Pharmingen, San Diego, CA) and the 
DNA content was analyzed by WinMDI 2.8 software. 
2.2.6 Apoptotic cell death determination by DAPI staining 
Nuclear condensation/fragmentation as a morphological marker for apoptosis was 
determined by DAPI (4, 6-diamidino-2-phenylindole) staining (Shi et al., 2005). In 
brief, after the indicated treatment, cells were fixed with ice-chilled 70% ethanol for 
30 min before staining with DAPI (300 nM in PBS) and visualized under an inverted 
fluorescence microscope. Cells with clear condensed nuclei were considered as 
apoptotic cells. Ten randomly selected fields with more than 200 cells were examined. 
The percentage of apoptotic cells to total cells was presented as means ± SD.  
2.2.7 Caspase 3/7 activity assay 
Caspase 3/7 activity was measured as described previously (Wenzel et al., 2004). 
Briefly, after the indicated treatment, the cytosolic supernatants were extracted in 
0.5% NP-40, 20 mM HEPES pH 7.4, 84 mM KCl, 10 mM MgCl2, 0.2 mM EDTA, 0.2 
mM EGTA, 1 mM DTT, 1 mM PMSF and 1X protease inhibitor cocktail (Roche 
Applied Science, Indianapolis, IN). 20 μl of cell lysate was then incubated with 
fluorogenic caspase 3/7 tetrapeptide-substrate Ac-DEVD-AFC (50 μM) in the activity 
buffer (50 mM HEPES pH 7.4, 100 mM NaCl, 10% sucrose, 0.1% CHAPS and 10 
mM DTT). Cleavage of the caspase 3/7 substrate was determined at an emission 
wavelength of 510 nm after excitation at 410 nm using a TECAN SpectraFluor Plus® 
fluorescence and absorbance microplate reader (Tecan Austria GmbH, Austria). 
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2.2.8 Protein preparation for 2D-DIGE 
After the designated treatment, both adherent and floating HepG2 cells were 
collected and lysed in lysis buffer (7 M urea, 2 M thiourea, 4% w/v CHAPS, 25 mM 
NaF, 1 mM Na3VO4, 1X HALT protease inhibitor (Pierce, Rockford, IL, USA), 50 
μg/ml DNAse I and 50 μg/ml RNAse A). The protein concentration was estimated 
using the Coomassie® Plus Protein Assay Reagent Kit (Pierce, Rockford, IL, USA).  
2.2.9 2D-DIGE 
To ensure reproducibility, three different batches of control, AE- and EM-treated 
cells were used (Table 2.1). Duplicate experiments were also performed for each 
sample. Protein labeling for 2D-DIGE was conducted according to the Ettan DIGE 
user manual (GE Healthcare, Bucks, UK). The control, treated and pooled standard 
(which contained all control and treated samples in equal portions) samples were 
labeled with 200 pmol Cy3, Cy5 and Cy2 respectively. In each 2D-DIGE gel, 75 μg of 
protein sample mixtures, including the Cy3-labeled control, Cy5-labeled treated and 
Cy2-labeled pooled standard samples (each in 25 μg), were prepared for loading. 
The first dimensional electrophoresis step, isoelectric focusing (IEF), was 
conducted as described previously (Neo et al., 2005) with minor modifications, on 
precast 18 cm pH 4-7 linear Immobilized pH gradient (IPG) strips using the IPGphor 
IEF unit (GE Healthcare, Bucks, UK),. Briefly, the pre-labeled samples were loaded 
using the cup-loading method near the anodic end of the strips in the universal strip 
holders. IEF was then carried out as follows: (i) 200 V, 200 Vhr; (ii) 500 V, 250 Vhr; 
(iii) 1000 V, 500 Vhr; (iv) 1000 V – 8000 V, 2250 Vhr and (v) 8000 V, 36000 Vhr. 
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Table 2.1 Experimental plan for 2D-DIGE. Altogether, three different batches of 
samples (each in duplicate) were analyzed by 2D-DIGE. C1, C2, and C3 were control 
samples treated with DMSO for 24 hr; AE1, AE2 and AE3 were samples treated with 
40 μM AE 24 hr; EM1, EM2 and EM3 were samples treated with 40 μM EM for 24 
hr. Pooled standards were combinations of all samples and then labeled with Cy2.  
 
After reduction with 1% DTT and alkylation with 2.5% iodoacetamide of the IEF 
strips, the second dimensional separation (SDS-PAGE) was conducted using 1 mm 
thick, 12.5%T polyacrylamide gel in a Protean II XL electrophoresis cell (Bio-Rad, 
Hercules, CA). Twelve gels were run together in dark at a setting of 30 mA per gel.  
2.2.10 Silver staining 
 Vorum Silver Staining was conducted as described previously (Liang et al., 2002; 
Neo et al., 2005). In brief, after fixation in 120 ml of fixing buffer (50% methanol, 12 
% acetic acid, 0.05 % formalin) overnight, the SDS-PAGE gels were subsequently 
washed in 120 ml of 35% ethanol for 20 min thrice, sensitized in sensitization buffer 
(0.2% silver nitrate 0.076% formalin) for 20 min, developed in developing buffer (6% 
Batch No. Gel No. Cy2-standard Cy3-Control Cy5-Treated
1 1, 2 pooled standards C1 AE1 
1 3, 4 pooled standards  C1 EM1 
2 5, 6 pooled standards C2 AE2 
2 7, 8 pooled standards C2 EM2 
3 9, 10 pooled standards  C3 AE3 
3 11, 12 pooled standards C3 EM3 
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sodium carbonate, 0.004% sodium thiosulphate, 0.05% formalin) till the silver spots 
appear. And finally the reaction was stopped in 1.46% sodium EDTA for 20 min.  
2.2.11 Protein visualization 
Gel Images of the separated proteins were obtained using the Molecular 
Dynamics Typhoon 9400 variable mode imager (GE Healthcare, Bucks, UK) with 
optimal excitation/emission wavelength for each DIGE fluor (Cy2 488/520 nm; Cy3 
532/580 nm; Cy5 633/670 nm, respectively) and viewed with the ImageQuant 
software (GE Healthcare, Bucks, UK). After image acquisition, gels were re-stained 
by silver staining and scanned on an UMAX ImageScanner (Fremont, CA, USA).  
2.2.12 Image analyses and quantitation 
The DIGE images were analyzed using the DeCyder V 5.02 software (GE 
Healthcare, Bucks, UK) according to the Ettan DIGE User Manual. In brief, the DIGE 
images underwent spot detection and quantification in the differential in-gel analyses 
module, with an average of 1600 spots per gel being detected. Next, the matched 
images were analyzed in the biological variation analyses module, which provided 
statistical data of the differentially-expressed spots. Statistically significance (p< 0.01, 
Student’s t-test) and consistent presence in at least 5 out of 6 gels were two criteria for 
the acceptance of the differentially-expressed protein spots. The selected spots were 
filtered based on an average expression level change of at least two-fold.  
2.2.13 In-gel tryptic digestion 
After protein spots were excised manually from silver stained gels, in-gel tryptic 
digestion procedure was conducted (Neo et al., 2005). In brief, each gel plug was 
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washed with H2O, incubated with 150 μl washing buffer [2.5 mM ammonium 
bicarbonate, 50% v/v acetonitrile (ACN)] at 4 °C overnight, reduced with 10 mM DTT 
at 37 °C for 1 hr, alkylated with 55 mM iodoacetamide in the dark at room 
temperature for 45 min, and finally digested in 10 μl trypsin solution (20 μg/ml trypsin 
in 20 mM ammonium bicarbonate) at 37 °C for at least 16 hr. Peptide mixture were 
then extracted with 10 μl of extraction buffer [50% v/v ACN, 0.1% trifluoroacetic acid 
(TFA)] and finally concentrated by Speedvac to about 1-2 μl. 
2.2.14 Mass spectrometry and database searching 
Peptide mixtures were analyzed by MALDI-TOF/TOF in an Applied Biosystems 
4700 Proteomics Analyzer (Foster City, CA), after the trypsin digest were crystallized 
with alpha-cyano-4-hydroxy cinnamic acid matrix solution (5 mg/ml, with 50% ACN, 
0.1% TFA) and spotted onto a MALDI target (192-well) plate. The MS results were 
automatically acquired with a trypsin autodigest exclusion list and the five most 
intense ions selected for MS/MS analysis. The collision gas was atmospheric air and 
the energy was 1 kV. Interpretation was carried out using the GPS Explorer software 
(Applied Biosystems, Foster City, CA) and database searching using the in-house 
MASCOT program (Matrix Science, London, UK). Both combined MS/MS/MS and 
MS/MS searches were conducted with the following settings: MSDB database 
(http://csc-fserve.hh.med.ic.ac.uk/msdb.htm), all entries, peptide tolerance at 200 ppm, 
MS/MS tolerance at 0.3 Da, carbamidomethylation of cysteine (fixed modification), 
phosphorylation at serine, threonine, and tyrosine (variable modifications), methionine 
oxidation (variable modifications) and N-terminus acetylation (variable modification).  
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2.3 Results 
2.3.1 AE, but not EM induced specific cytotoxicity in hepatoma cells 
As shown in Fig. 2.1A and 2.1C by the MTT assay, AE treatment dose- and time- 
dependently inhibited the cell proliferation in HepG2 cells. Similar results were 
obtained in another hepatoma HCC-M cells (Fig. 2.1B and 2.1D); suggesting that such 
an effect was not cell-type specific. These results were consistent with the other 
reported findings that AE was cytotoxic to hepatoma cells (Kuo et al., 2002; Shieh et 
al., 2004). In contrast, its analogue EM was less cytotoxic. The IC50 of EM treatment 
for both HepG2 and HCC-M cells was more than 40 μM (Fig. 2.1A and 2.1B), which 
was twice that for AE (20 μM). This higher cytotoxicity of AE versus EM was found 
to be similar in other cancer cells, e.g. lung carcinoma cells (Lee, 2001) and Merkel 
carcinoma cells (Fenig et al., 2004).  
To evaluate whether AE could specifically inhibit hepatoma cells against other 
non-tumorous normal cells, trypan blue exclusion assay was carried out after 
treatment of AE in several immortal normal cells, including HepG2 cells. As shown in 
Fig. 2.2A, AE dose-dependently decreased the total HepG2 cell number but increased 
the percentage of dead cells (these cells failed to exclude trypan blue due to cell 
membrane damage). On the contrary, higher concentration (up to 100 μM) of AE 
treatment did not induce evident cytotoxicity in BEAS-2B (human airway epithelial 
cell line), OK (opossum kidney proximal tubule cell line), and HACAT (human 
keratinocyte cell line) cells. These findings suggested that AE treatment inhibited 
hepatoma cell growth specifically. 
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Fig. 2.1 AE induced higher cytotoxicity than EM. The HepG2 and Hcc-M cell 
viability was measured by MTT assay in the absence (control) or presence of AE or 
EM as indicated. The control cells were treated with same volume of DMSO vector 
(<0.2%). (A, B). HepG2 and HCC-M cells were treated with increasing doses of AE 
or EM for 48 hr. The percentage of viable cell compared with the control cells was 
presented as means ± SD. (C, D). HepG2 and HCC-M cells were treated with 40 μM 
AE or EM for the indicated times from 12 to 48 hr. The MTT absorbance from each 
group was presented as means ± SD. 
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Fig. 2.2 Specific cytotoxic effects of AE on HepG2 cells as compared to other 
normal immortal cells. AE treatment (20, 40 and 100 μM for 48 hr) was conducted in 
human hepatoma HepG2 cells (A), human airway epithelial BEAS-2B cells (B), 
human keratinocyte HACAT cells (C), and opossum kidney proximal tubule OK cells 
(D). Cell viability (total cells) and the percentage of dead cells with damaged cell 
membrane to exclude tryphan blue were determined by trypan blue exclusion assay. 
At least three batches of samples were tested. The percentage of viable cell and 
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2.3.2 AE induced apoptotic cell death and G2/M arrest 
The preliminary morphological observation revealed that AE treatment induced an 
increasing number of shrunk cells and floating cells, which was an indication of cell 
death. As shown in Fig. 2.3A and 2.3B by DAPI nuclear staining, AE treatment induced 
typical apoptotic nuclear fragmentation and chromatin condensation in HepG2 cells 
time-dependently. This induced apoptosis was further found to be caspase-dependent, 
because pretreatment with the pan-caspase inhibitor z-VAD could substantially protect 
AE-induced apoptosis (Figs. 2.3A, B). Consistently, AE treatment time-dependently 
increased the caspase-3/7 activity from 12 hr till 48 hr time-dependently (Fig. 2.3C). 
The result of DNA content analysis by flow cytometry provided further evidence that 
AE induced nuclear fragmentation, as shown by the increased sub-G1 proportions in 
AE-treated cells (Fig. 2.4). In addition, AE also increased the G2/M proportion, 
indicating its role in G2/M cell cycle arrest. All these effects by AE treatment were 
consistent with earlier reports reported for lung carcinoma (Lee et al., 2005), glioma 
(Mijatovic et al., 2005a) and leukemia cells (Chen et al., 2004a).  
On the contrary, although EM also increased the caspase 3/7-like activity (Fig. 
2.3C), it induced a lower level of apoptotic nuclear fragmentation (Fig. 2.3 B) and 
minimal G2/M cell cycle arrest (Fig. 2.4). The lower percentage of apoptotic cells 
induced by EM was apparently in line with EM’s lower cytotoxicity as determined by 
the MTT assay (Fig. 2.1).  
Taken together, the above results suggested that AE had a higher potential in 
inducing marked apoptotic cell death and cell cycle arrest than EM.   
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Fig. 2.3 AE induced apoptotic cell death. HepG2 cells were pretreated 
with/without 25 μM pan-caspase inhibitor z-VAD-FMK (z-VAD, 30mins) and then 
treated with 40 μM AE or EM as indicated. The nuclear morphology was checked by 
DAPI staining under a fluorescent microscope. (A), Representative DAPI-stained 
nuclei after the indicated treatment were shown. Cells with clear condensed nuclei 
were considered as apoptotic cells. (B), Ratio of the number of apoptotic to total cells 
were presented (n=3). Ten randomly selected fields for more than 200 cells were 
examined. (C), After the indicated treatment with 40 µM AE or EM, caspase-3/7 
activity was determined by measurement of the cleavage of Ac-DEVD-AFC.  
# p<0.01 when compared to treatment only group. 
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Fig. 2.4 AE induced DNA fragmentation and G2/M cell cycle arrest. HepG2 and 
HCC-M cells were treated with 40 μM AE (or EM) for 24 hr or 48 hr as indicated. 
After trypsinization and PI staining, the cell DNA content (subG1, G1/S and G2/M) 
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2.3.3 AE affected the expression of multiple proteins.  
To obtain a comprehensive understanding of the anti-cancer effects of AE, the 
HepG2 cell proteome after treatment with/without 40 μM AE for 24 hr were analyzed 
by 2D-DIGE. As reported earlier, under this treatment condition, only a small 
proportion of cells (10%) succumbed to cell death (Fig. 2.1B), thus ensuring that the 
changes of protein expression were a direct result of AE treatment but not from the 
induced apoptosis. In parallel, the cell proteome after EM treatment was also analyzed 
and compared with that of AE.  
Since the preliminary 2-DE experiment using pH 3-10 non-linear IPG strips 
showed that most of the differentially-expressed proteins were located in the pH 4-7 
region (data not shown), 18 cm pH 4-7 linear IPG zoom strips were subsequently 
chosen for 2D-DIGE experiments. In total, over 1600 proteins were separated by 
2D-DIGE. As shown in Fig 2.5A and Table 2.2, AE treatment affected the expression 
level of multiple proteins. In these cells, 40 protein spots with an expression ratio 
higher than 2.0 were found to be differentially expressed. 22 proteins (from 27 spots) 
were successfully identified by MALDI TOF/TOF MS/MS (Table 2.2). A 
representative MS/MS analysis and database search using the MASCOT program for 
the matched peptides of PRDX6 was shown in Fig. 2.6. On the contrary, EM affected 
the expression level of much fewer protein spots than AE (Fig. 2.5B), which was in 
line with EM’s lower cytotoxicity (Fig. 2.1). The differentially-expressed proteins 
affected by AE or EM treatment were annotated on the representative 2D-DIGE gels, 
respectively (Fig. 2.5).  
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Fig. 2.5 AE and EM treatment affected multiple proteins. The proteome of HepG2 cells treated with/without AE (A) or EM (B) were 
analyzed by 2D-DIGE. Significantly differentially-expressed proteins were labeled as Swiss-Prot entry number (e.g. ACTB stand for 
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Table 2.2 List of differentially expressed proteins in AE- or EM-treated cells identified by MALDI TOF/TOF MS/MS. Average volume 
ratio (Av. Vol. ratio) were obtained from the DeCyder software. Apparent Mr and pI was estimated using in-house program. Mr in kDa. 
Av.Vol. Ratio b) Accession No. a) Protein name Theoretical
Mr/pI 
Apparent
Mr/pI AE EM 
Score Matched Peptides Sequences(c) Sequence 
Coverage (%)
PRDX2_HUMAN Peroxiredoxin 2 22/5.7 28/5.4 5.86 1.46 359 92-109;  120-127; 140-150 18 



























19-28; 85-95; 96-113; 197-206; 
239-254; 292-312 







NUCB1_HUMAN Nucleobindin 1 54/5.1 76/5.1 2.98 1.04 308 54-69; 88-97; 153-163; 190-199; 
311-323; 350-357 
14 
CH60_HUMAN 60 kDa heat shock protein, 
mitochondrial 












61-72; 253-270; 271-292; 373-389; 
432-448 
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Av.Vol. Ratio b) Accession No. a) Protein name Theoretical
Mr/pI 
Apparent
Mr/pI AE EM 
Score Matched Peptides Sequences(c) Sequence 
Coverage (%)
STMN1_HUMAN Stathmin 17/5.8 20/5.4 2.90 1.38 63 14-26 33 
NDKA_HUMAN Nucleoside diphosphate kinase A (p16) 20/5.4 24/5.5 2.85 1.49 153 7-18; 57-66; 106-114 50 










588-603; 815-826; 1445-1453 
254-279; 588-603; 815-826; 




PARK7_HUMAN protein DJ-1 20/6.3 28/5.9 2.47 1.56 127 13-27; 33-48;  68 
TCPB_HUMAN T-complex protein 1, beta subunit  57/6.0 60/6.1 2.43 1.26 65 120-130; 181-188; 358-375; 501-515 41 
MPPA_HUMAN Mitochondrial processing peptidase 
alpha subunit 
58/6.4 60/6.15 2.43 1.26 176 84-99; 159-177; 251-268; 270-288 37 
VINC_HUMAN Vinculin 124/5.5 120/6.0 2.38 1.24 114 114-132; 548-561; 608-629; 833-853; 40 
PDIA3_HUMAN Protein disulfide-isomerase A3 57/6.0 72/5.7 2.37 1.60 155 336-344; 352-363; 472-282 35 
PRDX4_HUMAN Peroxiredoxin 4 30/5.9 29/5.6 2.33 1.32 100 187-200; 213-223 9 
RUVB1_HUMAN RuvB-like 1  50/6.0 54/6.3 2.33 1.36 187 318-333; 340-357 7 
IF5A1_HUMAN Eukaryotic translation initiation factor 
5A-1 
17/5.1 17/5.0 2.29 1.27 111 117-139 46 
ECHM_HUMAN Enoyl-CoA hydratase, mitochondrial 31/8.3 31/5.8 2.19 1.45 81 119-127; 158-178 39 
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Av.Vol. Ratio b) Accession No. a) Protein name Theoretical
Mr/pI 
Apparent
Mr/pI AE EM 
Score Matched Peptides Sequences(c) Sequence 
Coverage (%)
Q5SZX8_HUMAN Chaperonin Containing TCP1, subunit 3 
isoform b 
61/6.1 72/6.1 2.04 1.26 206 203-215; 427-437; 438-448 6 
Q86U75_HUMAN Dihydropyrimidinase-like 2 68/5.6 72/6.2 2.03 1.08 64 174-189; 190-211 6 
CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A 16/5.2 17/5.4 2.01 1.04 193 30-46; 88-99; 113-124 50 
MTND_HUMAN 1,2-dihydroxy-3-keto-5-methylthiopente
ne dioxygenase  
22/5.6 24/5.6 -2.20 -1.41 100 2-15; 83-96; 97-108; 109-116;  68 
ABHEB_HUMAN Abhydrolase domain-containing protein 
14B 
22/5.9 26/6.0 -2.40 -1.06 168 9-22; 33-42; 43-56 32 
COF1_HUMAN d) Cofilin-1 19/8.2 22/6.4 -1.12 -4.33 249 35-45; 54-73; 74-81; 82-92; 96-112; 
133-144 
72 
GRB2_HUMAN d) Splice isoform GRB3-3 of growth factor 
receptor-bound protein 2 
20/5.5 23/6.4 1.09 -2.78 110 84-95; 102-108 71 
 
a). Represents entry numbers from Swiss-Prot database.  
b). Positive value signifies up-regulation against control samples and negative value signifies down-regulation in terms of fold-differences. 
All ratio is statistically significant with t<0.01 (Student’s t test). 
c). The matched peptides are shown in relation to the amino acid sequences of individual protein.  
d). Represent differentially-expressed proteins only found in EM-treated cells.  
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Fig. 2.6 A representative TOF-TOF MS/MS analysis of PRDX6. After trypsin 
digestion, protein spots were analyzed by MS/MS and database search using the 
MASCOT program. The matched peptides were annotated with amino acid sequence 
and score. The bottom panel of (A) showed the MS/MS results of one selected 
peptide.  
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2.3.4 General functional classification of AE-affected proteins 
In HepG2 cells, AE treatment altered the expression level of multiple proteins. In 
terms of subcellular location, most differentially-expressed proteins resided in the 
cytoplasm. Others may predominantly resided in the mitochondrion (CH60, CPSM, 
MPPA, ECHM), nucleus (NDKA, PARK7, IF5A1, ABHEB), endoplasmic reticulum 
(PDIA3) or Golgi apparatus (NUCB1).  
On the other hand, in terms of known protein function, these affected proteins 
were found to be involved in different aspects of cellular functions, including redox 
regulation, protein folding, cell cytoskeleton and adhesion, metabolism, and 
transcription/translation. It is noteworthy that in AE-treated cells, many differentially 
expressed proteins were found to be functionally related to oxidative stress and cancer 
initiation/progression (Fig. 2.7).  
 On the contrary, EM treatment only affected a few proteins (Fig. 2.5 and Table 
2.2), which was in line with its lower cytotoxicity (Fig. 2.1). Among the affected 
proteins, redox-sensitive proteins PARK7, PDIA3, ACTG were up-regulated by EM, 
which was similar to AE treatment. However the up-regulation levels for these three 
proteins by EM were much lower than that for AE (Table 2.2). Whether up-regulation 
of these proteins was a direct result of the treatment by rhubarb hydroxyanthraquinone 
(EM and AE) or indirectly as a consequence of the induced oxidative stress was yet to 
be determined. It is noteworthy that cofilin was significantly down-regulated by EM, 
but not AE. Although this protein has been found to be associated with both apoptosis 
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and metastasis (Chua et al., 2003; Wang et al., 2006b), the significance of the 
down-regulation of cofilin after EM treatment had to be determined.  
Taken together, AE differentially affected the expression level of multiple 
proteins with known anti-cancer properties, thus indicating the possible functional 
effects of AE. In contrast, EM affected fewer proteins and also at a lower expression 




Fig. 2.7 Schematic representation of the affected proteins in AE-treated cells. AE 
affected multiple proteins which have been reported to be involved in oxidative stress 
and/or cancer. Some cancer–related proteins were labeled with their known functions.  
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2.4 Discussion 
The present study demonstrated that AE treatment affected multiple proteins that 
are functionally associated with oxidative stress and cancer.  
AE exhibited a higher cytotoxicity in hepatoma cells than in several immortal 
normal cells, including human airway epithelial BEAS-2B cells, opossum kidney 
proximal tubule OK cells and human keratinocyte HACAT cells (Fig. 2.2). This 
specific anti-cancer effect of AE has been consistently demonstrated in several earlier 
in vitro cell studies, including human oral squamous cell carcinoma (HSC-2) and 
salivary gland tumor (HSG) cell lines vs. human gingival fibroblasts (HGF) cells (Shi 
et al., 2001), human neuroectodermal tumor cells vs. normal human lung fibroblast 
MRC5 cells and hemopoietic progenitor cells (Pecere et al., 2000), mouse L929 
fibrosarcoma and rat C6 astrocytoma cells vs. primary astrocytes and fibroblasts 
(Mijatovic et al., 2004). Taken together, this anti-cancer specificity may potentiate AE 
as a specific chemotherapeutics drug. It is noteworthy that endothelial cells (bovine 
aortic endothelial BAEC cells and human umbilical vein endothelial HUVEC cells) 
were recently reported to be sensitive to AE (Cardenas et al., 2006). This property was 
suggested to be useful for modulation of angiogenesis and anti-cancer effects 
(Cardenas et al., 2006). 
Furthermore, AE exhibited a higher cytotoxicity than its analogue EM in 
hepatoma cells (Fig. 2.1). This result of AE’s higher cytotoxicity is consistent with 
previous studies conducted in Merkel cell carcinoma (Fenig et al., 2004), lung 
carcinoma CH27 (Lee, 2001), human oral squamous cell carcinoma (HSC-2) and 
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salivary gland tumor (HSG) cell lines (Shi et al., 2001). It would be immensely 
informative to understand the molecular mechanism responsible for this higher 
cytotoxicity of AE over EM, since AE had been reported to be less competent in 
inhibiting most kinases than EM (reviewed in section 1.1.5).  
AE was shown to induce apoptosis and G2/M cell cycle arrest (Fig. 2.3 and 2.4), 
but the underlying mechanism for this effect is yet to be determined. In order to 
elucidate this phenomenon, a proteomics investigation was conducted to obtain a 
global view of the affected proteins by AE treatment. More importantly, proteomic 
approaches can also monitor post-translational modifications of proteins (e.g. protein 
phosphorylation and ubiquitination, key regulations for protein activity and turnover), 
considering that AE and EM may affect protein phosphorylation by inhibiting 
different kinases activities. In this study, 2D-DIGE, a quantitative 2-DE method was 
used. In 2D-DIGE, the same amount of control samples and treated samples were 
labeled with fluorescent dyes Cy3 or Cy5 respectively and loaded together in the same 
gel to minimize the gel-to-gel variance. Moreover, the introduction of a pooled 
internal standard (which consisted of equal amount of all control and treated samples 
and labeled with Cy2 dye) enabled accurate quantification and matching between 
different gels (Alban et al., 2003). The fluorescence intensities (as indicators for the 
protein expression levels) were then determined by the DeCyder V 5.02 software. This 
method had greatly increased data quality and confidence.  
The 2D-DIGE result (Fig. 2.5) showed that AE treatment affected several 
proteins, which are functionally associated with oxidative stress and cancer 
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initiation/progression (Fig. 2.7). Redox-sensitive proteins, including peroxiredoxin-2, 
-4 and -6, protein disulfide-isomerase A3 (PDIA3), actin (ACTG or ACTB), 60 KD 
heat shock protein (CH60), protein DJ-1 (PARK7) and enoyl-CoA hydratase (ECHM) 
were among those markedly up-regulated in AE-treated cells (Table 2.2). The 
up-regulation of these redox-sensitive proteins (Fig. 2.7, Box: redox-sensitive 
proteins) has been frequently reported in several earlier studies in which oxidative 
stress was involved (Cesaratto et al., 2005; Fratelli et al., 2002; Fratelli et al., 2003). 
These up-regulation of these proteins are common cellular responses and function to 
reduce the induced oxidative stress, thus suggesting the involvement of oxidative 
stress in AE treatment in the present study. Besides, two other redox-sensitive proteins 
with volume ratio slightly less than 2 that were up-regulated in AE-treated cells were 
alpha enolase (ENOA, up-regulated in two spots, 1.94 and 1.89 fold) and thioredoxin 
reductase 1 (TRXR1, up-regulated 1.86 fold) (Fig. 2.5). These two redox-sensitive 
proteins have also been reported to be up-regulated and oxidized in many in vitro and 
in vivo systems under oxidative stress (Cesaratto et al., 2005; Fratelli et al., 2002). 
Besides, alpha enolase, as a tumor suppressor, is an inhibitory binding protein of 
c-myc promoter and in turn suppress transcription and cell growth (Feo et al., 2000). 
Furthermore, the MALDI TOF/TOF MS/MS results suggested that methionine 
oxidation was found in the peptide fragments of some proteins (e.g. protein DJ-1, 
ENOA, TRXR1, and GARS protein) in the AE-treated but not in the untreated cells 
(data not shown), further supporting the involvement of oxidative stress.  
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Oxidative stress may cause reversible or irreversible damage to certain 
redox-sensitive proteins and in turn affect the cell fate by inducing cell death or cell 
senescence (see section 1.3.2). For example, oxidation of 2-Cys peroxiredoxin was 
recently found to be a molecular switch controlling the transcriptional response to the 
increasing level of hydrogen peroxide (Bozonet et al., 2005; Wood et al., 2003). Of 
the differentially-expressed proteins affected by AE treatment, peroxiredoxins (e.g. 
PRDX2, PRDX4 and PRDX6) are among the list of most highly up-regulated 
proteins. It is worth noting that PRDX2, PRDX4 and PRDX6 are also named as 
thioredoxin peroxidase 1, thioredoxin peroxidase AO372 and non-selenium 
glutathione peroxidase, respectively. Peroxiredoxins have also been reported to be 
increased in cells stressed with oxidants such as H2O2 (Cesaratto et al., 2005; Fratelli 
et al., 2002) or ionizing radiation (Wang et al., 2005). These proteins share a 
conserved sequence region that contained a reactive cysteinyl residue near the 
N-terminus of the proteins, which may probably act as a reaction intermediate to 
reduce the peroxide. PRDX-2 and -4 belonged to the 2-Cys subgroup of 
peroxiredoxins while PRDX 6 belonged to the 1-Cys subgroup, based on their 
cysteinyl residue site. Under oxidative stress, the reactive Cys residues are ready to be 
oxidized to form cysteine sulfenic acid (Cys-SOH), and further oxidized to cysteine 
sulfinic acid (Cys-SO2H) or cysteine sulfonic acid (Cys-SO3H) (Kwak et al., 2006). 
Recently, it was reported that oxidation of peroxiredoxins in the form of Cys-SO2H 
and/or Cys-SO3H is a sensitive marker of oxidative stress in HepG2 cells in vitro and 
transplanted livers during ischemia/reperfusion in vivo (Cesaratto et al., 2005). Taken 
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together, the up-regulation and oxidation of these redox-sensitive proteins found in the 
present study suggested that oxidative stress might be involved in the cytotoxicity of 
AE. But whether AE directly induce oxidative stress and the role of oxidative stress in 
AE-induced apoptotic cell death are yet to be determined. This part will be discussed 
in the next Chapter. 
Besides these redox-sensitive proteins, the other proteins affected by AE are 
related to cancer initiation and/or progression (Fig. 2.7, Box: cancer-related proteins). 
For example, up-regulation of p16 and stathmin are associated with DNA synthesis 
inhibition (Ivanchuk et al., 2001; Serrano, 2000) and G2/M cell cycle arrest (Kong et 
al., 1992) respectively. Tumor suppressor protein p16 functions in inhibiting CDK4/6 
activity and DNA replication (Sherr, 2004). On the other hand, stathmin is known to 
play a critical role in the regulation of the microtubule filament system. In its active 
hypophosphorylated form, it can promote depolymerization of microtubules and/or 
preventing polymerization of tubulin heterodimers, which plays a key role in cell 
mitosis (see review (Kong et al., 1992)). Disruption of stathmin function either by 
forced or inhibited expression both results in reduced cellular proliferation and G2/M 
cycle arrest (Luo et al., 1998; Marklund et al., 1994). It is of interest to note that the 
up-regulation of stathmin has also been reported to be associated with G2/M arrest in 
pancreatic ductal carcinoma cell lines treated with trichostatin-A, a potent inhibitor of 
histone deacetylases (Cecconi et al., 2003). Thus, up-regulation of these two proteins 
may be responsible for the anti-proliferative effect of AE.  
In the study here, 1, 2-dihydroxy-3-keto-5-methylthiopentene dioxygenase 
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(MTND) was found to be down-regulated by AE. Considering that this protein had 
been reported to be essential for hepatitis C virus replication (Yeh et al., 2001), the 
findings in this study suggested that AE could have an anti-hepatitis potential. This 
effect may account for the anti-hepatitis effect of Rhubarb application in TCM.  
Interestingly, AE treatment up-regulated the expression level of nucleoside 
diphosphate kinase A (NDKA, or nm23 as gene name), a metastasis suppressor (Fig. 
2.5 and Table 2.2). Low expression of NDKA had been reported to be correlated with 
poor patient prognosis and survival in several epidemiological cohort studies, 
including hepatocellular carcinoma (Hartsough and Steeg, 2000). The present finding 
of up-regulation of NDKA by AE thus suggested that AE may also have an 
anti-metastatic capability, although its analogue EM had been shown to inhibit 
invasion (Huang et al., 2004), migration (Huang et al., 2005) and adhesion (Huang et 
al., 2006b) in human carcinoma cells. Thus, AE treatment altered the expression level 
of multiple proteins, which may contribute to its anti-cancer potentials, including 
inhibition of DNA synthesis and HCV replication as well as cancer metastasis. Some 
of these representative proteins have been selected for further functional studies and 
these findings are reported in Chapter 4. 
On the contrary, EM, although structurally similar to AE, only caused mild 
up-regulation of the redox-sensitive proteins DJ-1, actin and protein disulfide 
isomerase (Fig. 2.5 and Table 2.2). This probably corresponding to its lower 
cytotoxicity in HepG2 cells (Fig. 2.1). Besides, cofilin was significantly 
down-regulated in EM-treated cells but not in AE-treated cells (Fig. 2.5 and Table 2.2). 
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It is worth noting that in the 2D-DIGE map, this protein was located at around pI 6.4. 
However, its theoretical pI is 8.2 (which is beyond the pI range of 4-7 IPG strip). It 
indicated that this acidic form of cofilin (pI 6.4) may be a phosphorylated form of 
cofilin. Cofilin has been reported to be a member of the cofilin/actin depolymerization 
factor family. It regulates actin dynamics by promoting the rate of actin 
depolymerization and facilitating actin filament turnover (Chen et al., 2000). Cofilin 
has also been recently reported to be directly associated with invasion, intravasation, 
and metastasis of mammary tumors (Wang et al., 2006b). On the other hand, cofilin 
can also function as a pro-apoptotic protein. Mitochondrial translocation of 
dephosphorylated cofilin was found to be an essential step in apoptosis induction 
before cytochrome c release (Chua et al., 2003). Transfection of mutated cofilin (at its 
phosphorylation site) can suppress its mitochondrial translocation and subsequent 
apoptosis-stimulating action (Chua et al., 2003). However in the present study, the 
decrease of acidic form of cofilin in EM-treated cells but not in AE-treated cells may 
not be crucial for apoptosis, because EM can only induce mild apoptotic cells death at 
a latter time point when compared with AE. This down-regulation of (phosphorylated) 
cofilin may just be derived from the inhibition of its upstream kinase (e.g. Lim kinase), 
since EM is capable of inhibiting many kinases. The role of this protein in 
EM-induced cell death will be further discussed in Chapter 4.  
In the present study, the pH 4-7 IPG strips were chosen for 2D-DIGE 
investigation, because most affected proteins were found in this region in a 
preliminary study using pH 3-10 none-linear IPG strips. The usage of 18cm pH 4-7 
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zoom strips double the gel resolution in this region compared with that of pH 3-10 
strips and is helpful to separate proteins with similar pI, Mr in this range. Nevertheless, 
other proteins that possibly account for AE-induced anti-proliferative effects may 
reside outside of this pI range. Those proteins will not be present in the gel of 
2D-DIGE using pH 4-7 zoom strips. On the other hand, considering the wide dynamic 
range of protein concentration (10 to 12 order of magnitude) in cells, 2D-DIGE may 
not be sensitive enough to detect proteins with low abundance. Thus these proteins 
would not be studied here.  
In summary, AE induced higher cytotoxicity in hepatoma cells than EM through 
induction of apoptosis and cell cycle arrest. Using 2D-DIGE, we revealed that AE 
treatment affected several proteins that are functionally associated with oxidative 
stress, cell cycle arrest, anti-metastatic, and other anti-cancer activities. Some of these 
proteins were then selected for further functional studies and will be reported in the 
subsequent chapters. 













ALOE-EMODIN INDUCED APOPTOSIS THROUGH OXIDATIVE STRESS 
AND SUSTAINED JNK ACTIVATION 
 
   86
3.1 Introduction 
In the previous Chapter of proteomic investigation, AE was found to alter the 
expression of a number of proteins involved in oxidative stress, cell cycle arrest, 
anti-metastasis and apoptosis. Among the affected proteins, redox-sensitive proteins 
(e.g. PRDX and DJ-1) were found to be highly up-regulated, suggesting that oxidative 
stress may be involved in AE-induced cytotoxicity. This should not be surprising, as 
the quinone structure of AE is highly redox active. It could, for example, form a redox 
cycle with its semiquinone radicals, leading to the formation of ROS (Pryor, 1982; 
Watanabe and Forman, 2003). Furthermore, AE was recently reported to induce DNA 
damage via excessive ROS production in human lung cancer cells (Lee et al., 2006a).  
 To minimize oxidative damage resulting from excessive production of ROS, cells 
are equipped with both enzymatic and non-enzymatic antioxidant defenses, including 
superoxide dismutase (SOD), catalase, and a variety of low molecular weight 
antioxidants such as glutathione and vitamins. Particularly, the GSH / GSSG couple 
provides an efficient protective system against the redox imbalance (Chandra et al., 
2000). Many chemotherapeutic drugs may induce apoptotic cell death by exhausting 
the intracellular thiol buffer system through depletion of GSH (Ghibelli et al., 1995) 
or redistribution of GSH (Voehringer et al., 1998). The unbalanced redox states may 
further trigger downstream cellular signaling events, such as mitochondrial 
dysfunction and other signaling pathways which lead to apoptotic cell death (Chandra 
et al., 2000).  
 Among the various redox-activated cell signaling pathways are the 
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well-established mitogen-activated protein kinases (MAPKs) (Benhar et al., 2002). 
There are three subgroups of MAPKs: ERK (extracellular signal-regulated kinases), 
JNKs (c-Jun N-terminal kinases) and p38. It has been well-established that JNK and 
p38 mainly play a pro-apoptotic function in response to various cellular stress, while 
the ERK subgroup is primarily involved in proliferative responses (Kyriakis and 
Avruch, 2001; Lewis et al., 1998; Shen and Liu, 2006). AE has been reported as an 
inhibitor of the ERK pathway (Mijatovic et al., 2005a) and an inducer of p38 pathway 
(Yeh et al., 2003) in human carcinoma cells. However, the involvement of JNK 
pathway in AE-induced oxidative stress and apoptosis has not been reported yet.  
 The present study aims to investigate the role of oxidative stress and MAPK 
pathway in AE-induced apoptotic cell death. The results obtained demonstrated that 
JNK are the key effector molecules in AE-induced apoptosis in response to 
AE-mediated oxidative stress and protein oxidation.  
3.2 Materials and methods 
3.2.1  Reagents, antibodies and plasmid 
AE, EM, hydrogen peroxide, GSH-monomethylester, buthionine-L-sulfoximine, 
mercaptosuccinic acid and other chemicals were purchased from Sigma-Aldrich (St 
Louis, MO). Cell permeable JNK inhibitor III was from Merck (San Diego, CA).  
Antibodies against cytochrome c and GST-π were purchased from BD 
Pharmingen (San Diego, CA). The following antibodies were bought from Cell 
Signaling (Beverly, MA): caspase-3, caspase-8, caspase-9, PARP, phospho-cJun 
(ser63), phospho-cJun (ser73), Cu/Zn-SOD, ASK1, phospho-ERK (Thr202/Tyr204) 
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and COX IV. Antibodies against DNP, peroxiredoxins, phospho-JNK (Thr183/Tyr185), 
JNK1, JNK2, Trx and tubulin, together with small interfering RNA (siRNA) specific 
against human peroxiredoxin 2 and total peroxiredoxin, JNK1, JNK2 and control 
(non-silencing) siRNA were from Santa Cruz (Santa Cruz, CA). 
Anti-peroxiredoxin-SO3 IgG was from Labfrontier (Seoul, Korea). Rainbow-colored 
protein molecular weight marker was obtained from GE Healthcare (Amersham, 
Bucks, UK). The SuperSignal Dura ECL kit was from Pierce (Rockford, IL).  
The pEGFP-N1 expression vector was from Clontech (Palo Alto, CA). The 
pEGFP-C3/sod1 vector was a kind gift from Dr. J. J. Bower at West Virginia 
University. The dominant-negative JNK1 and JNK2 expression vectors (JNK1-DN 
and JNK2-DN) and constitutive active JNNK2-JNK1 vector were generous gifts from 
Dr. A.G. Porter (Li et al., 2004). The wild-type HA-ASK1, C-terminal coiled-coil 
domain deletion mutant of ASK1 expression vector and the anti-phospho-ASK1 
(thr845) antibody were graciously provided by Dr. H. Ichijo (Tobiume et al., 2002).  
3.2.2  Cell culture and treatments 
The human hepatocellular carcinoma cell lines, HepG2, HCC-M and Hep3B cells 
were cultured as described previously (Liang et al., 2002; Neo et al., 2005). Briefly, 
the hepatoma cells were grown in the DMEM or MEM medium (with 100 U/ml 
penicillin, 100 μg/ml streptomycin, 3.7 g/L sodium bicarbonate, pH 7.4) plus 10% 
FBS in standard incubator conditions (37℃, 5% CO2). AE was dissolved in DMSO as 
a stock solution of 100 mM. In all treatments, the control group was treated with the 
same amount of DMSO.  
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3.2.3  Determination of apoptosis 
Nuclear fragmentation and chromatin condensation as a marker for apoptotic cell 
death was determined in section 2.2.6. 
3.2.4  Analysis of intracellular glutathione (GSH/GSSG) 
Intracellular glutathione were analyzed as described previously (Zhang et al., 
2004a). Briefly, after the indicated treatment, the same number of cells were collected 
and lysed in lysis buffer (0.1 M sodium phosphate, 5 mM EDTA, pH 8.0). After cell 
homogenization using an ultrasonic probe, proteins were precipitated by mixing with 
25% metaphosphoric acid. The supernatant was then collected and the GSH contents 
were measured by adding ο-phthaladehyde (50 μg/ml) for 15 min before fluorescence 
excitation at 350 nm and detection at 420 nm. For the detection of GSSG, the same 
amount of supernatant was reacted with N-ethylmaleimide (0.04M) for 30 min to 
eliminate free GSH. Then the solution was diluted 10 times with 0.1 M NaOH before 
the ο-phthaladehyde (50 μg/ml) reaction and fluorescence measurement.  
3.2.5  Measurement of ROS production in cells 
The intracellular production of ROS was estimated using chloromethyl-2,7- 
dichlorofluorescein diacetate (CM-H2DCFDA, Molecular Probe, Eugene, OR) as 
described previously with minor modifications (Zhang et al., 2004a). Briefly, after 
designated treatments, cells were trypsinized and incubated with CM-H2DCFDA (5 
μM) at 37 °C for 30 min. Afterwards, cells were collected and washed three times with 
PBS. 10000 cells were immediately measured by flow cytometry (BD Pharmingen, 
San Diego, CA) with excitation at 488 nm and emission at 525 nm.  
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3.2.6  Measurement of mitochondrial outer membrane potential 
The mitochondrial outer membrane potential (MOMP) was estimated using 
tetramethylrhodamine methyl ester (TMRM, Molecular Probe, Eugene, OR) (Zhang et 
al., 2004a). Briefly, at the end of each designated treatments, trypsinized cells were 
incubated with 200 nm TMRM at 37 °C for 15 min. Afterwards, cells were washed 
three times with PBS before detection with excitation/emission at 488/535 nm.  
3.2.7 Cell subfractionation and detection of the release of mitochondrial proteins 
Cell subfractionation were conducted as described previously (Zhang et al., 
2004b). In brief, after the indicated treatment, cells were re-suspended in ice-chilled 
isotonic homogenization buffer (250 mM sucrose, 10 mM KCl, 1.5 mM MgCl2, 1 mM 
EDTA, 0.1 mM PMSF, 10 mM Tris, pH 7.4) for 10 min. After passing through gauge 
#27 needles for 20 times to break the cell membrane, the cell homogenates were 
subjected to a series of centrifugation steps (50 × g for 10 min, 500 × g for 20 min and 
finally 15000 × g for 20 min) to fractionate unbroken cells, heavy nuclear fraction and 
mitochondria fraction, respectively. The mitochondria rich fractions were lysed with 
Western blotting lysis buffer (see below). After a final centrifugation step at 60,000g 
at 4°C for 20 min, an equal amount of mitochondrial and cytosolic proteins were 
subjected to Western blotting for detection of cytochrome c.  
3.2.8 Co-immunoprecipitation 
The co-immunoprecipitation was conducted as described previously (Huang et al., 
2005). In brief, after the designated treatment, cells were collected and treated with the 
co-immunoprecipitation lysis buffer (50mM HEPES, pH 7.6, 250 mM NaCl, 0.1% 
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NP-40, 5mM EDTA, 0.5mM PMSF and 1X Complete® proteinase inhibitor cocktail 
(Roche Molecular Biochemicals, Indianapolis, IN)) for 30 min on ice. Equal amount 
of protein samples (500 μg) were incubated with 2 μg IgG antibodies against JNK1/2 
or Trx respectively and rotated overnight at 4°C. The protein-antibody complexes 
were then incubated with protein A/G agarose beads (Roche Molecular Biochemicals, 
Indianapolis, IN) for 1 hr. The beads bound with protein-antibody complexes were 
washed with iced-cold lysis buffer five times and then eluted with SDS sample 
loading buffer before SDS-PAGE. 
3.2.9 Western blotting 
Western blotting were conducted as described previously (Huang et al., 2005). 
After the indicated treatment and cells collection, protein samples were treated with 
lysis buffer (20 mM Tris, 0.5% NP-40, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 2 
mM DTT, 0.5 mM PMSF, 20 mM β-glycerol phosphate, 0.5 mM sodium vanadate and 
1X Complete® protease inhibitor). For analysis of MAPK molecules, cells were lysed 
in SDS lysis buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol and 1X 
Complete® protease inhibitor).  
Protein concentration was determined by the Bio-Rad DC protein assay (Bio-Rad, 
Hercules, CA). Equal amounts of proteins were then fractionated on 11% SDS-PAGE 
in the Mini-PROTEAN II system (BioRad, Hercules, CA) and blotted onto PVDF 
membranes (Millipore, Bedford, MA). It is worth noting that oligomerization of 
GST-π was analyzed in non-reducing conditions (i.e. no DTT in lysis buffer and no 
β-mercaptoethanol in SDS sample loading buffer) (Adler et al., 1999).  
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After blocking with 5% nonfat milk in TBST buffer (10 mM Tris-HCl, pH 7.5, 
100 mM NaCl, 0.1% Tween 20) for 1 hr at room temperature, the transblotted 
membrane was probed with various first antibodies and then second antibodies 
individually. The signals were then visualized with SuperSignal® West Dura Kit 
(Pierce, Rockford, IL) according to the manufacturer’s protocol. Densitometric 
measurements were performed using the Kodark 1D 3.5 Image Station (Kodark, 
Rochester, NY). 
3.2.10 Derivatization of protein carbonyls for 1-DE and 2-DE Western blotting 
Protein samples were derivatized with 2, 4-dinitrophenylhydrazine (DNPH) by 
two methods for either 1-DE or 2-DE Western blotting. For 1-DE Western blotting, 
cells were collected as mentioned above and lysed in 6% SDS lysis buffer (62.5 mM 
Tris-HCl, pH 6.8, 6% SDS, 10% glycerol and 1X Complete® protease inhibitor). 
Equal amount of protein extract was incubated with 10 mM DNPH (in 5% 
trifluoroacetic acid) and vortexed for 20 min at room temperature. The reaction was 
then terminated by adding 1.5 volumes of neutralizing solution (2 M Tris, 30% 
glycerol).  
On the other hand, post-isoelectric derivatization of protein carbonyls was 
conducted for 2-DE samples as described previously (Conrad et al., 2001). In brief, 
the IPG strips were incubated with/without 10 mM DNPH for 20 min. The reaction 
was then stopped by incubation with the neutralizing solution (2 M Tris, 30% glycerol) 
for 15 min. Following this, the second dimensional separation was conducted as 
described in section 2.2.9.  
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3.2.11 Colloidal silver staining 
The colloidal silver stain was used to visualize the protein profiles after the 
Western blotting step (Liang et al., 2002; Neo et al., 2005). After washing the 
membranes with fresh water thrice (5 min each), they were incubated with 25 ml of 
staining solution (2 mg/ml silver nitrate, 2 mg/ml sodium citrate, 8 mg/ml iron sulfate) 
for 15-30 min until a clear image appeared.  
3.2.12  Gene transient transfection for over-expression or knocking-down  
Gene transient over-expression and knocking-down experiment were conducted 
by electroporation using the Nucleofector® purchased from Amaxa (Gaithersburg, 
MD) according to the manufacturer’s user manual. In brief, 1-5 X 106 cells were 
collected and re-suspended in 100 μl of Nucleofector® solution. The cell suspension 
was then mixed with 1-5 μg DNA (gene construct or empty vectors) or 0.5-3 μg 
siRNA as designated and immediately transferred into an Amaxa cuvette. The 
electroporation was performed using the Nucleofector® program T-28. Afterwards, 
cells were re-suspended in fresh DMEM medium. Designated treatment was 
conducted for 36 hr after transfection in the gene over-expression assay or 48 hr in the 
knockdown study.   
3.3 Results 
3.3.1  AE induced mitochondrial-mediated apoptosis 
The results in Chapter 2 revealed that AE was capable of inducing 
caspase-dependent apoptosis in human hepatoma cells. Here the cell death signaling 
pathway was further investigated. As shown in Fig. 3.1A, AE induced time- and 
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dose-dependent cleavage/activation of caspase-9 and caspase-3. Consistently, AE 
induced increasing cleavage of poly (ADP-ribose) polymerase (PARP), one of the 
caspase-3 substrates. However, there was no evidence of cleavage/activation of 
caspase-8 (Fig. 3.1A), the initiator caspase for the death receptor-mediated extrinsic 
apoptotic pathway. Next, there was drastic translocation of cytochrome c from 
mitochondria to cytosol, preceding activation of caspase 9 and 3 (Fig. 3.1B). In 
addition, AE treatment decreased mitochondrial outer membrane potential (MOMP) in 
the TMRM assay, indicating that mitochondrial membrane integrity/function was 
impaired (Fig. 3.2C). These results thus suggested that AE-induced apoptosis was 
mainly executed via the mitochondria-mediated intrinsic cell death pathway. And this 
conclusion was comparable to the results conducted in neuroblastoma cells, for which 
mitochondrial-dependent intrinsic but not extrinsic apoptotic pathway activation was 
involved in AE-induced apoptosis (Pecere et al., 2003).  
Another two hepatoma cell lines (HCC-M and Hep3B cells) were studied to 
determine whether mitochondrial-mediated apoptosis by AE was HepG2 cell specific. 
It is noteworthy that both p53 wide-type cells (HepG2 and HCC-M) and p53 deficient 
cells (Hep3B) succumbed to AE-induced apoptosis, as evidenced by the 
time-dependent increase of nuclear condensation (Fig. 3.1C) and the cleavage of 
caspase-9, caspase-3 and PARP, but not caspase-8 (Fig. 3.8A). Therefore these 
findings suggested that AE-induced apoptosis is not cell line specific and it is believed 
that the apoptosis process involved the intrinsic pathway in human hepatoma cells.  
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Fig. 3.1 AE induced mitochondrial-mediated apoptosis. (A). After the indicated 
treatment, HepG2 cells were collected and subjected to Western blotting for detection 
of cleavage of procaspase-3, -8, -9 and PARP. (B). Mitochondrial and cytosolic 
fractions from cells treated with/without AE were fractionated as described in 
Materials and Methods. Cytochrome c was then probed in each fraction, with COX IV 
as mitochondrial loading control and tubulin as the cytosolic loading control. (C). 
Three different hepatoma cells (HepG2, HCC-M and Hep3B) were incubated with 40 
μM AE for 24 and 48 hrs. Cell death was determined by DAPI staining as above.  
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Fig. 3.2 AE increased ROS generation but decreased MOMP. (A) Kinetics of 
AE-induced ROS generation in HepG2 cells was measured using CM-H2DCFDA 
(5µM). Cells were treated with 40 µM AE as indicated. The cells were stained with 
CM-H2DCFDA (5 µM, 30mins) and then washed with PBS before measurement of 
the DCFDA intensity by flow cytometry. (B). DCFDA assay were carried out as (A). 
The percentage of cells with high DCFDA fluorescence in cells treated with 40 µM 
AE, EM or DMSO (for control cell) for the indicated time is shown as means ± SD 
(n=5). ** p<0.01 when compared to control group. (C). AE decreased mitochondrial 
outer membrane potential (MOMP). HepG2 cells were treated with/without 40 μM AE 
for 24 hr. Cells were then collected and stained with 200 nM TMRM for the 
determination of MOMP.  
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3.3.2 AE induced oxidative stress 
The up-regulation of several redox-sensitive proteins found by 2D-DIGE 
suggested that oxidative stress might be involved in the cytotoxicity of AE. To 
confirm this, CM-H2DCFDA, a ROS indicator was utilized to study the production of 
ROS. As shown in Fig. 3.2 A and B, HepG2 cells exhibited a time-dependent increase 
of ROS production. Similar results were also obtained in the HCC-M and Hep3B cells 
(Fig. 3.8B). This result was comparable to a report for human lung carcinoma cells 
(Lee et al., 2006a), thus suggesting AE was capable of inducing oxidative stress in 
cancer cells. It is interesting to note that although EM is similar in structure to AE, it 
only caused minimal ROS production in HepG2 cells, corresponding to its ability of 
inducing a less extensive and lower level of redox-sensitive proteins, as shown by the 
2D-DIGE result (Fig. 2.5 and Table 2.2).  
3.3.3 AE induced protein carbonyl formation 
Oxidative stress may cause reversible or irreversible damage to DNA, lipid and/or 
certain proteins and in turn affectes the cell fate by inducing cell death or cell 
senescence. It has been reported that AE induced DNA damage through ROS 
generation (Lee et al., 2006a), but the authors did not show whether DNA damage 
accounted for AE-induced cytotoxicity or not. On the other hand, oxidatively modified 
proteins had been shown to play an important role in the modulation of protein 
function, cellular signaling and a number of human diseases (Nystrom, 2005). 
Assessment of the irreversibly protein-bound carbonyls, a widely used biomarker for 
protein oxidative modification (Levine, 2002), was thus conducted in this study.  
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As shown in Fig. 3.3A, in HepG2 cells AE treatment time-dependently increased 
the content of protein carbonyls, suggesting that AE treatment caused irreversible 
protein oxidation. Unfortunately, in 1D Western blotting, the proteins with carbonyl 
modifications were hard to be identified. However, as shown in Fig. 3.3B, the proteins 
with protein carbonyl were well separated and detected in 2D Western blotting. The 
positions of these proteins in the 2D map of HepG2 cells indicated that beta-tubulin 
(TBB1), 60 KD heat shock protein (CH60) and protein disulfide-isomerase A3 
(PDIA3) were oxidatively modified via protein carbonyl formation (Fig. 3.3B). 
Protein oxidation by carbonyl formation in HSP60 and beta-tubulin under oxidative 
stress had been reported before (Aksenov et al., 2001; Levine, 2002). Protein 
carbonyls may escape proteolysis and form cytotoxic high molecular weight 
aggregates (Nystrom, 2005), but the exact functional implications of protein carbonyl 
formation in AE-induced cytotoxicity has yet to be determined.  
3.3.4 AE induced peroxiredoxin oxidation 
The oxidative property of AE caused protein oxidation in cells, but how this 
affected AE-induced cytotoxicity is still unknown. The 2D-DIGE revealed that the 
most highly up-regulated proteins induced by AE (Table 2.2) were peroxiredoxins, 
which have recently been reported to confer resistance to cell death caused by 
oxidative stress (Chang et al., 2004; Kim et al., 2000; Veal et al., 2004). On the other 
hand, oxidation of these proteins was regarded as a sensitive marker of oxidative 
stress in HepG2 cells in vitro and liver tissue in vivo (Cesaratto et al., 2005). The role 
of these proteins and their effects upon oxidation were determined in this section.  
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As shown in Fig. 3.4A, AE treatment caused time-dependent oxidation in 
peroxiredoxins when probed by a specific monoclonal antibody which recognized the 
sulfinic and sulfonic forms of the 2-Cys peroxiredoxin. Moreover, 2D Western studies 
confirmed the oxidation of PRDX-2 and -4 in the 2D map (Fig. 3.4B). It is noteworthy 
that the total peroxiredoxin level remained unchanged (Fig. 3.4A), suggesting that the 
up-regulated peroxiredoxins were predominantly in the oxidized form. In contrast, EM 
and DMSO vector as negative control had no effect on the oxidation of peroxiredoxins 
(Fig. 3.4A), which was consistent with their low cytotoxicity (Fig.3.1). Oxidation of 
PRDX-6 was not detected in this experiment, because PRDX-6 belonged to the 1-Cys 
subgroup which could not be detected by this antibody. 
It is interesting to note that protein DJ-1 could also be detected by this 
monoclonal antibody against oxidized peroxiredoxins (Fig. 3.4B). Protein DJ-1 has a 
similar homology to the carboxyl-terminal domain of catalase in Escherichia coli. In 
human umbilical vein endothelial cells, DJ-1 was also found to be sensitive to 
H2O2-mediated oxidation (Kinumi et al., 2004). Recently, it has benn reported that 
protein DJ-1 can scavenge H2O2 by oxidizing itself and in turn cause cell death 
(Kinumi et al., 2004). This non-specific binding in the present study may be due to the 
fact that all three cysteines (Cys-46, -53 and -106) in DJ-1 could be oxidized to 
cysteine sulphonic acid (Kinumi et al., 2004). Collectively, these findings provided 
convincing evidence that AE treatment could lead to oxidative stress and oxidation of 
2-Cys peroxiredoxins. 
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Fig. 3.3 AE induced protein carbonyl formation. (A). Protein carbonyl formation 
was measured by 1D Western blotting as indicated. (B). 200 μg proteins from control 
and AE-treated cells were loaded in 18 cm pH 4-7 IPG strips for IEF. Then the strips 
were incubated with (for Ctrl and AE) or without (for NC) DNPH solution before 
SDS-PAGE and transbloting. NC which was incubated without DNPH was used as 
negative control. The left panel is the Western-blot image of proteins with carbonyl 
modification. The right panel is the colloidal silver stained images after Western 
blotting of the same PVDF membrane, which represented the overall protein profile.  
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Fig. 3.4 AE induced peroxiredoxin oxidation. (A). After the indicated treatment 
(with H2O2 as a positive control), peroxiredoxin oxidation was detected by 1D 
Western blotting. (B). 2D-Western of peroxiredoxin oxidation. Peroxiredoxin 
oxidation in cells treated with AE (40 μM, 24 hr) was analyzed by 2D-Western blot. 
The bottom panel is a representative 2D-DIGE image labeled with identified proteins 
as indicated. (C). HepG2 cells were transfected with PRDX siRNA or control siRNA, 
together with EGFP as a transfection marker. The cells after treatment were visualized 
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3.3.5 AE induced cell death by exhausting intracellular GSH 
Peroxiredoxin functions as a protein antioxidant by oxidizing itself. As expected, 
transient knocking-down of antioxidant peroxiredoxins by siRNA sensitized HepG2 
cells to cell death induced by AE (Fig. 3.5C). For example, in cells with a lower 
expression of peroxiredoxins, a drastic increase of apoptotic cell death was induced by 
AE treatment, when compared with cells with normal level of peroxiredoxins (Fig. 
3.5C). This finding indicated that AE treatment induced ROS-dependent apoptotic cell 
death. Since the cysteinyl residues of peroxiredoxins were being oxidized, it might be 
important to determine whether AE also affected the intracellular GSH, the 
predominant small-molecule antioxidant.  
As shown in Fig. 3.5A, AE decreased the ratio of reduced glutathione to oxidized 
glutathione (GSH/GSSG) as early as after 2hr. The involvement of the GSH buffer 
system in AE-induced apoptosis was then examined. Pretreatment with 
buthionine-L-sulfoximine (BSO, 500 μM for 24hrs), a specific GSH synthesis 
inhibitor (Shen et al., 2000), significantly decreased the intracellular GSH level (Fig. 
3.5B) and augmented apoptosis by AE (Fig. 3.5C). In contrast, a GSH donor 
glutathione monomethyl ester (GSH-MEE, 5 mM for 2hrs) (Kannan et al., 2004) 
significantly enhanced the intracellular GSH level (Fig. 3.5B) and subsequently 
blocked AE-induced apoptosis (Fig. 3.5C).  
Collectively, the above results suggested that AE treatment may induce apoptotic 
cell death by inducing oxidative stress and exhausting the intracellular GSH buffer 
system. 
   103
 
Fig. 3.5 AE induced cell death by exhausting intracellular GSH. (A). At the end of 
the indicated treatments, the ratio of intracellular GSH and GSSG level was analyzed, 
as described in Material and Methods. (B, C). After pretreatment with GSH synthesis 
inhibitor, buthionine-L-sulfoximine (BSO, 500 μM for 24 hr) or GSH donor, 
glutathione monomethylester (GSH-MEE, 5 mM for 2 hr), cells were additionally 
treated with AE for 6 hr to determine the intracellular GSH level (B) or 24 hr to 
determine apoptotic cell death (C). The GSH and GSSG content were expressed in 
nanomoles per million cells. The percentage of apoptotic cell death were determined 
and counted by DAPI staining as mentioned above.  
** indicates p<0.05 when compared with control cells.  
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3.3.6 AE induced sustained activation of JNK 
 It has been well established that MAPKs such as JNK are redox sensitive and are 
involved in apoptosis (Kyriakis and Avruch, 2001; Lewis et al., 1998; Shen and Liu, 
2006). Thus it might be important to examine whether the redox-sensitive MAPK 
pathways (JNK, p38 and ERK) were involved in AE-induced hepatoma cell apoptosis. 
As shown in Fig. 3.6, AE treatment induced sustained phosphorylation/activation of 
JNK from 3 hr up to 48 hr, which is also evidenced by the phosphorylation of its 
downstream substrate c-Jun. On the contrary, no evident JNK and c-Jun 
phosphorylation could be found within the first 1 hr (Fig. 3.7). Thus AE-induced JNK 
activation was a delayed and sustained action, but not an early and transient process. 
On the other hand, phosphorylation/activation of p38 remained unchanged by AE (Fig. 
3.6), although AE had been reported to induce apoptosis in human lung non small cell 
carcinoma cell line H460 via the p38 pathway (Yeh et al., 2003). The pro-survival 
ERK pathway, however, was found to be inhibited by AE, as evidenced by the 
decreased phosphorylation/activation of ERK. This inhibitory effect was similar to the 
finding carried out using glioma cells (Kannan et al., 2004). It is noteworthy that 
peroxiredoxin oxidation occurred coincidently with JNK activation and ERK 
inhibition, implying an inherent association of oxidative stress and JNK activation 
and/or ERK deactivation (Fig. 3.6). The JNK activation in HCC-M and Hep3B cells 
were also investigated. Similar results of sustained JNK activation, together with 
caspase cleavage/activation and peroxiredoxin oxidation were observed (Fig. 3.8A); 
suggesting that sustained JNK activation may contribute to AE-induced cell death.  
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Fig. 3.6 AE induced sustained JNK activation and ERK inhibition. HepG2 cells 
were treated with the indicated dose of AE for a series of times as indicated. The 
phosphorylation/activation of JNK, ERK, p38 and peroxiredoxin oxidation was 
detected by Western blotting.  
 
Fig. 3.7 AE was incapable of activating JNK within 1 hr. HepG2 cells were 
treated with 40 μM AE for the indicated time. The phosphorylation/activation of JNK 
and c-Jun was detected by Western blotting.  
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Fig. 3.8 AE induced oxidative stress, JNK activation and apoptosis in hepatoma 
cells. (A) HepG2, HCC-M and Hep3B cells were treated with 40 μM AE for the 
indicated times. At the end of treatment, the cells were collected and lysed. The 
caspase cleavage/activation, JNK phosphorylation/activation, and peroxiredoxin 
oxidation were detected by Western blotting. (B) HepG2, HCC-M and Hep3B cells 
were treated with 40 μM AE for 24 hr. The ROS generation was detected by DCF 
assay as indicated in the Material and Methods. 
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3.3.7 AE-induced apoptosis and JNK activation was ROS-dependent 
To further investigate the association of oxidative stress with MAPK activation 
and apoptosis, antioxidant sod1 (pEGFP-C3/sod1) was over-expressed in HepG2 cells. 
Over 90% cells were transfected with EGFP-sod1 and the expression level sustained 
as long as 72 hr (data not shown). As shown in Fig. 3.9A, over-expression of 
antioxidant sod1 efficiently prevented AE-induced oxidative stress, as indicated by the 
significant decrease of peroxiredoxin oxidation (Fig. 3.9A). Coincidently, 
over-expression of sod1 decreased AE-induced JNK phosphorylation/activation (Fig. 
3.9B). As a result of the decreased oxidative stress and JNK activation, sod1 
over-expression substantially protected HepG2 cells against AE-induced apoptosis, as 
shown by the decrease of caspase-9 activation and PARP cleavage (Fig. 3.9A) and the 
percentage of cells with nuclear condensation (Fig. 3.9B). Taken together, the above 
results suggested that oxidative stress-mediated JNK may be the effector molecule in 
AE-induced apoptosis.  
On the contrary, AE-induced ERK deactivation was unaffected by sod1 
over-expression (Fig. 3.9A), although the level of AE-induced apoptosis was 
comparatively lower in sod1 over-expressed cells. It may suggest that ERK inhibition 
by AE was ROS-independent. It may also indicate that ERK inhibition was 
dispensable for AE-induced apoptosis. Whether AE could directly inhibit ERK or its 
upstream kinase has yet to be established, but its analogue EM had been shown to be a 
direct kinase inhibitor of ERK (Zhou et al., 2006). 
   108
  
Fig. 3.9 Over-expression of antioxidant sod1 reduced AE-induced JNK activation 
and apoptosis by AE. HepG2 Cells were electro-transfected with sod1-GFP. After 36 
hr, cells were treated with AE or DMSO for 24 hr. (A). Cleavage of caspase-9 and 
PARP, oxidation of peroxiredoxin and phosphorylation/activation of JNK were 
investigated by Western blotting. (B) The percentage of apoptotic cells (with shrunk 
cell morphology) among the transfected cells was determined from a total of 200 
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3.3.8 JNK activation played a crucial role in AE-induced apoptosis 
The role of the JNK pathway in apoptosis is both cell type- and 
stimulus-dependent. The proapoptotic effect of JNK also depended on the extent and 
duration of its activation (Shen and Liu, 2006). Thus it is important to evaluate the 
role of JNK activation in AE-induced apoptosis through both pharmacological and 
genetic approaches. On the one hand, it was found that AE–induced apoptosis could 
be partially prevented by the cell permeable JNK inhibitor III (Fig. 3.10A).  
On the other hand, AE-induced apoptosis could be blocked by either 
knocking-down JNK or exogenously expressing dominant negative JNK. 
Knocking-down of both JNK-1 and -2 genes by specific siRNA significantly 
decreased JNK expression level as well as its phosphorylation/activation status, when 
compared with cells transfected with control siRNA (Fig. 3.10B). As expected, 
AE-induced apoptotic cell death was also inhibited, as evidenced by the decline in the 
cleavage of caspase-9, PARP (Fig. 3.10B) and the percentage of cell death (Fig. 
3.10C). Taken together, JNK activation was involved in AE-induced apoptosis. This 
hypothesis was further supported by the protective effect of over-expressing dominant 
negative JNK1 and JNK2 (DN-JNK1/2). Similar to the result of knocking-down assay, 
inhibition of JNK activity by over-expression of DN-JNK1/2 protected cells from 
AE-induced apoptosis (Figs. 3.10D and E). On the contrary, over-expression of 
constitutively active JNKK2-JNK1, which maintained sustained JNK1 activation, 
consistently augmented AE-induced apoptosis (Fig. 3.12A). In summary, the above 
findings indicated that sustained JNK activation was crucial for AE-induced apoptosis. 
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Fig. 3.10. JNK activation by AE was crucial for AE-induced apoptosis. (A). Cell 
death was determined after pretreatment with cell permeable JNK inhibitor III for 1 hr 
and then 40 μM AE for 48 hr. (B, C). JNK1 and JNK2 (JNK1/2) were transiently 
knocked-down in HepG2 cells by specific siRNA. After 48 hr, transfected cells were 
treated with AE for 24 hr. (D, E) HepG2 cells were transiently transfected with 
dominant negative JNK1 and JNK2 protein vector (HA-JNK-DN) and then treated 
with AE for 24 hr. Cleavage of caspase-9 and PARP, oxidation of peroxiredoxin and 
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3.3.9 ASK1 enhanced JNK activation and AE-induced apoptosis 
It is well-established that oxidative stress can induce JNK activation by activating 
its upstream apoptosis signal-regulating kinase1 (ASK1)  (Shen and Liu, 2006). The 
activation of redox-sensitive ASK1 has been reported to be initiated by ASK1 
oligomerization after dissociation from its inhibitory binding partner Trx in the 
presence of oxidative stress (Saitoh et al., 1998). Here the role of redox-sensitive 
ASK1 in AE-induced apoptosis was examined. As shown in Fig. 3.11A, AE induced 
sustained ASK1 activation from 6 hr to 24 hr by phosphorylation at Thr845, a 
conserved site for ASK1 activation by ROS (Tobiume et al., 2002), while the total 
ASK1 expression level remained unchanged. Coincidently, ASK1 that co-precipitated 
with Trx was also decreased (Fig. 3.11B); suggesting that ASK1 activation is initiated 
by its dissociation from Trx.  
To further assess the role of ASK1 activation in AE-induced sustained JNK 
activation and apoptosis, transient over-expression of mutant ASK1 with the 
C-terminal coiled-coil domain deletion (a dominant negative mutant for ASK1 
oligomerization (Tobiume et al., 2002)) was carried out. As expected, over-expression 
of the redox-insensitive mutant ASK1 failed to phosphorylate JNK (Fig. 3.11C) and in 
turn prevented AE-induced apoptosis (Fig. 3.11D). On the contrary, over-expression of 
the wild-type ASK1 augmented JNK phosphorylation/activation and sensitized cells to 
AE-induced apoptosis (Fig. 3.12B), similar to the action of over-expression of 
constitutively active JNKK2-JNK1. Collectively, the above data suggested that ASK1 
was crucial for AE-induced sustained JNK activation and apoptosis. 
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Fig. 3.11 ASK1 contributed to AE-induced JNK activation and apoptosis. (A). 
Active phosphorylation/activation of ASK1 (thr845) in AE-treated cells was analyzed 
by Western blotting. (B). ASK1 co-precipitated with Trx was decreased by AE 
treatment as determined by co-immunoprecipitation assay. (C, D). HepG2 cells were 
transiently electro-transfected with empty vector or dominant negative coiled-coil 
deletion mutant of ASK1 (coil-ASK1). After 36 hr, transfected cells were treated with 
AE for 24 hr. Western blotting showed activation of ASK1 and JNK, and cleavage of 
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Fig. 3.12 Over-expression of JNKK2-JNK1 and ASK1 sensitized cells to 
AE-induced apoptosis. Cells were over-expressed with/without JNKK2-JNK1 (A) or 
wild type ASK1 (B) vectors before treatment with AE for 12 hr.  
 
Fig. 3.13 GST-π oxidation by AE contributed to JNK activation. (A) After the 
indicated treatment, GST-π co-precipitated with JNK was probed as indicated. (B). 
After the indicated treatment, cells were lysed and loaded onto non-reducing or 
reducing gels as described in Material and Methods. The reduced form of GST-π in 
non-reducing gel and total GST-π in reducing gel was determined by Western blotting.  
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3.3.10 Dissociation of GST-π from JNK was involved in JNK activation 
Similar to ASK1, JNK could be activated by another redox-sensitive pathway. 
Resembling ASK1-Trx, JNK can form an inactive complex with GST-π (Adler et al., 
1999). Upon oxidative stress, protein oxidation of the cystinyl residues of GST-π 
promoted GST-π oligomerization and released it from the inactive complex with JNK. 
Importantly, this module is independent of the ASK1/JNK pathway. Thus, it might be 
important to assess whether AE treatment could induce JNK activation via 
dissociation of its inhibitory binding subunit GST-π from the inactive JNK-GST-π 
complex, another redox-sensitive mechanism for JNK activation (Adler et al., 1999).   
As shown in Fig. 3.13A, the inhibitory binding of GST-π with JNK decreased 
from as early as 3 hr, which was similar to the time of JNK activation (Figure 3.6). 
This dissociation had been reported to be initiated from the oxidative cross-linking of 
GST-π (Adler et al., 1999). Next, as shown in Fig. 3.13B, it was found that the 
reduced monomeric form of GST-π in the non-reducing gel but not the total GST-π in 
reducing gel was decreased upon treatment of AE from 3 hrs, suggesting that GST-π 
aggregation mediated by cysteinyl oxidation occurred upon AE treatment. This was 
consistent with the dissociation of inhibitory Trx from inactive ASK1-Trx complex 
(Fig. 3.11B). Therefore, AE may also initiate JNK activation by dissociation of the 
inactive JNK-GST-π complex via oxidative stress.  
3.4 Discussion 
In this study, it was found that AE induced apoptosis via oxidative stress and 
sustained JNK activation in hepatoma cells.  
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Sustained oxidative stresses are maintained in cancer cells (Toyokuni et al., 1995). 
This high but tolerable production of reactive oxygen species (ROS) may help cancer 
cells survive and proliferate through activating redox-sensitive transcription factors 
and responsive genes (e.g. NF-kB and AP1). However, when intolerably high levels of 
ROS production (e.g. induced by therapeutic agents) reached certain threshold, such 
as irreversible DNA damage, cells may switch to senescence or apoptotic cell death 
(Buttke and Sandstrom, 1995). Through manipulation of the redox balance, some 
phytochemicals, such as anthraquinones from rhubarb (Huang et al., 2006a), and 
polyphenols from grapes (Delmas et al., 2003) seemed to be good candidates for a 
direct or combined application in cancer chemotherapeutics and/or chemopreventics. 
But on the one hand, AE and other anthraquinones can counteract the harmful 
oxidative injury caused by other strong oxidants (Arosio et al., 2000; Lin et al., 1996; 
Malterud et al., 1993). On the other hand, therapeutic dose of AE and other 
anthraquinones can selectively induce apoptosis via sustained and site-directed 
oxidative stress (Lee et al., 2006a).   
Owing to its quinone structure, AE may generate ROS in cells. This effect had 
been confirmed recently (Lee et al., 2006a) and by the present study. To exclude the 
possibility that the cytotoxicity induced by AE was derived from an artificial 
production of H2O2 in the culture medium, the amount of H2O2 in the culture medium 
(without cell) was determined by ferrous oxidation-xylenol orange FOX assay 
(Nourooz-Zadeh et al., 1994). Less than 10 μM H2O2 could be detected (data not 
shown) when AE was incubated alone in DMEM medium for as long as 24 hr. Thus, 
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AE was unlikely to induce its cytotoxicity via artificial production of H2O2 in the 
culture medium. 
The results in the present study showed that exposure of AE interrupted the redox 
balance and decreased the intracellular GSH/GSSG ratio and in turn induced the 
intrinsic apoptotic pathway. Pretreatment of the cell-permeable GSH synthesis 
inhibitor BSO sensitized AE-induced cell death, while the glutathione-donor 
GSH-MEE completely protected it (Fig. 3.5). Consistently, over-expression of 
antioxidant enzyme sod1 effectively protected cells from AE-induced apoptosis (Fig. 
3.9). These results clearly suggested the crucial proapoptotic role of oxidative stress in 
AE-induced apoptosis.  
Protein oxidation, especially on the cysteinyl residues, may be crucial for 
AE-induced apoptosis. In most eukaryotes, peroxiredoxins are highly conserved and 
are highly abundant antioxidant enzymes (Wood et al., 2003). Oxidation of 
peroxiredoxins, as a sensitive marker for protein oxidation in HepG2 cells in vitro and 
liver in vivo (Cesaratto et al., 2005), was found to increase dose- and 
time-dependently after AE treatment in the present study (Fig. 3.4A). It has been 
reported that oxidation of the unique peroxiredoxin homolog Tpx1 in 
Schizosaccharomytes pombe was essential for peroxide-induced activation of the 
JNK/p38 homologue Sty1 (Veal et al., 2004). Wood and his colleagues (Wood et al., 
2003) suggested that eukaryotic peroxiredoxins evolved to act as a “floodgate”: 
peroxiredoxins are sensitive to H2O2 but can be rapidly inactivated to allow increasing 
H2O2 levels to stimulate signal transduction. In the present study, knocking-down of 
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peroxiredoxins sensitized the cells to AE-induced apoptosis (Fig. 3.4B); suggesting 
that peroxiredoxin oxidation may play an anti-apoptotic role. Although peroxiredoxins 
normally function to protect cells from oxidative stress-induced apoptotic cell death 
(Chang et al., 2004; Kim et al., 2000), the physiological association of peroxiredoxins 
and JNK in mammalian cells and the proposed “floodgate” effect of endogenous 
peroxiredoxins (Wood et al., 2003) remained to be further investigated.  
In addition, protein oxidation in terms of extra-molecular cross-linking occurred 
in GST-π and decreased its reduced monomeric form (Fig. 3.13B), which had been 
reported as an essential redox-sensitive pathway for JNK activation (Adler et al., 
1999). The coincidence in the decrease of GST-π co-precipitation with JNK and JNK 
activation suggested that JNK activation was initiated by AE-induced GST-π oxidation 
(Fig. 3.13A). In addition, ASK1 (the JNK upstream kinase) could be activated in a 
similar mode by dissociation from its inhibitory binding subunit Trx in the presence of 
ROS (Saitoh et al., 1998). Consistently, Trx that co-precipitated with ASK1 was 
decreased from 6 hrs onwards (Fig. 3.11B), which may in turn activate ASK1. Taken 
together, AE-induced oxidative stress may activate JNK and ASK1 by oxidizing their 
respective redox-sensitive inhibitory binding subunit GST-π and Trx.  
It has now been well recognized that activation of JNK consisted of two different 
modes. The earlier and transient activation was through the signaling cascade of 
proinflammatory cytokines (tumor necrosis factor-α and interleukin-1), while the 
delayed and sustained activation was mediated by ROS (Shen and Liu, 2006; Shen 
and Pervaiz, 2006). On the other hand, the proapoptotic effect of JNK depended on the 
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extent and duration of its activation: sustained JNK activation may lead to apoptotic 
cell death, whereas transient activation was not capable of inducing apoptosis and 
even have an anti-apoptotic effect. The sustained JNK activation was suggested to be 
mainly due to its upstream kinase ASK1, another redox-sensitive proapoptotic kinase 
(Shen and Liu, 2006). ASK1 is a ubiquitously expressed MAPKKK that activate both 
JNK and p38 by phosphorylating the respective MAPKKs. In the presence of ROS, 
ASK1 itself was activated by oligomerization after dissociation from its inhibitory 
binding subunit Trx (Tobiume et al., 2002).  
Induction of differentiation but not apoptosis had been observed to be 
accompanied with ERK inhibition (within 4 hr) in rat C6 glioma cells by AE treatment, 
although JNK and p38 pathways were not involved (Mijatovic et al., 2005a). However, 
in that study the delayed and sustained mode of JNK activation was not investigated. 
In the present study, AE treatment resulted in sustained activation of JNK which was 
responsible, at least partially, for apoptosis induction in the hepatoma cells. It is 
clearly demonstrated by the findings that AE-induced apoptosis could be reversed by 
both pretreatment of pharmacological JNK inhibitor and genetic manipulation of JNK 
expression. This action by AE could also be found in some other dietary 
phytochemicals. For example, diallyl disulfide (an oil-soluble compound in garlic 
extracts), curcumin,(a polyphenolic pigment in Curcuma longa), phenethyl 
isothiocyanate (PEITC, from watercress) and epigallocatechin-3-gallate (EGCG, from 
green tea extract) were found to be capable of inducing apoptosis via ROS-dependent 
JNK signaling cascade in neuroblastoma (Filomeni et al., 2003), colon cancer (Collett 
   119
and Campbell, 2004; Hu et al., 2003) and pancreatic cancer cells (Qanungo et al., 
2005), respectively. Results from these studies and the present finding therefore 
suggested that certain phytochemicals may activate the therapeutic redox-sensitive 
pathways (e.g. JNK, p38) and apoptosis in cancer cells, via increasing ROS 
production and/or decreasing ROS scavenging capacity.   
The ERK deactivation by AE was found to be ROS-independent and not involved 
in AE-induced apoptosis because over-expression of antioxidant sod1 could not 
reverse AE-induced ERK deactivation (Fig. 3.9). But the exact mechanism of ERK 
inhibition by AE is yet to be determined. One possibility is that AE might directly 
inhibit ERK and/or its upstream kinase, and this action is ROS-independent, because 
its analogue EM had been found to moderately inhibit the ERK kinase assay (Sarno et 
al., 2003). 
In conclusion, the present study elucidated a novel anticancer function of AE in 
hepatoma cells. These findings suggested that AE may induce apoptosis via marked 
oxidative stress and sustained JNK activation.  
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4.1 Introduction 
Accumulating data had shown that AE was involved in a myriad of functions, 
including anti-cancer, hepatoprotective and other effects, although the precise 
molecular mechanisms are not fully understood. One effective strategy is to find the 
key molecular pathways that are involved in these molecular functions via proteomics. 
This approach had been successfully applied in the study of lung cancer cells (Lee et 
al., 2005). However the author focused on only one affected protein, nucleophosmin. 
It was suggested that the release and degradation of nucleophosmin from the nucleus 
to the cytoplasm was associated with AE-induced apoptosis. Unfortunately, the other 
differentially- expressed proteins in that study were not characterized.  
As described in Chapter 2, a more reliable and quantitative 2D method, 2D-DIGE, 
was used to obtain a global view of the differentially- expressed proteins in hepatoma 
cells affected by AE here. Our results revealed that several proteins were associated 
with oxidative stress and/or anti-cancer effects (Fig. 2.7). On the one hand, the 
oxidative stress and protein oxidation induced by AE treatment was found to account 
for the sustained activation of the proapoptotic ASK1/JNK pathway and subsequent 
apoptotic cell death.  
On the other hand, the other differentially expressed proteins may also be 
important for the AE-induced anti-cancer actions. For example, p16 is a well- 
established CDK4 inhibitor and capable of inhibiting DNA synthesis (Kim and 
Sharpless, 2006; Sherr, 2004), while nucleoside diphosphate kinase A (NDKA) is a 
potent metastasis inhibitor (Hartsough and Steeg, 2000). These affected proteins 
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indicated that the anti-cancer effects of AE might be conducted through multiple 
signaling pathways. It is noteworthy that these affected pathways may work 
synergistically, but not exclusively. However, how AE execute anti-cancer effect via 
these proteins is still unknown. In this Chapter, some representative proteins affected 
by AE will be further validated and characterized.  
In Chapter 2, EM was also subjected to 2D-DIGE analysis. It was observed that 
EM affected fewer proteins with lower expression level changes, which is in line with 
its lower cytotoxicity in HepG2 cells. Among those affected proteins, phosphorylated 
(or acidic) form of cofilin is the most down-regulated protein (Fig. 2.5 and Table 2.2). 
It has been reported that active dephosphorylation of cofilin is associated with cancer 
metastasis (Wang et al., 2006b). In addition, mitochondrial translocation of 
dephosphorylated cofilin was an early step in apoptosis (Chua et al., 2003). Thus, in 
the present Chapter, the role of cofilin in EM-treated cells will be further investigated.  
4.2  Materials and methods 
4.2.1 Chemical and reagents 
AE, EM, crystal violet and other chemicals were purchased from Sigma-Aldrich 
(St Louis, MO). Recombinant human epithelial growth factor (EGF) was purchased 
from Calbiochem (San Diego, CA). The matrigel BD Falcon® 8.0 µm Cell Culture 
Inserts were bought from BD (Becton Dickinson, Franklin Lakes, N.J.). Antibodies 
against p16, cofilin and phospho-cofilin (ser 3) were obtained from Cell Signaling 
Technology (Beverly, Mass). Antibodies against Rb, phospho-Rb (pRb, at site 
ser795), NDKA and tubulin were from Santa Cruz Technology (Santa Cruz, Calif).  
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4.2.2  Cell culture 
The human hepatoma cell lines HepG2 and HCC-M and human breast cancer cell 
line MD-MBA-231 cells were cultured in DMEM medium (with 100 U/ml penicillin, 
100 μg/ml streptomycin, 3.7 g/L sodium bicarbonate, pH 7.4) plus 10% FBS in 
standard incubator conditions (37 °C, 5% CO2).  
4.2.3 BrdU incorporation assay 
Bromodeoxyuridine (BrdU) incorporation assay was carried out according to the 
BrdU Flow Kits instruction manual (BD Pharmingen, San Diego, CA). In brief, at the 
end of the designated treatment period, HepG2 cells were incubated and labeled with 
10 μM BrdU for 30 min at 37 °C. The newly synthesized DNA was thus incorporated 
with BrdU within the above incubation step. Labeled cells were then collected and 
fixed/permeabilized in 100 μl BD Cytofix/Cytoperm buffer for 15 min at room 
temperature twice. After washing with BD Perm/Wash buffer, cells were resuspended 
in 100 μl DNase (300 μg/ml) for 1 hr at 37 °C to expose the incorporated BrdU. 
Afterwards, cells were incubated with FITC-coupled anti-BrdU IgG for 20 min and 
later counter-stained with 7-AAD (7-amino-actinomycin D) to show the BrdU 
incorporation rate and total DNA content, respectively. Finally, cells were added with 
1 ml staining buffer and kept in the dark at 4 °C before measurement of the FITC 
intensity and total DNA content by flow cytometry. The excitation/emission 
wavelength for detection of FITC-coupled BrdU was 488/525 nm, while for detection 
of 7-AAD is at 488/660 nm. The result was analyzed by WinMDI 2.8 software 
(Scripps Institute, La Jolla, CA). 
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4.2.4  Wound healing assay  
Wound healing assay was conducted to study the migration potential of cancer 
cells upon AE or EM treatment as described previously (Huang et al., 2004; , 2005). 
In brief, HepG2 and MD-MBA-231 cells were grown on glass coverslips in a cell 
culture incubator in standard condition until formation of a confluent monolayer. The 
cells were then starved in FBS-free DMEM medium overnight. Straight wounds were 
created manually using a sterile pipette tip. Then fresh medium were replaced and 
supplemented with/without increasing dose of AE or EM. In the meantime, cell 
migration was stimulated by 5% FBS or 20 ng/ml EGF. Microscopic photographs 
were taken at 0 and 24 hr under an inverted microscope.  
4.2.5  Matrigel assay 
Matrigel assay was conducted to determine the invasive potential of cancer cells 
using BD Falcon® 8.0 µm Cell Culture Inserts (Becton Dickinson, Franklin Lakes, 
N.J.), as described previously (Albini et al., 1987; Huang et al., 2004). In brief, after 
starvation in FBS-free DMEM medium overnight, HepG2 and MD-MBA-231 cells 
were collected using cell dissociation buffer (Sigma-Aldrich, St Louis, MO) and 
re-suspended in FBS-free DMEM medium. Cells were then pretreated with/without 
increasing dose of AE or EM for 1 hr before seeding into the transwell chambers. 
Afterwards, cell invasion were stimulated with 5% FBS or 20 ng/ml EGF for 20 hr. At 
the end of treatment period, cells that migrated to the lower surfaces of the membrane 
were fixed with 100% methanol for 2 min and stained with 0.5% crystal violet 
solution (in 25% methanol) for 2 min. Cells on top of the upper surfaces of the 
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membrane which failed to migrate through the membrane were removed by scraping. 
After rinsing with distilled water, migrated cells stained with purple color were 
quantified in five random fields under an inverted microscope.  
4.2.6  Western blotting 
The Western blotting was carried out as described earlier (section 3.2.9).  
4.3  Results 
4.3.1  Inhibition of DNA synthesis via up-regulation of p16 by AE 
 Tumor suppressor protein p16 is a member of the cyclin-dependent kinase 4 
(CDK4 or INK4) inhibitor protein family. It functionally competes with cyclin-D for 
association with cyclin-dependent kinase 4/6 (CDK4/6) and keeping CDK4/6 inactive. 
The cyclin-D/CDK4 complex is known to phosphorylate the retinoblastoma (Rb) 
protein at mid-G1 phase, which is thought to be a critical step in the progression 
through G1 into S-phase of the cell cycle (Sherr, 2004).  
In the present study, the 2D-DIGE results in Chapter 2 (Fig. 2.5 and Table 2.2) 
revealed that protein p16 was up-regulated two-fold only in AE-treated cells, but not 
in EM-treated cells. As shown in Fig. 4.1A, 1D Western experiment confirmed that 
upon treatment with AE, p16 was up-regulated after 6 hr and peaked at 12 hr of 
treatment. This AE-induced up-regulation of p16 could also be observed in HCC-M 
cells (data not shown), suggesting this effect is not HepG2 cell specific. To evaluate 
this effect on the downstream Rb pathway, the active phosphorylation of the 
downstream Rb protein (ser 795, a critical phosphorylation site for CDK4 (Grafstrom 
et al., 1999; Pan et al., 1998)) was also probed.  
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Fig. 4.1 AE inhibited DNA replication via up-regulation of p16. (A). AE affected 
phosphorylation of Rb protein via up-regulation of p16. HepG2 cells were treated with 
AE (40 μM) for the indicated time. Protein expression level of p16, phosphorylated 
form of Rb (ser 795, critical CDK4 phosphorylation site) and total Rb were analyzed 
by Western blotting. (B). AE decreased DNA synthesis. HepG2 cells were treated 
with 40 μM AE for the indicated time. After treatment, cells were incubated with 
BrdU for 30 mins, and then stained with FITC-coupled anti-BrdU and counter-stained 
with 7AAD. S, G1 and G2/M phase of cells are shown as indicated with the 
percentage of the total cell populations (n=3).  
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It was found that AE treatment decreased active phosphorylation of Rb protein on 
the CDK4 specific site Ser795 while the total Rb protein level remained unchanged 
(Fig 4.1A). Furthermore, the BrdU incorporation assay confirmed that there was a 
decrease of de novo DNA synthesis after treatment with AE from 6hr to 24 hr (Fig. 
4.1B), which was coincident with the up-regulation of p16 and loss of Rb 
phosphorylation at Ser795. As shown in Fig. 2.1, AE (40 μM, 24 hr) inhibited cell 
growth to half the level of that of control cells, which cannot be totally explained by 
the marginal increase of apoptotic cell death and G2/M cell cycle arrest by AE at that 
time point (Fig. 2.3 and 2.4). Thus, this is the first evidence showing that the cell 
growth inhibition in terms of DNA synthesis inhibition, especially in the early phase, 
was at least partially resulted from the inactivation of pRb-E2F pathway by 
up-regulation of the CDK4 inhibitor p16 upon AE treatment. 
4.3.2 AE inhibited cell migration via up-regulation of NDKA 
Interestingly, the 2D-DIGE results revealed that AE up-regulated a metastasis 
suppressor, nucleoside diphosphate kinase A (NDKA, or nm23 as gene name). Low 
expression of NDKA had been reported to be correlated with poor patient prognosis 
and survival in several epidemiological cohort studies, including hepatocellular 
carcinoma (Boissan and Lacombe, 2006). A recent study using nm23 knockout mice 
demonstrated that loss of NDKA protein expression promoted lung metastasis in the 
SV40 mouse model of liver carcinogenesis (Boissan and Lacombe, 2006). On the 
contrary, forced over-expression of NDKA in highly metastatic carcinoma can 
significantly reduce the metastatic efficiency of the cells in vivo. In the present study, 
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NDKA expression was up-regulated by AE but not EM treatment (Fig. 2.5 and Table 
2.2). As confirmed by 1D Western blotting in Fig. 4.2, AE treatment 
dose-dependently increased the expression level of NDKA. Whether AE could inhibit 
metastasis had not been reported before, although previous findings showed that its 
analogue EM was capable of inhibiting cancer cell invasion (Huang et al., 2004), 
migration (Huang et al., 2005) and adhesion (Huang et al., 2006b). Thus the present 
finding of up-regulation of NDKA suggested that AE treatment may also have an 




Fig. 4.2 AE increased expression level of NDKA. HepG2 cells were starved in 
serum-free DMEM medium overnight and then treated with increasing dose of AE 
from 10 to 40 μM in the fresh medium in the presence of FBS for 20 hr. At the end of 
treatment, cells were collected and lysed for Western-blot analysis of NDKA and 
tubulin.  
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Fig. 4.3 AE inhibited cancer cell migration. Human hepatoma cell line HepG2 
cells and breast cancer cell line MD-MBA-231 cells were cultured to form a confluent 
monolayer. Artificial straight wounds were created using a sterile pipette tip. After 3 
rinses with PBS, fresh FBS-free medium was replaced. Cells were pretreated with 
indicated dose of AE for 1 hr and then the cell medium were supplemented with 5% 
FBS (or 20 ng/ml EGF) as stimulus. Microscopic photographs were taken at 0 and 24 
hr. 
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Fig. 4.4 AE inhibited cancer cell invasion. Cancer cell invasion was investigated 
using BD Falcon® 8.0-µm Cell Culture Inserts. After re-suspension and pretreatment 
of different concentrations of AE for 1 hr, HepG2 cells were seeded into the transwell 
chambers and supplemented in the presence or absence of 5% FBS (or 20 ng/ml 
EGF). After 24 hr, cells were stained with crystal violet and photographed under an 
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In order to verify the effect of NDKA by AE on cell migration, wound healing 
assays were conducted. As shown in Fig. 4.3, both FBS and EFG could stimulate 
recovery of the artificial wound through cancer cell migration. However, AE 
dose-dependently inhibited the wound recovery (Fig. 4.3A), which was coincident 
with the up-regulation of metastasis inhibitor NDKA by AE (Fig 5.2). It is noteworthy 
that AE, even in a lower concentration without evidence of cytotoxicity (such as 10 
μM), exhibited a significant inhibitory effect, suggesting that the anti-migration effect 
by AE was not a result of its cytotoxicity. Similarly, this effect was consistently 
observed in breast MD-MBA-231 cancer cells (Fig. 4.3B), suggesting a common 
inhibitory effect on cancer cell migration. Thus, AE may inhibit cell migration via 
up-regulation of NDKA, although the mechanism has yet to be determined.  
To further determine whether AE could repress cancer cell invasion, Matrigel cell 
invasion assay was explored as well in AE-treated HepG2 cells. As shown in Fig. 4.4, 
incubation of FBS (5%) or EGF (20 ng/ml) was capable of promoting cancer cell 
invasion through Matrigel®-coated membrane. In contrast, AE treatment could 
drastically reverse this action in a dose-dependent manner from 10 to 40 μM. 
Collectively, these findings indicated that AE, similar to its analogue EM (Huang et al., 
2004; , 2005), was potent in inhibiting both cancer cell migration and cell invasion. 
The up-regulation of metastasis inhibitor NDKA was found to be associated with the 
anti-invasion and anti-migration effects of AE in this study. But it is still unknown 
how AE regulated the expression level of NDKA and whether up-regulation of this 
protein is functionally essential for the anti-metastatic effect.  
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4.3.3 Down-regulation and dephosphorylation of cofilin by EM 
As mentioned in Chapter 2, EM treatment of HepG2 cells only affected a few 
proteins (Fig. 2.5 and Table 2.2), which was in line with its lower cytotoxicity (Fig. 
2.1). The most drastic change in protein expression was cofilin, which was 4.33-fold 
lower in EM-treated cells than that of control cells. It is noteworthy that this 
differentially-expressed protein spot exited in its acidic form because of its pI shift 
from the value of theoretical 8.2 to the experimentally observed value of 6.4. The 1D 
Western-blot confirmed that EM treatment decreased the cofilin phosphorylation (Ser 
3), as well as its total protein expression, in a dose-dependent manner (Fig. 4.5A). 
These results were confirmed by 2D Western-blot using pH 3-10 non-linear IPG 
strips. As shown in Fig. 4.5B, the anti-cofilin IgG recognized three protein spots with 
different pIs at pH 6.4, 7.3 and 8.2 respectively in the DMSO-vector-treated cells. 
However upon EM treatment, only one spot with a pI at 8.2 and with a lower intensity 
could be detected. This suggested EM treatment could inhibit phosphorylation of 
cofilin. The down-regulation of dephosphorylated cofilin also suggested an 
anti-metastatic role of EM, considering that active dephosphorylated cofilin (regulated 
by LIM kinase) was essential for cell motility and metastasis (Ghosh et al., 2004; 
Wang et al., 2006b; Zebda et al., 2000). The effect of EM on HepG2 cell migration 
was then evaluated as well. As expected, EM similarly inhibited cell migration (Fig. 
4.6), as what was observed in AE-treated cells. These results corroborate the previous 
findings that EM could inhibit invasion (Huang et al., 2004), migration (Huang et al., 
2005) and adhesion (Huang et al., 2006b) in human carcinoma cells. How EM 
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inhibited cofilin phosphorylation is still unknown. Considering EM is a 
well-established kinase inhibitor, this inhibitory effect of cofilin phosphorylation 
could be due to a direct inhibition by EM against LIM kinase, the upstream regulatory 
kinase of cofilin. However, this speculation is yet to be confirmed. On the other hand, 
unlike AE, EM has no effect on NDKA expression (Fig. 4.5A).  
In contrast, treatment of AE at the same concentration failed to decrease cofilin 
phosphorylation. Interestingly, AE treatment repressed the total cofilin expression 
(Fig. 4.5A). Comparatively, unphosphorylated cofilin, the key factor for metastasis, 
may be decreased by AE. This finding also suggested that AE may have a potential 
role in anti-metastasis through down-regulation of dephosphorylated cofilin. Because 
AE only repressed the active dephosphorylated form of cofilin but not cofilin 
phosphorylation, AE may have a specific potential in inhibiting cofilin function, 
although the exact mechanism is yet to be determined. Therefore, these findings 
indicated that EM, as well as AE, could inhibit cancer cell migration, but through a 
different molecular mechanism.  
4.4 Discussion 
The anti-cancer effects of AE were operated through different molecular 
pathways. Besides the redox-sensitive proteins which are responsible for AE-induced 
apoptosis, another two proteins, p16 and NDKA, were also validated in this Chapter. 
On the other hand, cofilin, the most down-regulated protein in EM-treated cells, was 
also studied for its possible association with cancer cell migration. 
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Fig. 4.5 EM inhibited both phosphorylated and dephosphorylated forms of cofilin. 
(A). HepG2 cells were treated with EM or AE as indicated. Then the cell lysate were 
subjected to Western blotting for detection of phospho-cofilin (Ser 3), total cofilin, 
NDKA and tubulin. (B). Cell lysate from the control cells and EM-treated cells (40 
μM, 24 hr) were subjected to 2-DE and then Western-blot. Cofilin in both acdic forms 
and basic forms were analyzed as indicated. The pI and molecular weight of the 
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Fig. 4.6 EM inhibited cancer cell migration. Human hepatoma cell line HepG2 
cells and breast cancer cell line MD-MBA-231 cells were cultured to form a confluent 
monolayer. Artificial straight wounds were created using a sterile pipette tip as 
mentioned above. After rinsing 3 times with PBS, fresh FBS-free medium were 
replaced. Cancer cells were pretreated with the indicated dose of EM for 1 hr. Then 
the cell medium was supplemented with 5 % FBS (or 20 ng/ml EGF) as stimulus. 
Microscopic photographs were taken at 0 and 20 hr. 
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AE had been shown previously to affect G1/S phase in many cancer cell lines, 
including hepatoma cells (Acevedo-Duncan et al., 2004; Chen et al., 2004a; Kuo et al., 
2004; Kuo et al., 2002; Mijatovic et al., 2005a). Some studies suggested that the 
p53-p21 pathway may account for G1/S cell cycle arrest induced by AE (Kuo et al., 
2002; Pecere et al., 2003). However, these two studies focused mainly on the 
apoptotic role of p53 and p21 by AE. The exact molecular mechanism for AE-induced 
cell cycle arrest is still not clear. In the present study, the 2D-DIGE results 
successfully identified another G1/S cycle arrest that involved protein p16, which was 
responsible for the inhibition of CDK4 functions and subsequently DNA synthesis. On 
the contrary, p53 and p21 were not identified in the present 2D-DIGE experiment. 
This might be due to the narrow pH range (4-7) of IPG strips used in the present 
experiment, since p53 has a pI of 6.7. Subsequent 2D Western using the extended pH 
3-10 IPG strips confirmed that p53 was up-regulated in AE-treated cells (data not 
shown).  
The discovery of p16 by 2D-DIGE (Fig. 2.5 and Table 2.2), however, revealed 
another potential molecular pathway responsible for AE-induced G1/S cell cycle arrest. 
Further Western-blot validation confirmed its up-regulation and interference of 
down-stream Rb-E2F molecular pathway. Up-regulation of p16, the CDK4 inhibitor, 
was well established in blocking Rb phosphorylation in the CDK4-specific site Ser 
795 (Kim and Sharpless, 2006; Sherr, 2004) and subsequently decreased DNA 
synthesis (Fig. 4.1A and B). On the contrary, the induction of p21 had been generally 
believed to preferentially inhibit CDK2 but not CDK4 activity (Bartek and Lukas, 
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2001; Boulaire et al., 2000; Brugarolas et al., 1995; Poon et al., 1996). Thus, 
AE-induced p16, at least, could partially account for the repressed DNA synthesis, 
although the present study could not exclude the involvement of other CDK inhibitors.  
Various stimuli had been reported to induce p16 in vitro and in vivo, especially the 
DNA-damaging stimuli such as UV light, oxidative stress and chemotherapeutic 
agents (Chen et al., 2004b; Ito et al., 2006; Meng et al., 2003; Pavey et al., 1999). 
Since AE was capable of inducing intracellular ROS generation, p16 was probably 
induced by such a mechanism in the early stage of AE treatment. But when the 
generated ROS reached an intolerable level, the effect by AE treatment against DNA 
synthesis may switch to induction of the apoptosis pathway. This speculation is still 
yet to be confirmed. Induction of p16 was often found to occur 2-4 weeks after 
DNA-damaging stress through MAPK activation (Ito et al., 2006; Robles and Adami, 
1998; Wang et al., 2006c). It is noteworthy that in the present study p16 was induced 
after 6 hr and peaked at 12 hr by AE treatment of HepG2 and HCC-M cells (Fig. 
4.1A). Since only a few selected cancer cells were analyzed after AE treatment, 
whether AE could induce p16 in other cancer cells and/or in vivo at such a fast rate is 
yet to be determined. 
On the other hand, 2D-DIGE identified another up-regulated protein, nucleoside 
diphosphate kinase A (NDKA, gene name as nm23-H1). This protein is the first 
metastasis inhibitor to be identified (Steeg, 2003). Expression level of NDKA was 
reported in most studies to be negatively associated with some types of human solid 
tumors, such as liver, colon, breast and melanoma (Boissan and Lacombe, 2006; 
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Nakayama et al., 1992; Ouatas et al., 2003; Steeg, 2003), although the mechanisms 
responsible for the changes in NDKA expression were unclear. Experimental 
manipulation of NDKA consistently affected the cancer metastatic efficiency in vivo. 
Genetic nm23-null mice were susceptible to lung metastasis in the SV40 mouse model, 
while there was no observable effect on primary liver carcinogenesis (Boissan and 
Lacombe, 2006). In the present study, the up-regulation of NDKA by AE thus 
indicated a novel anti-metastatic effect of AE. This speculaton should not be a surprise 
given that its analogue EM could inhibit cancer cell migration (Huang et al., 2004; , 
2005; Kim et al., 2005). However, the present study revealed that AE and EM may 
inhibit cancer cell migration through different molecular mechanisms. Up-regulation 
of NDKA only occurred in AE-treated cells, but not in EM-treated cells. Although the 
present study could not exclude other relevant pathways, up-regulation of NDKA by 
AE may render an inhibitory effect against cancer cell migration.  
On the contrary, in EM-treated cells, 2D-DIGE detected fewer differentially- 
expressed proteins. Among them, cofilin at pI 6.2 was the most highly down-regulated 
protein spot after EM treatment. This suggested a potential role of EM in inhibiting 
cofilin phosphorylation (probably by inhibition of the upstream kinase LIM kinase 1 
(LIMK)). The 2D Western blot revealed that the inactive phosphorylated form, 
together with the active dephosphorylated form of cofilin was down-regulated by EM 
treatment. Dephosphorylation of cofilin has been reported to an essential step for 
mitochondria-mediated apoptosis (Chua et al., 2003), but in the present study, EM was 
unlikely to initiate apoptosis through this pathway. This is because the active 
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dephosphorylated form of cofilin was decreased rather than increased (Fig. 4.5B). 
More importantly, there was no translocation of cofilin from cytosol to mitochondria 
in the process of apoptosis and cytochrome c translocation (data not shown).  
The down-regulation of the dephosphorylated form of cofilin was probably 
associated with the inhibition of cancer cell migration by EM, considering the findings 
that this specific cofilin isoform is required for cell motility and cancer metastasis 
(Ghosh et al., 2004; Wang et al., 2006b; Zebda et al., 2000). Cofilin functioned in the 
regulation of actin dynamics by promoting the rate of actin depolymerization and 
facilitating actin filament turnover (Bailly and Jones, 2003; Chen et al., 2000). This 
protein and its upstream kinase, LIM kinase 1, were both up-regulated in invasive 
cells (Wang et al., 2004a). More importantly, inhibition of cofilin activity by either 
gene knockdown or expression of constitutively active LIMK inhibited cell motility 
(Hotulainen et al., 2005; Yamaguchi et al., 2005; Zebda et al., 2000). In contrast, 
cofilin overexpression was found to be associated with motility of glioblastoma tumor 
cells in a concentration-dependent manner (Yap et al., 2005). In the present study, 
both EM and AE treatment repressed total cofilin expression. In addition, EM 
inhibited cofilin phosphorylation. These results may again indicate the anti-migration 
role of EM and AE, which is evidenced by the impaired cell capability to recover in 
wound healing assay (Figs. 4.4 and 5.6).  
Taken together, 2D-DIGE has proven to be an effective approach in identifying 
susceptible protein targets that participate in the relevant molecular pathways upon AE 
treatment. Besides the redox-sensitive proteins responsible for AE-induced apoptosis, 
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up-regulation of p16 and NDKA were found to be associated with G1/S cell cycle 
arrest and anti-metastatic effects, respectively. On the other hand, EM decreased both 
dephosphorylated and phosphorylated forms of cofilin, suggesting its role in 
anti-migration.  
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 Rhubarb root (Rheum palmatum), is one of the earliest and best-known Chinese 
herbal medicine. It has been used for centuries in China and ranked as a top medicinal 
herb (Li, 1982; Yang, 1997). Aloe-emodin (AE) is one of the main 
hydroxyanthraquinones found in Rhubarb root. This hydroxyanthaquinone exhibits 
multiple pharmacological effects, including anti-viral, anti-inflammatory, 
hepatoprotective, anti-hepatitis and anti-cancer potential (Agarwal et al., 2000; Arosio 
et al., 2000; Huang et al., 2006a; Kim et al., 2004; Pecere et al., 2000; Woo et al., 
2002). Although AE has been reported to be potent in inhibiting cancer cell growth 
and induction of apoptotic cell death (Huang et al., 2006a), the precise molecular 
mechanisms are yet to be determined.  
Considering the structural similarity of AE to its analogue emodin (EM), it was 
believed that AE might share similar anti-cancer molecular pathways with that of the 
well-studied hydroxyanthraquinone EM. Based on literature reports, the anti-cancer 
potency of EM was mainly attributed to its inhibition on the pro-survival protein 
tyrosine kinases (e.g. p56LCK and HER-2/neu), and a number of other kinases (e.g. 
CK2, PI3K and AKT1) (Battistutta et al., 2000; Frew et al., 1994; Jayasuriya et al., 
1992; Zhang et al., 1995; Zhou et al., 2006). In contrast, AE was found to be a poor 
kinase inhibitor (Huang et al., 2006a; Sarno et al., 2002) and yet it exhibited similar or 
higher cytotoxicity against a variety of cancer cells, compared to EM (Fenig et al., 
2004; Lee, 2001; Shi et al., 2001). Thus it might be of great interest to examine the 
molecular mechanism for AE-induced anti-cancer effects.  
Recently, several investigations using conventional biochemical approaches had 
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shown that the p53-p21 molecular pathway is connected with the anti-cancer effect of 
AE (Kuo et al., 2002; Pecere et al., 2003). However, no comprehensive studies have 
ever been carried out to identify the molecular targets of AE. In an earlier study, Lee 
and his colleagues (2005) utilized 2-DE to find the proteins affected by AE in lung 
carcinoma H460 cells. They showed that cytosol translocation and degradation of 
nucleophosmin occurred during AE-induced apoptosis. However, this finding was 
basically descriptive. It was unable to reveal whether the expression change of 
nucleophosmin was functional or causative. Moreover, it was unclear whether AE 
only affected this specific protein but not others.  
In this study, a comprehensive proteomic investigation was carried out to 
systematically investigate the anti-cancer targets and relevant molecular pathways of 
AE-treated HepG2 cells in vitro. The investigation consists of two major portions: (i) 
identification and classification of the differentially-expressed proteins in AE-treated 
cells by 2D-DIGE (Chapter 2); and (ii) biochemical validation and characterization of 
the affected proteins and the associated molecular pathways involved in AE-induced 
apoptosis (Chapter 3), and the other anti-cancer effects (Chapter 4). In addition, 
parallel experiments were also conducted in EM, to compare the molecular targets of 
these two structurally similar hydroxyanthraquinones.   
5.1 Anticancer potential of AE: implication of proteomic findings 
Proteomics is a systematic approach to determine the diverse properties of 
proteins in a simultaneous manner for a comprehensive understanding of the structure, 
function and regulation of biological systems (Patterson and Aebersold, 2003). 
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Proteomics and other complementary methods (e.g. genomics) have widened and 
deepened “the scope of biological studies from the traditional reductionist biochemical 
analysis of single proteins to proteome- (or genome-) wide measurement” (Patterson 
and Aebersold, 2003). These systematic strategies are especially important and 
applicable to cancer and other complex diseases, since a single molecular pathway 
may not be responsible for these diseases. Thus, the emerging ‘system biology’ 
approaches may aid to describe the biological systems comprehensively through 
integration of diverse types of data.  
Different gel-dependent and –independent methods have been developed to 
determine the proteome expression in a complex sample mixture. Among them, 2-DE 
separates thousands proteins simultaneously according to two different properties, 
usually molecular weight and pI. The resolution and reproducibility of 2-DE have 
improved substantially with the introduction of commercially-available narrow pI 
range IPG gels and cyanine dyes (Alban et al., 2003; Gorg et al., 2004; Righetti et al., 
2004). In the present study, 2D-DIGE (2D difference gel electrophoresis) analysis 
using 4-7 zoom IPG strips was applied. In 2D-DIGE, proteins extracted from pooled 
internal standard, control and treated samples were separately labeled with different 
dyes (Cy2, Cy3 and Cy5), respectively. The protein mixtures were then loaded and 
separated on the same 2D gel and the amount of protein in each group were then 
quantified according to the fluorescent intensity of the dyes labeled. Differentially 
expressed proteins were selected by a direct comparison of the fluorescent intensity of 
individual protein spots (Cy5/Cy2 vs. Cy3/Cy2) and identified by MALDI TOF/TOF 
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MS/MS. This method has greatly increased the reproducibility, data quality and 
confidence of 2-DE (Alban et al., 2003). Despite the maturity and unmatched 
performance of 2D-DIGE, this methodology is still compromised by some technical 
concerns, such as protein co-migration, because protein detection is based on the 
assumption that one protein is present in each spot. However, under stringent 
screening criteria based on the comparison of the theoretical with the experimental 
molecular weight and pI, unmatched proteins could be excluded afterwards.  
A number of proteomic approaches have been conducted recently in the search for 
potential protein targets of some commonly-used or potential cancer therapeutic 
agents, including a number of phytochemical compounds extracted from medicinal 
herb or vegetables, such as all-trans retinoic acid, the acid form of vitamin A (Harris et 
al., 2004; Wu et al., 2004), dibenzoylmethane from licorice (Frazier et al., 2004), 
flavone and quercetin from soy bean (Herzog et al., 2004a; Herzog et al., 2004b; 
Wenzel et al., 2004), paclitaxel from the bark of Taxus brevifolia (MacKeigan et al., 
2003), β-phenylethyl isothiocyanate from watercress (Neo et al., 2005), mushroom 
extract (Wang et al., 2004b) and grape seed extract (Deshane et al., 2004). All these 
studies provided a list of affected proteins, which allowed a comprehensive 
understanding of the induced effects after treatment by an individual agent.  
However, most of the above studies only used proteomic methods to identify the 
up-regulated or down-regulated proteins and validate some candidate proteins using 
reverse transcriptase-polymerase chain reaction (RT-PCR) and/or Western blotting 
without detailed characterization of the functional proteins. This approach simply 
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reflects a descriptive change in expression level rather than functional validation. The 
only exception was that of Ting and her colleagues, who confirmed the functional role 
of the affected proteins by applying exogenous expression or siRNA knocking-down 
experiment (MacKeigan et al., 2003). This study successfully revealed the power of 
integrating the proteomic profiling and functional analysis to discover novel 
therapeutic targets and potential cancer biomarkers.  
In therapeutics studies using proteomic approaches, for example, up-regulated 
and/or down-regulated proteins may not be the direct protein targets of the drug. 
However, this information is still informative because some affected proteins could be 
mediators, end-products or even by-products in a series of functional changes induced 
by the therapeutic agents. Based on this information, a follow-up functional analysis 
of the affected proteins and/or associated proteins may aid to disclose the real 
therapeutic targets and molecular pathways responsible for the observed effects. On 
the other hand, proteomic approaches may detect some proteins with known 
pharmacological and/or toxicological functions, but are unrelated with the known 
therapeutic effect. This information may reveal some novel properties of the 
therapeutic agents. On this basis, the descriptive nature of proteomic profiling could 
be very informative if it is integrated with further functional biochemical validation 
and characterization, as shown by the study conducted in Ting’s lab (MacKeigan et al., 
2003). In the present study, a similar approach that integrate 2D-DIGE proteomic 
profiling with functional cellular studies was conducted to better understand the 
anti-cancer effects of AE on HepG2 cells. In the present investigation, cellular 
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biochemical studies were firstly carried out to confirm the anti-cancer potential of AE, 
including inhibition of cell growth and induction of apoptosis. More importantly, it 
was also to determine the optimal dose and exposure time for subsequent studies.  
As shown in Fig. 2.1, AE induced higher cytotoxicity than its analogue EM, 
suggesting that AE had a higher potential in induction of apoptotic cell death and cell 
cycle arrest. This finding confirmed several earlier studies on Merkel cell carcinoma 
(Fenig et al., 2004), lung carcinoma CH27 (Lee, 2001), human oral squamous cell 
carcinoma (HSC-2) and salivary gland tumor (HSG) cell lines (Shi et al., 2001). It is 
also worth noting that AE also exhibited a higher cytotoxic effect against cancer cells 
than non-cancerous immortal cells (Fig. 2.2).  
2D-DIGE  successfully separated around 1600 proteins spots (Fig. 2.5) and 40 of 
these spots were either up- or down-regulated by more than 2-fold in the Cy5-labeled 
treated samples versus the Cy3-labeled control samples. These results were 
summarized in Table 2.2. These differentially-expressed proteins were found to be 
distributed mostly in cytoplasm, followed by in the mitochondria and nucleus, 
respectively. These affected proteins were functionally classified and found to be 
associated with oxidative stress, cell cycle arrest, anti-metastasis and anti-hepatitis 
(Fig. 2.7). For example, the redox-sensitive proteins formed the largest protein cluster 
upon AE treatment; suggesting AE’s effect in inducing oxidative stress. Among them, 
the antioxidant protein, peroxiredoxin was most highly up-regulated (Table 2.2). To 
assess whether these redox-sensitive proteins play a proapoptotic or anti-apoptotic role 
in AE-induced apoptosis, some of these redox-sensitive proteins and their associated 
   148
pathways were then investigated (Chapter 3). In addition, AE up-regulated p16 (Fig. 
3.5), a crucial CDK4 inhibitor responsible for 1/S cycle arrest. Although AE had been 
reported to affect the p21 pathway and in turn initiated G1/S arrest (Kuo et al., 2002; 
Pecere et al., 2003), its association with up-regulation of p16 and induction of G1/S 
arrest had never been reported before. Here, the up-regulation of p16 and the relevant 
pathway were also validated and characterized using a biochemical approach (Chapter 
4). It was also noted that in hepatoma cells, AE also increased the expression level of 
NDKA (Fig. 2.5). This protein is known to be a cancer metastasis inhibitor (Boissan 
and Lacombe, 2006). Its up-regulation suggested a novel potential anti-metastatic 
function of AE. To validate this potential functional role of NDKA up-regulation, 
biochemical assays for cell migration and invasion were conducted (see Chapter 4). 
Taken together, the 2D-DIGE proteomic analysis successfully provided some new 
candidate protein targets for the known anti-cancer effects of AE.  
Our results also revealed that EM, an analogue of AE, had a lower cytotoxicity 
(see Fig. 2.1) and affected a narrower spectrum of protein targets than AE in hepatoma 
cells (Table 2.5). In EM-treated cells, for example, the redox-sensitive proteins 
PARK7, PDIA3 and ACTG were the most highly up-regulated proteins, but their 
levels of differential expression were lower than that for AE (Table 2.5). On the other 
hand, acid form of cofilin was found to be down-regulated by EM but not AE (Fig. 2.5 
and Table 2.2), although the molecular mechanism is yet unknown. The decreased 
phosphorylation of cofilin may be a result of an inhibition of its up-stream kinase by 
EM, a well-reported kinase inhibitor (Huang et al., 2006a; Sarno et al., 2002).  
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It is worth noting that the above mentioned proteins have been functionally 
correlated with AE- or EM-induced anti-cancer effects, although the other 
differentially-expressed proteins may also play a role in the regulation of cell fate. 
Extensive experiments, such as exogenous gene over-expression or knock-down of the 
affected protein will aid to explore its functional role in AE treatment in HepG2 cells. 
Using pH range of 6-10 IPG strips in a future study may help to identify some other 
important basic proteins responsible for AE’s anti-cancer effects. For example, p53 
was reported to be associated with apoptosis induced by AE (Kuo et al., 2002; Pecere 
et al., 2003), but it was not identified in the present study. However, the 
2D-Western-blot analysis using the wide-range pH 3-10 IPG strips revealed the 
up-regulation of p53 upon AE treatment (data not shown). Similarly, other proteomic 
approaches such as HPLC-based fractionation of proteins/peptides may help to find 
some important hydrophobic and low abundant proteins (Alban et al., 2003; Gorg et 
al., 2004), which were not detected in the present gel-based experiment.  
5.2   Anticancer potential of AE: induction of apoptosis through ROS 
generation and ASK1/JNK pathway 
Redox radicals are found to be important signal transduction molecules involved 
in cell proliferation, senescence and apoptosis (necrosis). These actions are generally 
mediated by ROS through reversible or irreversible oxidative modification of key 
cellular macromolecules (DNA, protein and lipids). It has long been believed that 
redox radicals and oxidative stress are associated with cancer and other diseases 
(Jacobson et al., 1997; Kerr et al., 1972; Okada and Mak, 2004).  
   150
It seemed to be contradictory at first sight that ROS can both promote cell 
malignant transformation and kill cancer cells. But increasing evidence favors the idea 
that ROS exhibited such a ‘double-edged sword’ effect depending on its strength and 
duration. On the one hand, persistent oxidative stress was found in cancer cells 
(Toyokuni et al., 1995). This increased ROS generation has been proposed to be 
derived from mutations that occurred in nuclear or mitochondrial genes encoding the 
components of the mitochondrial electron transport chain (Wallace, 2005); and result 
in oncogenic transformation and higher proliferative potentials in these mutated cells 
as compared to their normal parental cells (Klaunig and Kamendulis, 2004; Loo, 
2003). Nuclear factor-κB (NF-κB) and AP-1 are the most important transcription 
factors reported to be affected by free redox radicals in these processes (Bubici et al., 
2006; Clive and Greene, 1996; Gloire et al., 2006; Loo, 2003).  
 On the other hand, when ROS generation reaches an intolerable level, suicidal or 
therapeutic pro-apoptotic pathways, such as the well-established redox-sensitive 
ASK1-JNK pathways, are ready to be activated (Benhar et al., 2002; Trachootham et 
al., 2006). The already elevated level of ROS thus makes cancer cells more vulnerable 
than normal cells comparatively. This assumption was mostly supported by a variety 
of cellular studies using cancer therapeutic drugs to induce senescence and/or 
apoptotic cell death in cancer cells (Dolado et al., 2007; Muller et al., 1998; Rosato et 
al., 2003; Takahashi et al., 2006). Taken together, a low level of ROS generation may 
help oncogenic transformation but a higher level of ROS makes cancer cells 
susceptible to the induced cell death and cell growth arrest. If this ‘double-edged 
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sword’ effect of ROS works under in vivo conditions in human, therapies could be 
developed accordingly through delicate modulation of redox balance: either to keep a 
relatively reducing environment in normal cells to protect oncogenic transformation, 
or to strengthen ROS generation beyond the tolerable limit to induce apoptotic cell 
death in vulnerable cancer cells.  
Interestingly, many phytochemicals with polyphenol structure (such as 
epigallocatechin gallate extracted from tea, resveratrol from grape and apigenin from 
soy bean) exhibit a dual-role in the production of radical species and subsequent 
oxidative stress (Loo, 2003). On the one hand, the phenolic structure enables 
phytochemicals to counteract the harmful oxidative injury induced by other strong 
oxidants (Shahidi and Wanasundara, 1992), whilst the therapeutic dose of phenolic 
phytochemicals can selectively induce oxidative stress in cancer cells (Loo, 2003). 
The option to be an antioxidant or oxidant for phenolic phytochemicals thus depends 
on the basal cellular oxidant/antioxidant level, the dose of phenolic chemicals, and 
other crucial factors.  
Similar to these phytochemicals, AE has been reported to be capable of reducing 
excessive ROS generation induced by other strong oxidants both in vitro and in vivo 
(Arosio et al., 2000; Malterud et al., 1993). In the present study, this compound was 
also found to up-regulate a cluster of redox-sensitive proteins (e.g. peroxiredoxin, 
DJ-1, PDIA3, etc.), as revealed in the 2D-DIGE study (Fig. 2.7). This finding 
suggested that AE, similar to other so-called “antioxidant” phytochemicals, can induce 
excessive ROS generation. Further biochemical validation using the ROS indicator 
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CM-H2DCFDA, and Western blotting, confirmed that AE can induce oxidative stress 
(Fig. 3.2) and in turn initiate ROS-dependent mitochondria-mediated intrinsic 
apoptotic cell death in hepatoma cells (Fig. 3.1).  
In the present study, higher level of apoptosis was induced in AE-treated cells 
compared with that of EM (Figs. 2.3 and 2.4). This action may be derived from AE’s 
potency in inducing a higher level of ROS production and sustained JNK activation. 
Aloe-EM treatment caused marked oxidative stress and depletion of intracellular 
glutathione (GSH) in hepatoma cells (Figs. 3.2 and 3.5). This redox-inducing action in 
turn caused deleterious protein oxidations (Figs. 3.3 and 3.4). It has been well 
established protein oxidations are essential for the regulation of apoptosis (Benhar et 
al., 2002; Trachootham et al., 2006).  
In this study, oxidation of protein peroxiredoxins, GST-π and Trx occurred upon 
AE treatment (Figs 3.4, 3.12 and 3.13). Peroxiredoxin functioned as antioxidant 
protein (Wood et al., 2003) and as shown in this study, knocking-down of this protein 
by siRNA sensitized AE-induced apoptosis (Fig. 3.4). In contrast, exogenous 
expression of antioxidant Cu/Zn-SOD or pretreatment of GSH donor (GSH-MEE) 
protected cells from excessive ROS generation and apoptosis (Figs. 3.5 and 3.9). On 
the other hand, redox-sensitive GST-π and Trx are inhibitory binding subunit of JNK 
and ASK1 (JNK upstream kinase) respectively (Adler et al., 1999; Saitoh et al., 1998). 
Oxidation of these two proteins activated JNK, and in turn initiated 
mitochondria-mediated apoptosis (Figs. 3.12 and 3.13). The essential pro-apoptotic 
role of sustained JNK activation was then validated by both pharmacological 
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inhibition and genetic over-expression of dominant negative JNK (Figs. 3.10 and 3.11). 
These results, which have not been reported hitherto, revealed that AE induced 
apoptosis via oxidative stress and constitutive JNK activation. This ROS-dependent 
action by AE is comparable to that of other phenolic phytochemicals, such as 
pathenolide, sulforaphane, diallyl disulfide, phenethyl isothiocyanate, curcumin and 
epigallocatechin-3-gallate (Collett and Campbell, 2004; Filomeni et al., 2003; Hu et 
al., 2003; Qanungo et al., 2005; Singh et al., 2005; Zhang et al., 2004a), thus 
suggesting a common ROS-dependent cell death pathway.  
In the present study the redox-sensitive MAPK p38 was found to be unaffected 
(Fig. 3.6), although AE has been shown to induce p38-invovled apoptosis in lung 
carcinoma cells (Yeh et al., 2003). This inconsistency might be due to different 
characteristics of the cell lines. On the other hand, MAPK ERK activation was 
generally believed to be pro-survival (Reddy et al., 2003; Torres, 2003). ERK 
inhibition was previously found to be accompanied with induction of differentiation 
and apoptosis after AE treatment in rat C6 glioma cells (Mijatovic et al., 2005a). In 
the present study, ERK was constitutively deactivated by AE (Fig. 3.6). However, the 
ERK inhibition was found to be ROS-independent and dispensable for apoptosis (Fig. 
3.9). The reason how AE inhibit ERK phosphorylation is yet to be determined. 
Considering that its analogue EM is an ERK inhibitor, AE may also exhibit direct 
inhibition on ERK or upstream kinases.  
Taken together, the results of this study have provided clear evidence that 
conventional “antioxidant” phytochemicals like AE can have therapeutic potential 
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through induction of oxidative stress and ROS-dependent apoptotic pathway. 
5.3  Biochemical validation of other affected proteins that involved in G1/S 
arrest and anti-migration effect 
Besides the redox-sensitive proteins which are responsible for the 
apoptosis-inducing effect, further biochemical validation and characterization of p16 
and NDKA established two novel anti-cancer properties of AE. It was found that AE 
induced cell growth inhibition via up-regulation of p16 and anti-metastasis via 
up-regulation of NDKA. These two effects have not been reported thus far, but were 
implicated by the result of 2D-DIGE (Fig. 2.7).  
The G1/S growth inhibition by AE was previously suggested to be initiated by 
activation of the p53-p21 pathway (Kuo et al., 2002; Pecere et al., 2003). The 
discovery of p16 by 2D-DIGE in the present study (Table 2.2), however, revealed 
another potential molecular pathway responsible for AE-induced G1/S cell cycle arrest. 
Further Western-blot validation confirmed its up-regulation and interference of 
downstream Rb-E2F molecular pathway (Fig 4.1). Tumor suppressor protein p16 is a 
CDK4 inhibitor. This protein functions in deactivating CDK4/6 and its downstream 
protein, Rb, and in turn represses DNA synthesis through G1 into S-phase of the cell 
cycle (Sherr, 2004). The role of the up-regulated p16 in G1/S arrest was confirmed in 
the present study, by blocking the Rb phosphorylation at the CDK4 specific site 
Ser795 (Fig 4.1). On the contrary, the induction of p21 has been generally believed to 
preferentially inhibit CDK2 but not CDK4 activity (Bartek and Lukas, 2001; Boulaire 
et al., 2000; Brugarolas et al., 1995; Poon et al., 1996). Thus, up-regulation of p16 by 
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AE, at least, partially accounted for the repression of DNA synthesis, although the 
present study can not exclude the involvement of other CDK inhibitors. More 
importantly, inhibition of this pathway happened early in the treatment after 6 hr, 
which may explain how AE inhibited cell growth at early stage before induction of 
apoptosis after 24 hr.  
On the other hand, up-regulation of the metastasis inhibitor NDKA by AE but not 
EM (Fig. 2.7) may enable the anti-metastatic effect of AE. Expressional level of 
NDKA was reported in most studies to be negatively associated with cancer metastatic 
potentials (Boissan and Lacombe, 2006; Nakayama et al., 1992; Ouatas et al., 2003; 
Steeg, 2003). Recently, the essential anti-metastatic role of NDKA was demonstrated 
by the increased lung metastasis in NDKA knockout mice of liver carcinogenesis 
(Boissan and Lacombe, 2006). Although the anti-metastatic effect of AE has never 
been reported before, its analogue EM was found to be capable of inhibiting cancer 
cell invasion (Huang et al., 2004), migration (Huang et al., 2005) and adhesion 
(Huang et al., 2006b). The finding of NDKA up-regulation by AE was confirmed by 
conventional Western blotting (Fig. 4.2). Furthermore, the anti-metastatic function of 
NDKA up-regulation was confirmed using the cell migration and invasion assay (Figs. 
4.3 and 4.4). AE treatment dose-dependently inhibited cell migration (delayed 
recovery of wound healing) and invasion stimulated by either FBS or EGF in 
hepatoma HepG2 cells and breast carcinoma MD-MBA-231 cells. 
The exact mechanisms of how AE up-regulates p16 and NDKA are still unknown. 
The present study could only provide a functional association between the 
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expressional regulation of these two proteins (p16 and NDKA) and the observed 
anti-cancer effects (G1/S arrest and anti-migration), respectively. Further experiments 
directed to the transcriptional regulation and/or protein turnover of these two proteins, 
are needed to obtain a better understanding of the mechanisms.  
 The proteome changes in EM-treated cells were also investigated in parallel with 
AE. The results suggested that EM induced fewer protein changes. Besides the 
redox-sensitive proteins, EM decreased significantly cofilin phosphorylated form as 
well as its dephosphorylated form (Fig. 4.5). Based on the literature, the 
down-regulation of the dephosphorylated form of cofilin by EM was probably 
associated with two different known functions: pro-apoptosis (Chua et al., 2003) or 
anti-metastasis (Ghosh et al., 2004; Wang et al., 2006b; Zebda et al., 2000). However, 
in the present study, EM is unlikely to initiate apoptosis through down-regulation of 
cofilin. This is because the level of active pro-apoptotic dephosphorylated form of 
cofilin was decreased rather than increased (Fig. 4.5B). More importantly there is no 
translocation of cofilin from cytosol to mitochondria in the process of apoptosis 
induction and cytochrome c translocation as reported previously (Chua et al., 2003). 
Instead, the anti-metastatic effect of EM was confirmed by the cell migration assay 
(Fig. 4.6). Thus, the decreased expression of cofilin may account for the 
anti-migration effect of EM. How EM inhibits the phosphorylation of cofilin is yet 
unknown. This action is possibly through inhibition of its up-stream kinase, LIMK by 
EM, a well-known kinase inhibitor. Similarly, AE also decreased the expression level 
of dephosphorylated cofilin but it did not affect its phosphorylated form. This again 
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reflects the difference between AE and EM in inhibiting protein kinases (see Chapter 
2). The decreased level of cofilin may be a possible reason for AE-induced 
anti-migration effect, although the mechanisms are yet to be determined.  
5.4 Summary and conclusions 
In the present study, the anti-cancer properties of AE have been systematically 
investigated by an integrated proteomics and biochemical approach. The investigation 
comprised of three main parts: (i) 2D-DIGE analysis of the proteome change in 
AE-treated HepG2 cells; (ii) biochemical validation and characterization of proteins 
associated with apoptosis; (iii) biochemical validation and characterization of other 
anti-cancer proteins. The major findings and the pathways involved are summarized in 
Fig. 5.1. One of the main findings is that AE induced apoptosis through oxidative 
stress (protein oxidation of peroxiredoxins, GST-π and Trx) and ASK1/JNK activation. 
Furthermore, the regulation of tumor suppressor p16 and metastasis suppressor NDKA 
induced by AE may account for the G1/S arrest and anti-metastatic effects, 
respectively.  
In summary, the findings from this study suggest that such an integrated approach 
has led to a better understanding of the anti-cancer effects of AE. The findings also 
demonstrated that AE exhibited potent anti-cancer properties through multiple 
molecular pathways.   




 Fig.5.1 Mechanisms involved in the anti-cancer effects of AE. 
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Anticancer effects of aloe-emodin on HepG2 cells: cellular and 
proteomic studies. 
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Abstract: Aloe-emodin (AE) is one of the main bioactive anthraquinones of Rheum 
palmatum, a widely used herbal medicine. Several recent studies suggested that AE 
possesses potent anticancer properties, although the mechanisms are yet to be fully 
elucidated. The present study aimed to identify the molecular targets of AE in a human 
hepatocellular carcinoma cell line, HepG2. We first found that AE was more cytotoxic 
and effective in inducing apoptosis and cell cycle arrest than its analog emodin (EM). 
Proteomic study using 2-D DIGE revealed that AE affected multiple proteins 
associated with oxidative stress, cell cycle arrest, antimetastasis, and hepatitis C virus 
replication. For example, peroxiredoxins (PRDX) and DJ-1, both of which are 
redox-sensitive proteins, were among those markedly up-regulated, suggesting the 
presence of oxidative stress in AE-treated cells. Further biochemical studies 
demonstrated that AE enhanced the intracellular level of reactive oxygen species and 
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oxidation of PRDX-2, -4, and DJ-1. In addition, AE inhibited DNA synthesis via 
up-regulation of the CDK4 inhibitor p16 and inhibition of Rb phosphorylation. 
Furthermore, AE was able to decrease cell migration via up-regulation of the 
metastasis inhibitor, nm23. Taken together, AE induced anticancer effects in HepG2 
cells via multiple pathways by affecting different protein targets. 
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Critical role of oxidative stress and sustained JNK activation in 
aloe-emodin-mediated apoptotic cell death in human hepatoma cells. 
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Abstract: Aloe-emodin (AE), one of the main bioactive anthraquinones of Rheum 
palmatum, possesses potent antitumor properties. Our previous proteomic study 
revealed that AE-induced apoptosis was associated with oxidative stress and oxidation 
of many redox-sensitive proteins. In this study, we aimed to further dissect the cell 
death-signaling pathways in AE-induced apoptosis. AE was found to cause redox 
imbalance and deplete the intracellular-reduced glutathione (GSH). Manipulation of 
the intracellular GSH with buthionine-L-sulfoximine (a GSH synthesis inhibitor) 
sensitized, and with glutathione monomethyl ester (a GSH donor) protected the 
AE-induced apoptosis, respectively. More importantly, AE treatment led to evident 
and sustained activation of c-Jun N-terminal kinase (JNK), an important 
stress-responsive mitogen-activated protein kinase (MAPK). Over-expression of 
antioxidant gene sod1 significantly reduced AE-induced JNK activation and cell death, 
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suggesting that oxidative stress-mediated JNK is the effector molecule in AE-induced 
apoptosis. Such a notion was clearly supported by subsequent studies in which JNK 
activation was inhibited by JNK inhibitor, JNK small interfering RNA knockdown or 
over-expression of dominant-negative JNK. In addition, we provided evidence 
demonstrating the critical role of apoptosis signal-regulating kinase 1, a 
well-established MAPK kinase kinase, in AE-induced JNK activation and apoptotic 
cell death. Finally, we showed that dissociation of inactive JNK–Glutathione 
S-transferase pi (GST-pi) complex was also involved in JNK activation through 
GST-pi oxidation. Taken together, these results suggest that AE-induced apoptotic cell 
death is mediated via oxidative stress and sustained JNK activation. 
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Anti-cancer properties of anthraquinones from Rhubarb.  
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Abstract: Rhubarb has been used as a traditional Chinese medicine since ancient 
times and today it is still present in various herbal preparations. In this review the 
toxicological and anti-neoplastic potentials of the main anthraquinones from Rhubarb, 
Rheum palmatum, will be highlighted. It is interesting to note that although the 
chemical structures of various anthraquinones in this plant are similar, their 
bioactivities are rather different. The most abundant anthraquinone of rhubarb, emodin, 
was capable of inhibiting cellular proliferation, induction of apoptosis, and prevention 
of metastasis. These capabilities are reported to act through tyrosine kinases, 
phosphoinositol 3-kinase (PI3K), protein kinase C (PKC), NF-kappa B (NF-kB), and 
mitogen-activated protein kinase (MAPK) signaling cascades. Aloe-emodin is another 
major component in rhubarb found to have anti-tumor properties. Its anti-proliferative 
property has been demonstrated to be through the p53 and its downstream p21 
pathway. Our recent proteomic study also suggests that the molecular targets of these 
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two anthraquinones are different. However, both components were found to be able 
to potentiate the anti-proliferation of various chemotherapeutic agents. Rhein is the 
other major rhubarb anthraquinone, although less well studied. This compound could 
effectively inhibit the uptake of glucose in tumor cells, caused changes in 
membrane-associated functions and led to cell death. Interestingly, all three major 
rhubarb anthraquinones were reported to have in vitro phototoxic. This re-evaluation 
of an old remedy suggests that several bioactive anthraquinones of rhubarb possess 
promising anti-cancer properties and could have a broad therapeutic potential. 
 
